Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:drug interaction'
(id=6838831 ; fe=en:drug interaction ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=74585.27001953125 creation date=2017-06-25 touchdate=2025-08-14 00:40:07.000)
≈ 780 relations sortantes

  1. en:drug interaction -- r_associated #0: 46 / 1 -> interaction
    n1=en:drug interaction | n2=interaction | rel=r_associated | relid=0 | w=46
  2. en:drug interaction -- r_associated #0: 43 / 0.935 -> en:absence of signs or symptoms
    n1=en:drug interaction | n2=en:absence of signs or symptoms | rel=r_associated | relid=0 | w=43
  3. en:drug interaction -- r_associated #0: 43 / 0.935 -> en:injection site hemorrhage
    n1=en:drug interaction | n2=en:injection site hemorrhage | rel=r_associated | relid=0 | w=43
  4. en:drug interaction -- r_associated #0: 43 / 0.935 -> en:medication error
    n1=en:drug interaction | n2=en:medication error | rel=r_associated | relid=0 | w=43
  5. en:drug interaction -- r_associated #0: 43 / 0.935 -> en:nucleic acid hybridization
    n1=en:drug interaction | n2=en:nucleic acid hybridization | rel=r_associated | relid=0 | w=43
  6. en:drug interaction -- r_associated #0: 42 / 0.913 -> en:fecal incontinence
    n1=en:drug interaction | n2=en:fecal incontinence | rel=r_associated | relid=0 | w=42
  7. en:drug interaction -- r_associated #0: 42 / 0.913 -> en:finding by site
    n1=en:drug interaction | n2=en:finding by site | rel=r_associated | relid=0 | w=42
  8. en:drug interaction -- r_associated #0: 42 / 0.913 -> interactions
    n1=en:drug interaction | n2=interactions | rel=r_associated | relid=0 | w=42
  9. en:drug interaction -- r_associated #0: 41 / 0.891 -> en:injection site cyst
    n1=en:drug interaction | n2=en:injection site cyst | rel=r_associated | relid=0 | w=41
  10. en:drug interaction -- r_associated #0: 41 / 0.891 -> en:prognosis/outlook finding
    n1=en:drug interaction | n2=en:prognosis/outlook finding | rel=r_associated | relid=0 | w=41
  11. en:drug interaction -- r_associated #0: 41 / 0.891 -> en:rna folding
    n1=en:drug interaction | n2=en:rna folding | rel=r_associated | relid=0 | w=41
  12. en:drug interaction -- r_associated #0: 40 / 0.87 -> en:food-drug interactions
    n1=en:drug interaction | n2=en:food-drug interactions | rel=r_associated | relid=0 | w=40
  13. en:drug interaction -- r_associated #0: 40 / 0.87 -> en:granuloma
    n1=en:drug interaction | n2=en:granuloma | rel=r_associated | relid=0 | w=40
  14. en:drug interaction -- r_associated #0: 40 / 0.87 -> en:substrate cycling
    n1=en:drug interaction | n2=en:substrate cycling | rel=r_associated | relid=0 | w=40
  15. en:drug interaction -- r_associated #0: 39 / 0.848 -> en:aphasia
    n1=en:drug interaction | n2=en:aphasia | rel=r_associated | relid=0 | w=39
  16. en:drug interaction -- r_associated #0: 39 / 0.848 -> en:drug chemical incompatibility
    n1=en:drug interaction | n2=en:drug chemical incompatibility | rel=r_associated | relid=0 | w=39
  17. en:drug interaction -- r_associated #0: 39 / 0.848 -> en:dyspnea
    n1=en:drug interaction | n2=en:dyspnea | rel=r_associated | relid=0 | w=39
  18. en:drug interaction -- r_associated #0: 39 / 0.848 -> en:hydrogenation
    n1=en:drug interaction | n2=en:hydrogenation | rel=r_associated | relid=0 | w=39
  19. en:drug interaction -- r_associated #0: 39 / 0.848 -> en:prodromal symptoms
    n1=en:drug interaction | n2=en:prodromal symptoms | rel=r_associated | relid=0 | w=39
  20. en:drug interaction -- r_associated #0: 39 / 0.848 -> en:unevaluable reaction
    n1=en:drug interaction | n2=en:unevaluable reaction | rel=r_associated | relid=0 | w=39
  21. en:drug interaction -- r_associated #0: 39 / 0.848 -> en:up-regulation (physiology)
    n1=en:drug interaction | n2=en:up-regulation (physiology) | rel=r_associated | relid=0 | w=39
  22. en:drug interaction -- r_associated #0: 38 / 0.826 -> en:biosynthetic pathways
    n1=en:drug interaction | n2=en:biosynthetic pathways | rel=r_associated | relid=0 | w=38
  23. en:drug interaction -- r_associated #0: 38 / 0.826 -> en:finding by method
    n1=en:drug interaction | n2=en:finding by method | rel=r_associated | relid=0 | w=38
  24. en:drug interaction -- r_associated #0: 37 / 0.804 -> en:additive drug interaction
    n1=en:drug interaction | n2=en:additive drug interaction | rel=r_associated | relid=0 | w=37
  25. en:drug interaction -- r_associated #0: 37 / 0.804 -> en:hyperlactemia
    n1=en:drug interaction | n2=en:hyperlactemia | rel=r_associated | relid=0 | w=37
  26. en:drug interaction -- r_associated #0: 37 / 0.804 -> en:infection
    n1=en:drug interaction | n2=en:infection | rel=r_associated | relid=0 | w=37
  27. en:drug interaction -- r_associated #0: 36 / 0.783 -> en:clinical history and observation findings
    n1=en:drug interaction | n2=en:clinical history and observation findings | rel=r_associated | relid=0 | w=36
  28. en:drug interaction -- r_associated #0: 36 / 0.783 -> en:gangrene
    n1=en:drug interaction | n2=en:gangrene | rel=r_associated | relid=0 | w=36
  29. en:drug interaction -- r_associated #0: 36 / 0.783 -> en:radiation damage
    n1=en:drug interaction | n2=en:radiation damage | rel=r_associated | relid=0 | w=36
  30. en:drug interaction -- r_associated #0: 36 / 0.783 -> en:unexpected therapeutic effect
    n1=en:drug interaction | n2=en:unexpected therapeutic effect | rel=r_associated | relid=0 | w=36
  31. en:drug interaction -- r_associated #0: 36 / 0.783 -> interactions médicamenteuses
    n1=en:drug interaction | n2=interactions médicamenteuses | rel=r_associated | relid=0 | w=36
  32. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:abnormal laboratory test result
    n1=en:drug interaction | n2=en:abnormal laboratory test result | rel=r_associated | relid=0 | w=35
  33. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:abnormal vision
    n1=en:drug interaction | n2=en:abnormal vision | rel=r_associated | relid=0 | w=35
  34. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:abscess
    n1=en:drug interaction | n2=en:abscess | rel=r_associated | relid=0 | w=35
  35. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:adverse reaction to drug
    n1=en:drug interaction | n2=en:adverse reaction to drug | rel=r_associated | relid=0 | w=35
  36. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:aerobiosis
    n1=en:drug interaction | n2=en:aerobiosis | rel=r_associated | relid=0 | w=35
  37. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:agnosia
    n1=en:drug interaction | n2=en:agnosia | rel=r_associated | relid=0 | w=35
  38. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:alkylation process
    n1=en:drug interaction | n2=en:alkylation process | rel=r_associated | relid=0 | w=35
  39. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:atrophy
    n1=en:drug interaction | n2=en:atrophy | rel=r_associated | relid=0 | w=35
  40. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:biocatalysis
    n1=en:drug interaction | n2=en:biocatalysis | rel=r_associated | relid=0 | w=35
  41. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:body odor
    n1=en:drug interaction | n2=en:body odor | rel=r_associated | relid=0 | w=35
  42. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:calculus finding
    n1=en:drug interaction | n2=en:calculus finding | rel=r_associated | relid=0 | w=35
  43. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:cellulitis
    n1=en:drug interaction | n2=en:cellulitis | rel=r_associated | relid=0 | w=35
  44. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:citric acid cycle
    n1=en:drug interaction | n2=en:citric acid cycle | rel=r_associated | relid=0 | w=35
  45. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:decreased tolerance
    n1=en:drug interaction | n2=en:decreased tolerance | rel=r_associated | relid=0 | w=35
  46. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:dna methylation
    n1=en:drug interaction | n2=en:dna methylation | rel=r_associated | relid=0 | w=35
  47. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:drug antagonism
    n1=en:drug interaction | n2=en:drug antagonism | rel=r_associated | relid=0 | w=35
  48. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:drug physiologic incompatibility
    n1=en:drug interaction | n2=en:drug physiologic incompatibility | rel=r_associated | relid=0 | w=35
  49. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:drug synergism
    n1=en:drug interaction | n2=en:drug synergism | rel=r_associated | relid=0 | w=35
  50. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:endocrine system signs and symptoms
    n1=en:drug interaction | n2=en:endocrine system signs and symptoms | rel=r_associated | relid=0 | w=35
  51. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:enzyme activation
    n1=en:drug interaction | n2=en:enzyme activation | rel=r_associated | relid=0 | w=35
  52. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:enzyme activity alteration
    n1=en:drug interaction | n2=en:enzyme activity alteration | rel=r_associated | relid=0 | w=35
  53. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:finding of measures of urine output
    n1=en:drug interaction | n2=en:finding of measures of urine output | rel=r_associated | relid=0 | w=35
  54. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:finding related to physiologic substance
    n1=en:drug interaction | n2=en:finding related to physiologic substance | rel=r_associated | relid=0 | w=35
  55. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:general pathology
    n1=en:drug interaction | n2=en:general pathology | rel=r_associated | relid=0 | w=35
  56. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:hangover from any alcohol or other drugs substance
    n1=en:drug interaction | n2=en:hangover from any alcohol or other drugs substance | rel=r_associated | relid=0 | w=35
  57. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:interaction
    n1=en:drug interaction | n2=en:interaction | rel=r_associated | relid=0 | w=35
  58. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:lipolysis
    n1=en:drug interaction | n2=en:lipolysis | rel=r_associated | relid=0 | w=35
  59. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:malaise
    n1=en:drug interaction | n2=en:malaise | rel=r_associated | relid=0 | w=35
  60. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:medication
    n1=en:drug interaction | n2=en:medication | rel=r_associated | relid=0 | w=35
  61. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:neoplasm
    n1=en:drug interaction | n2=en:neoplasm | rel=r_associated | relid=0 | w=35
  62. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:nervous system finding
    n1=en:drug interaction | n2=en:nervous system finding | rel=r_associated | relid=0 | w=35
  63. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:neurotoxin
    n1=en:drug interaction | n2=en:neurotoxin | rel=r_associated | relid=0 | w=35
  64. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:nucleic acid renaturation
    n1=en:drug interaction | n2=en:nucleic acid renaturation | rel=r_associated | relid=0 | w=35
  65. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:papular lesion
    n1=en:drug interaction | n2=en:papular lesion | rel=r_associated | relid=0 | w=35
  66. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:perinatal disorder
    n1=en:drug interaction | n2=en:perinatal disorder | rel=r_associated | relid=0 | w=35
  67. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:pharmacology and toxicology
    n1=en:drug interaction | n2=en:pharmacology and toxicology | rel=r_associated | relid=0 | w=35
  68. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:phase i detoxification
    n1=en:drug interaction | n2=en:phase i detoxification | rel=r_associated | relid=0 | w=35
  69. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:phototrophic processes
    n1=en:drug interaction | n2=en:phototrophic processes | rel=r_associated | relid=0 | w=35
  70. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:prenylation
    n1=en:drug interaction | n2=en:prenylation | rel=r_associated | relid=0 | w=35
  71. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:proteolysis
    n1=en:drug interaction | n2=en:proteolysis | rel=r_associated | relid=0 | w=35
  72. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:psychological inhibition
    n1=en:drug interaction | n2=en:psychological inhibition | rel=r_associated | relid=0 | w=35
  73. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:sign
    n1=en:drug interaction | n2=en:sign | rel=r_associated | relid=0 | w=35
  74. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:stiffness
    n1=en:drug interaction | n2=en:stiffness | rel=r_associated | relid=0 | w=35
  75. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:stutter
    n1=en:drug interaction | n2=en:stutter | rel=r_associated | relid=0 | w=35
  76. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:syncope
    n1=en:drug interaction | n2=en:syncope | rel=r_associated | relid=0 | w=35
  77. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:transport process
    n1=en:drug interaction | n2=en:transport process | rel=r_associated | relid=0 | w=35
  78. en:drug interaction -- r_associated #0: 35 / 0.761 -> en:tyramine reaction
    n1=en:drug interaction | n2=en:tyramine reaction | rel=r_associated | relid=0 | w=35
  79. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:administrative drug regulation
    n1=en:drug interaction | n2=en:administrative drug regulation | rel=r_associated | relid=0 | w=34
  80. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:adverse drug interaction
    n1=en:drug interaction | n2=en:adverse drug interaction | rel=r_associated | relid=0 | w=34
  81. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:altered hormone level (nos)
    n1=en:drug interaction | n2=en:altered hormone level (nos) | rel=r_associated | relid=0 | w=34
  82. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:amination
    n1=en:drug interaction | n2=en:amination | rel=r_associated | relid=0 | w=34
  83. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:anaerobiosis
    n1=en:drug interaction | n2=en:anaerobiosis | rel=r_associated | relid=0 | w=34
  84. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:cyst
    n1=en:drug interaction | n2=en:cyst | rel=r_associated | relid=0 | w=34
  85. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:cytoprotection
    n1=en:drug interaction | n2=en:cytoprotection | rel=r_associated | relid=0 | w=34
  86. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:disease or disorder
    n1=en:drug interaction | n2=en:disease or disorder | rel=r_associated | relid=0 | w=34
  87. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:dna maintenance process
    n1=en:drug interaction | n2=en:dna maintenance process | rel=r_associated | relid=0 | w=34
  88. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:dna replication
    n1=en:drug interaction | n2=en:dna replication | rel=r_associated | relid=0 | w=34
  89. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:drug action increased
    n1=en:drug interaction | n2=en:drug action increased | rel=r_associated | relid=0 | w=34
  90. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:drug by legal status
    n1=en:drug interaction | n2=en:drug by legal status | rel=r_associated | relid=0 | w=34
  91. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:drug-drug pharmacodynamic interaction
    n1=en:drug interaction | n2=en:drug-drug pharmacodynamic interaction | rel=r_associated | relid=0 | w=34
  92. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:drug-drug pharmacokinetic interaction
    n1=en:drug interaction | n2=en:drug-drug pharmacokinetic interaction | rel=r_associated | relid=0 | w=34
  93. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:dysarthria
    n1=en:drug interaction | n2=en:dysarthria | rel=r_associated | relid=0 | w=34
  94. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:esterification
    n1=en:drug interaction | n2=en:esterification | rel=r_associated | relid=0 | w=34
  95. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:ethnologic
    n1=en:drug interaction | n2=en:ethnologic | rel=r_associated | relid=0 | w=34
  96. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:fatigue
    n1=en:drug interaction | n2=en:fatigue | rel=r_associated | relid=0 | w=34
  97. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:finding of grade
    n1=en:drug interaction | n2=en:finding of grade | rel=r_associated | relid=0 | w=34
  98. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:finding reported by subject or history provider
    n1=en:drug interaction | n2=en:finding reported by subject or history provider | rel=r_associated | relid=0 | w=34
  99. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:flushing
    n1=en:drug interaction | n2=en:flushing | rel=r_associated | relid=0 | w=34
  100. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:halogenation
    n1=en:drug interaction | n2=en:halogenation | rel=r_associated | relid=0 | w=34
  101. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:herbal interaction
    n1=en:drug interaction | n2=en:herbal interaction | rel=r_associated | relid=0 | w=34
  102. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:injection site fibrosis
    n1=en:drug interaction | n2=en:injection site fibrosis | rel=r_associated | relid=0 | w=34
  103. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:injection site hypersensitivity
    n1=en:drug interaction | n2=en:injection site hypersensitivity | rel=r_associated | relid=0 | w=34
  104. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:injection site inflammation
    n1=en:drug interaction | n2=en:injection site inflammation | rel=r_associated | relid=0 | w=34
  105. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:intracellular signaling process
    n1=en:drug interaction | n2=en:intracellular signaling process | rel=r_associated | relid=0 | w=34
  106. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:jaundice
    n1=en:drug interaction | n2=en:jaundice | rel=r_associated | relid=0 | w=34
  107. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:labelled drug-drug interaction medication error
    n1=en:drug interaction | n2=en:labelled drug-drug interaction medication error | rel=r_associated | relid=0 | w=34
  108. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:lipid peroxidation
    n1=en:drug interaction | n2=en:lipid peroxidation | rel=r_associated | relid=0 | w=34
  109. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:lipogenesis
    n1=en:drug interaction | n2=en:lipogenesis | rel=r_associated | relid=0 | w=34
  110. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:neuroleptic malignant syndrome
    n1=en:drug interaction | n2=en:neuroleptic malignant syndrome | rel=r_associated | relid=0 | w=34
  111. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:pharmacokinetics
    n1=en:drug interaction | n2=en:pharmacokinetics | rel=r_associated | relid=0 | w=34
  112. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:physical chemical interaction
    n1=en:drug interaction | n2=en:physical chemical interaction | rel=r_associated | relid=0 | w=34
  113. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:protein folding
    n1=en:drug interaction | n2=en:protein folding | rel=r_associated | relid=0 | w=34
  114. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:sample exam - general pathol
    n1=en:drug interaction | n2=en:sample exam - general pathol | rel=r_associated | relid=0 | w=34
  115. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:sleep disorder
    n1=en:drug interaction | n2=en:sleep disorder | rel=r_associated | relid=0 | w=34
  116. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:toxicant interaction
    n1=en:drug interaction | n2=en:toxicant interaction | rel=r_associated | relid=0 | w=34
  117. en:drug interaction -- r_associated #0: 34 / 0.739 -> en:viral infection
    n1=en:drug interaction | n2=en:viral infection | rel=r_associated | relid=0 | w=34
  118. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:adverse event associated with death
    n1=en:drug interaction | n2=en:adverse event associated with death | rel=r_associated | relid=0 | w=32
  119. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:altered neurotransmitter level (nos)
    n1=en:drug interaction | n2=en:altered neurotransmitter level (nos) | rel=r_associated | relid=0 | w=32
  120. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:body weight
    n1=en:drug interaction | n2=en:body weight | rel=r_associated | relid=0 | w=32
  121. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:claudication
    n1=en:drug interaction | n2=en:claudication | rel=r_associated | relid=0 | w=32
  122. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:cyanosis
    n1=en:drug interaction | n2=en:cyanosis | rel=r_associated | relid=0 | w=32
  123. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:disorders, general, functional and nec
    n1=en:drug interaction | n2=en:disorders, general, functional and nec | rel=r_associated | relid=0 | w=32
  124. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:distance of tumor from anal verge unknown
    n1=en:drug interaction | n2=en:distance of tumor from anal verge unknown | rel=r_associated | relid=0 | w=32
  125. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:dna cleavage
    n1=en:drug interaction | n2=en:dna cleavage | rel=r_associated | relid=0 | w=32
  126. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:drug evaluation
    n1=en:drug interaction | n2=en:drug evaluation | rel=r_associated | relid=0 | w=32
  127. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:edema, generalized
    n1=en:drug interaction | n2=en:edema, generalized | rel=r_associated | relid=0 | w=32
  128. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:enophthalmos
    n1=en:drug interaction | n2=en:enophthalmos | rel=r_associated | relid=0 | w=32
  129. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:halitosis
    n1=en:drug interaction | n2=en:halitosis | rel=r_associated | relid=0 | w=32
  130. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:headache
    n1=en:drug interaction | n2=en:headache | rel=r_associated | relid=0 | w=32
  131. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:hematuria
    n1=en:drug interaction | n2=en:hematuria | rel=r_associated | relid=0 | w=32
  132. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:increased drug level
    n1=en:drug interaction | n2=en:increased drug level | rel=r_associated | relid=0 | w=32
  133. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:injection site abscess
    n1=en:drug interaction | n2=en:injection site abscess | rel=r_associated | relid=0 | w=32
  134. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:injection site necrosis
    n1=en:drug interaction | n2=en:injection site necrosis | rel=r_associated | relid=0 | w=32
  135. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:injection site reaction
    n1=en:drug interaction | n2=en:injection site reaction | rel=r_associated | relid=0 | w=32
  136. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:integumentary system signs and symptoms
    n1=en:drug interaction | n2=en:integumentary system signs and symptoms | rel=r_associated | relid=0 | w=32
  137. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:macromolecular sequence alteration process
    n1=en:drug interaction | n2=en:macromolecular sequence alteration process | rel=r_associated | relid=0 | w=32
  138. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:molecular marker activity
    n1=en:drug interaction | n2=en:molecular marker activity | rel=r_associated | relid=0 | w=32
  139. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:neuropharmacology and toxicology
    n1=en:drug interaction | n2=en:neuropharmacology and toxicology | rel=r_associated | relid=0 | w=32
  140. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:nucleic acid denaturation
    n1=en:drug interaction | n2=en:nucleic acid denaturation | rel=r_associated | relid=0 | w=32
  141. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:overdose
    n1=en:drug interaction | n2=en:overdose | rel=r_associated | relid=0 | w=32
  142. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:pain
    n1=en:drug interaction | n2=en:pain | rel=r_associated | relid=0 | w=32
  143. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:parasitic infection
    n1=en:drug interaction | n2=en:parasitic infection | rel=r_associated | relid=0 | w=32
  144. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:pesticide interaction
    n1=en:drug interaction | n2=en:pesticide interaction | rel=r_associated | relid=0 | w=32
  145. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:polydipsia
    n1=en:drug interaction | n2=en:polydipsia | rel=r_associated | relid=0 | w=32
  146. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:respiratory system signs and symptoms
    n1=en:drug interaction | n2=en:respiratory system signs and symptoms | rel=r_associated | relid=0 | w=32
  147. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:sclerosis
    n1=en:drug interaction | n2=en:sclerosis | rel=r_associated | relid=0 | w=32
  148. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:skin manifestations
    n1=en:drug interaction | n2=en:skin manifestations | rel=r_associated | relid=0 | w=32
  149. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:suicide attempt
    n1=en:drug interaction | n2=en:suicide attempt | rel=r_associated | relid=0 | w=32
  150. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:superinfection
    n1=en:drug interaction | n2=en:superinfection | rel=r_associated | relid=0 | w=32
  151. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:symptom
    n1=en:drug interaction | n2=en:symptom | rel=r_associated | relid=0 | w=32
  152. en:drug interaction -- r_associated #0: 32 / 0.696 -> en:tuberculosis aggravated
    n1=en:drug interaction | n2=en:tuberculosis aggravated | rel=r_associated | relid=0 | w=32
  153. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:acquired immunodeficiency syndrome
    n1=en:drug interaction | n2=en:acquired immunodeficiency syndrome | rel=r_associated | relid=0 | w=31
  154. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:administrative statuses
    n1=en:drug interaction | n2=en:administrative statuses | rel=r_associated | relid=0 | w=31
  155. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:agglutination
    n1=en:drug interaction | n2=en:agglutination | rel=r_associated | relid=0 | w=31
  156. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:allosteric regulation
    n1=en:drug interaction | n2=en:allosteric regulation | rel=r_associated | relid=0 | w=31
  157. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:aod abuse and dependence potential
    n1=en:drug interaction | n2=en:aod abuse and dependence potential | rel=r_associated | relid=0 | w=31
  158. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:binding, competitive
    n1=en:drug interaction | n2=en:binding, competitive | rel=r_associated | relid=0 | w=31
  159. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:body temperature changes
    n1=en:drug interaction | n2=en:body temperature changes | rel=r_associated | relid=0 | w=31
  160. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:candidiasis
    n1=en:drug interaction | n2=en:candidiasis | rel=r_associated | relid=0 | w=31
  161. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:deamination
    n1=en:drug interaction | n2=en:deamination | rel=r_associated | relid=0 | w=31
  162. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:decreased immunoglobulin
    n1=en:drug interaction | n2=en:decreased immunoglobulin | rel=r_associated | relid=0 | w=31
  163. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:drug inverse agonism
    n1=en:drug interaction | n2=en:drug inverse agonism | rel=r_associated | relid=0 | w=31
  164. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:drug-disease interaction
    n1=en:drug interaction | n2=en:drug-disease interaction | rel=r_associated | relid=0 | w=31
  165. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:edema
    n1=en:drug interaction | n2=en:edema | rel=r_associated | relid=0 | w=31
  166. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:energy transfer
    n1=en:drug interaction | n2=en:energy transfer | rel=r_associated | relid=0 | w=31
  167. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:feminization
    n1=en:drug interaction | n2=en:feminization | rel=r_associated | relid=0 | w=31
  168. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:fungal infection
    n1=en:drug interaction | n2=en:fungal infection | rel=r_associated | relid=0 | w=31
  169. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:general clinical state finding
    n1=en:drug interaction | n2=en:general clinical state finding | rel=r_associated | relid=0 | w=31
  170. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:hemorrhage
    n1=en:drug interaction | n2=en:hemorrhage | rel=r_associated | relid=0 | w=31
  171. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:hirsutism
    n1=en:drug interaction | n2=en:hirsutism | rel=r_associated | relid=0 | w=31
  172. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:hot flashes
    n1=en:drug interaction | n2=en:hot flashes | rel=r_associated | relid=0 | w=31
  173. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:hydroxylation
    n1=en:drug interaction | n2=en:hydroxylation | rel=r_associated | relid=0 | w=31
  174. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:hypoxia
    n1=en:drug interaction | n2=en:hypoxia | rel=r_associated | relid=0 | w=31
  175. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:loss of consciousness
    n1=en:drug interaction | n2=en:loss of consciousness | rel=r_associated | relid=0 | w=31
  176. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:low birth weight
    n1=en:drug interaction | n2=en:low birth weight | rel=r_associated | relid=0 | w=31
  177. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:malignant hyperthermia syndrome
    n1=en:drug interaction | n2=en:malignant hyperthermia syndrome | rel=r_associated | relid=0 | w=31
  178. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:metaplasia
    n1=en:drug interaction | n2=en:metaplasia | rel=r_associated | relid=0 | w=31
  179. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:molecular mimicry
    n1=en:drug interaction | n2=en:molecular mimicry | rel=r_associated | relid=0 | w=31
  180. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:mycobacterium tuberculosis infection reactivated
    n1=en:drug interaction | n2=en:mycobacterium tuberculosis infection reactivated | rel=r_associated | relid=0 | w=31
  181. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:pharmacodynamics
    n1=en:drug interaction | n2=en:pharmacodynamics | rel=r_associated | relid=0 | w=31
  182. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:pharmacokinetic interaction
    n1=en:drug interaction | n2=en:pharmacokinetic interaction | rel=r_associated | relid=0 | w=31
  183. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:potentiating drug interaction
    n1=en:drug interaction | n2=en:potentiating drug interaction | rel=r_associated | relid=0 | w=31
  184. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:pulmonary pharmacology and toxicology
    n1=en:drug interaction | n2=en:pulmonary pharmacology and toxicology | rel=r_associated | relid=0 | w=31
  185. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:rna cleavage
    n1=en:drug interaction | n2=en:rna cleavage | rel=r_associated | relid=0 | w=31
  186. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:sarcoma
    n1=en:drug interaction | n2=en:sarcoma | rel=r_associated | relid=0 | w=31
  187. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:splenomegaly
    n1=en:drug interaction | n2=en:splenomegaly | rel=r_associated | relid=0 | w=31
  188. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:swelling
    n1=en:drug interaction | n2=en:swelling | rel=r_associated | relid=0 | w=31
  189. en:drug interaction -- r_associated #0: 31 / 0.674 -> en:tachycardia
    n1=en:drug interaction | n2=en:tachycardia | rel=r_associated | relid=0 | w=31
  190. en:drug interaction -- r_associated #0: 30 / 0.652 -> anomalie congénitale
    n1=en:drug interaction | n2=anomalie congénitale | rel=r_associated | relid=0 | w=30
  191. en:drug interaction -- r_associated #0: 30 / 0.652 -> contre-indication
    n1=en:drug interaction | n2=contre-indication | rel=r_associated | relid=0 | w=30
  192. en:drug interaction -- r_associated #0: 30 / 0.652 -> dosage
    n1=en:drug interaction | n2=dosage | rel=r_associated | relid=0 | w=30
  193. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:apraxias
    n1=en:drug interaction | n2=en:apraxias | rel=r_associated | relid=0 | w=30
  194. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:carbohydrate metabolic process
    n1=en:drug interaction | n2=en:carbohydrate metabolic process | rel=r_associated | relid=0 | w=30
  195. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:congenital abnormality
    n1=en:drug interaction | n2=en:congenital abnormality | rel=r_associated | relid=0 | w=30
  196. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:decreased core body temperature
    n1=en:drug interaction | n2=en:decreased core body temperature | rel=r_associated | relid=0 | w=30
  197. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:decreased drug level
    n1=en:drug interaction | n2=en:decreased drug level | rel=r_associated | relid=0 | w=30
  198. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:digestive system signs and symptoms
    n1=en:drug interaction | n2=en:digestive system signs and symptoms | rel=r_associated | relid=0 | w=30
  199. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:dose-response relationship, drug
    n1=en:drug interaction | n2=en:dose-response relationship, drug | rel=r_associated | relid=0 | w=30
  200. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:drug effect disorder
    n1=en:drug interaction | n2=en:drug effect disorder | rel=r_associated | relid=0 | w=30
  201. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:drug purity
    n1=en:drug interaction | n2=en:drug purity | rel=r_associated | relid=0 | w=30
  202. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:ectromelia
    n1=en:drug interaction | n2=en:ectromelia | rel=r_associated | relid=0 | w=30
  203. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:eye manifestations
    n1=en:drug interaction | n2=en:eye manifestations | rel=r_associated | relid=0 | w=30
  204. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:finding of histologic grading differentiation and/or behavior
    n1=en:drug interaction | n2=en:finding of histologic grading differentiation and/or behavior | rel=r_associated | relid=0 | w=30
  205. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:glycosuria
    n1=en:drug interaction | n2=en:glycosuria | rel=r_associated | relid=0 | w=30
  206. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:hypertriglyceridemic waist
    n1=en:drug interaction | n2=en:hypertriglyceridemic waist | rel=r_associated | relid=0 | w=30
  207. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:hypertrophy
    n1=en:drug interaction | n2=en:hypertrophy | rel=r_associated | relid=0 | w=30
  208. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:hyperuricemia
    n1=en:drug interaction | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=30
  209. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:intermediary metabolic process
    n1=en:drug interaction | n2=en:intermediary metabolic process | rel=r_associated | relid=0 | w=30
  210. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:labelled drug-food interaction medication error
    n1=en:drug interaction | n2=en:labelled drug-food interaction medication error | rel=r_associated | relid=0 | w=30
  211. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:lipoylation
    n1=en:drug interaction | n2=en:lipoylation | rel=r_associated | relid=0 | w=30
  212. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:metabolic side effects of drugs and substances
    n1=en:drug interaction | n2=en:metabolic side effects of drugs and substances | rel=r_associated | relid=0 | w=30
  213. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:multiple drug use
    n1=en:drug interaction | n2=en:multiple drug use | rel=r_associated | relid=0 | w=30
  214. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:necrotic process
    n1=en:drug interaction | n2=en:necrotic process | rel=r_associated | relid=0 | w=30
  215. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:nitrosation
    n1=en:drug interaction | n2=en:nitrosation | rel=r_associated | relid=0 | w=30
  216. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:overdose accidental
    n1=en:drug interaction | n2=en:overdose accidental | rel=r_associated | relid=0 | w=30
  217. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:pathologic keratinization
    n1=en:drug interaction | n2=en:pathologic keratinization | rel=r_associated | relid=0 | w=30
  218. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:pharmacodynamic interaction
    n1=en:drug interaction | n2=en:pharmacodynamic interaction | rel=r_associated | relid=0 | w=30
  219. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:physiological aspects
    n1=en:drug interaction | n2=en:physiological aspects | rel=r_associated | relid=0 | w=30
  220. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:reaction aggravation
    n1=en:drug interaction | n2=en:reaction aggravation | rel=r_associated | relid=0 | w=30
  221. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:renal colic
    n1=en:drug interaction | n2=en:renal colic | rel=r_associated | relid=0 | w=30
  222. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:reticulocytosis
    n1=en:drug interaction | n2=en:reticulocytosis | rel=r_associated | relid=0 | w=30
  223. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:rna processing, post-transcriptional
    n1=en:drug interaction | n2=en:rna processing, post-transcriptional | rel=r_associated | relid=0 | w=30
  224. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:sepsis
    n1=en:drug interaction | n2=en:sepsis | rel=r_associated | relid=0 | w=30
  225. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:signs and symptoms, respiratory
    n1=en:drug interaction | n2=en:signs and symptoms, respiratory | rel=r_associated | relid=0 | w=30
  226. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:stimulation, chemical
    n1=en:drug interaction | n2=en:stimulation, chemical | rel=r_associated | relid=0 | w=30
  227. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:synergistic drug interaction
    n1=en:drug interaction | n2=en:synergistic drug interaction | rel=r_associated | relid=0 | w=30
  228. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:therapeutic and nontherapeutic effects (excl toxicity)
    n1=en:drug interaction | n2=en:therapeutic and nontherapeutic effects (excl toxicity) | rel=r_associated | relid=0 | w=30
  229. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:therapeutic and nontherapeutic responses
    n1=en:drug interaction | n2=en:therapeutic and nontherapeutic responses | rel=r_associated | relid=0 | w=30
  230. en:drug interaction -- r_associated #0: 30 / 0.652 -> en:transcription
    n1=en:drug interaction | n2=en:transcription | rel=r_associated | relid=0 | w=30
  231. en:drug interaction -- r_associated #0: 30 / 0.652 -> fièvre
    n1=en:drug interaction | n2=fièvre | rel=r_associated | relid=0 | w=30
  232. en:drug interaction -- r_associated #0: 30 / 0.652 -> fièvre
    (médecine)
    n1=en:drug interaction | n2=fièvre
    (médecine)
    | rel=r_associated | relid=0 | w=30
  233. en:drug interaction -- r_associated #0: 30 / 0.652 -> maladie du système immunitaire
    n1=en:drug interaction | n2=maladie du système immunitaire | rel=r_associated | relid=0 | w=30
  234. en:drug interaction -- r_associated #0: 30 / 0.652 -> overdose
    n1=en:drug interaction | n2=overdose | rel=r_associated | relid=0 | w=30
  235. en:drug interaction -- r_associated #0: 29 / 0.63 -> atrophie
    n1=en:drug interaction | n2=atrophie | rel=r_associated | relid=0 | w=29
  236. en:drug interaction -- r_associated #0: 29 / 0.63 -> clairance
    n1=en:drug interaction | n2=clairance | rel=r_associated | relid=0 | w=29
  237. en:drug interaction -- r_associated #0: 29 / 0.63 -> doser
    n1=en:drug interaction | n2=doser | rel=r_associated | relid=0 | w=29
  238. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:accidental injury
    n1=en:drug interaction | n2=en:accidental injury | rel=r_associated | relid=0 | w=29
  239. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:allergic reaction
    n1=en:drug interaction | n2=en:allergic reaction | rel=r_associated | relid=0 | w=29
  240. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:antagonistic drug interaction
    n1=en:drug interaction | n2=en:antagonistic drug interaction | rel=r_associated | relid=0 | w=29
  241. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:asthenia
    n1=en:drug interaction | n2=en:asthenia | rel=r_associated | relid=0 | w=29
  242. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:autotrophic processes
    n1=en:drug interaction | n2=en:autotrophic processes | rel=r_associated | relid=0 | w=29
  243. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:chemistry
    n1=en:drug interaction | n2=en:chemistry | rel=r_associated | relid=0 | w=29
  244. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:chromosome disorder
    n1=en:drug interaction | n2=en:chromosome disorder | rel=r_associated | relid=0 | w=29
  245. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:clinical stage finding
    n1=en:drug interaction | n2=en:clinical stage finding | rel=r_associated | relid=0 | w=29
  246. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:congenital or acquired anatomic abnormality
    n1=en:drug interaction | n2=en:congenital or acquired anatomic abnormality | rel=r_associated | relid=0 | w=29
  247. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:device interaction
    n1=en:drug interaction | n2=en:device interaction | rel=r_associated | relid=0 | w=29
  248. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:drug agonism
    n1=en:drug interaction | n2=en:drug agonism | rel=r_associated | relid=0 | w=29
  249. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:drug interaction with drug
    n1=en:drug interaction | n2=en:drug interaction with drug | rel=r_associated | relid=0 | w=29
  250. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:drug therapeutic incompatibility
    n1=en:drug interaction | n2=en:drug therapeutic incompatibility | rel=r_associated | relid=0 | w=29
  251. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:effect of exposure to physical force
    n1=en:drug interaction | n2=en:effect of exposure to physical force | rel=r_associated | relid=0 | w=29
  252. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:enuresis
    n1=en:drug interaction | n2=en:enuresis | rel=r_associated | relid=0 | w=29
  253. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:enzyme activity finding
    n1=en:drug interaction | n2=en:enzyme activity finding | rel=r_associated | relid=0 | w=29
  254. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:erythema
    n1=en:drug interaction | n2=en:erythema | rel=r_associated | relid=0 | w=29
  255. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:exophthalmos
    n1=en:drug interaction | n2=en:exophthalmos | rel=r_associated | relid=0 | w=29
  256. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:fever
    n1=en:drug interaction | n2=en:fever | rel=r_associated | relid=0 | w=29
  257. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:fever chills
    n1=en:drug interaction | n2=en:fever chills | rel=r_associated | relid=0 | w=29
  258. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:generic and proprietary drug
    n1=en:drug interaction | n2=en:generic and proprietary drug | rel=r_associated | relid=0 | w=29
  259. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:genitourinary signs and symptoms
    n1=en:drug interaction | n2=en:genitourinary signs and symptoms | rel=r_associated | relid=0 | w=29
  260. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:heart murmur
    n1=en:drug interaction | n2=en:heart murmur | rel=r_associated | relid=0 | w=29
  261. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:heat stroke
    n1=en:drug interaction | n2=en:heat stroke | rel=r_associated | relid=0 | w=29
  262. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:immune system disorder
    n1=en:drug interaction | n2=en:immune system disorder | rel=r_associated | relid=0 | w=29
  263. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:injection site mass
    n1=en:drug interaction | n2=en:injection site mass | rel=r_associated | relid=0 | w=29
  264. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:intentional trauma
    n1=en:drug interaction | n2=en:intentional trauma | rel=r_associated | relid=0 | w=29
  265. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:lack of drug action
    n1=en:drug interaction | n2=en:lack of drug action | rel=r_associated | relid=0 | w=29
  266. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:masked infection
    n1=en:drug interaction | n2=en:masked infection | rel=r_associated | relid=0 | w=29
  267. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:myocardial stunning
    n1=en:drug interaction | n2=en:myocardial stunning | rel=r_associated | relid=0 | w=29
  268. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:nitrogen cycle
    n1=en:drug interaction | n2=en:nitrogen cycle | rel=r_associated | relid=0 | w=29
  269. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:pathology examination findings indeterminate
    n1=en:drug interaction | n2=en:pathology examination findings indeterminate | rel=r_associated | relid=0 | w=29
  270. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:phosphorylation process
    n1=en:drug interaction | n2=en:phosphorylation process | rel=r_associated | relid=0 | w=29
  271. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:potentiation, drug
    n1=en:drug interaction | n2=en:potentiation, drug | rel=r_associated | relid=0 | w=29
  272. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:premature aging syndrome
    n1=en:drug interaction | n2=en:premature aging syndrome | rel=r_associated | relid=0 | w=29
  273. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:protein multimerization
    n1=en:drug interaction | n2=en:protein multimerization | rel=r_associated | relid=0 | w=29
  274. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:radiation interaction
    n1=en:drug interaction | n2=en:radiation interaction | rel=r_associated | relid=0 | w=29
  275. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:structured product labeling limitation of use terminology
    n1=en:drug interaction | n2=en:structured product labeling limitation of use terminology | rel=r_associated | relid=0 | w=29
  276. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:transcriptional repression
    n1=en:drug interaction | n2=en:transcriptional repression | rel=r_associated | relid=0 | w=29
  277. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:ulceration
    n1=en:drug interaction | n2=en:ulceration | rel=r_associated | relid=0 | w=29
  278. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:urinary incontinence
    n1=en:drug interaction | n2=en:urinary incontinence | rel=r_associated | relid=0 | w=29
  279. en:drug interaction -- r_associated #0: 29 / 0.63 -> en:withdrawal and rebound effects
    n1=en:drug interaction | n2=en:withdrawal and rebound effects | rel=r_associated | relid=0 | w=29
  280. en:drug interaction -- r_associated #0: 29 / 0.63 -> explication
    n1=en:drug interaction | n2=explication | rel=r_associated | relid=0 | w=29
  281. en:drug interaction -- r_associated #0: 29 / 0.63 -> pharmacothérapie
    n1=en:drug interaction | n2=pharmacothérapie | rel=r_associated | relid=0 | w=29
  282. en:drug interaction -- r_associated #0: 29 / 0.63 -> substrat
    n1=en:drug interaction | n2=substrat | rel=r_associated | relid=0 | w=29
  283. en:drug interaction -- r_associated #0: 28 / 0.609 -> aliments
    n1=en:drug interaction | n2=aliments | rel=r_associated | relid=0 | w=28
  284. en:drug interaction -- r_associated #0: 28 / 0.609 -> ciclosporine
    n1=en:drug interaction | n2=ciclosporine | rel=r_associated | relid=0 | w=28
  285. en:drug interaction -- r_associated #0: 28 / 0.609 -> effets indésirables
    n1=en:drug interaction | n2=effets indésirables | rel=r_associated | relid=0 | w=28
  286. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:adenoma
    n1=en:drug interaction | n2=en:adenoma | rel=r_associated | relid=0 | w=28
  287. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:adverse incident outcome categories
    n1=en:drug interaction | n2=en:adverse incident outcome categories | rel=r_associated | relid=0 | w=28
  288. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:alcohol interaction
    n1=en:drug interaction | n2=en:alcohol interaction | rel=r_associated | relid=0 | w=28
  289. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:aspects of radiation effects
    n1=en:drug interaction | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=28
  290. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:bacterial infection
    n1=en:drug interaction | n2=en:bacterial infection | rel=r_associated | relid=0 | w=28
  291. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:bacterial resistance
    n1=en:drug interaction | n2=en:bacterial resistance | rel=r_associated | relid=0 | w=28
  292. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:chemical exposure
    n1=en:drug interaction | n2=en:chemical exposure | rel=r_associated | relid=0 | w=28
  293. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:chromatin structural process
    n1=en:drug interaction | n2=en:chromatin structural process | rel=r_associated | relid=0 | w=28
  294. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:dealkylation
    n1=en:drug interaction | n2=en:dealkylation | rel=r_associated | relid=0 | w=28
  295. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:depression, chemical
    n1=en:drug interaction | n2=en:depression, chemical | rel=r_associated | relid=0 | w=28
  296. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:drug resistance process
    n1=en:drug interaction | n2=en:drug resistance process | rel=r_associated | relid=0 | w=28
  297. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:electron transport
    n1=en:drug interaction | n2=en:electron transport | rel=r_associated | relid=0 | w=28
  298. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:evaluation finding
    n1=en:drug interaction | n2=en:evaluation finding | rel=r_associated | relid=0 | w=28
  299. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:fetal finding
    n1=en:drug interaction | n2=en:fetal finding | rel=r_associated | relid=0 | w=28
  300. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:fever, sweat, and hot flashes
    n1=en:drug interaction | n2=en:fever, sweat, and hot flashes | rel=r_associated | relid=0 | w=28
  301. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:food interaction
    n1=en:drug interaction | n2=en:food interaction | rel=r_associated | relid=0 | w=28
  302. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:genetic aspects
    n1=en:drug interaction | n2=en:genetic aspects | rel=r_associated | relid=0 | w=28
  303. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:hiv positivity
    n1=en:drug interaction | n2=en:hiv positivity | rel=r_associated | relid=0 | w=28
  304. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:hypergammaglobulinemia
    n1=en:drug interaction | n2=en:hypergammaglobulinemia | rel=r_associated | relid=0 | w=28
  305. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:immunology aspects
    n1=en:drug interaction | n2=en:immunology aspects | rel=r_associated | relid=0 | w=28
  306. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:increased tolerance
    n1=en:drug interaction | n2=en:increased tolerance | rel=r_associated | relid=0 | w=28
  307. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:influenza
    n1=en:drug interaction | n2=en:influenza | rel=r_associated | relid=0 | w=28
  308. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:injection site atrophy
    n1=en:drug interaction | n2=en:injection site atrophy | rel=r_associated | relid=0 | w=28
  309. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:injection site edema
    n1=en:drug interaction | n2=en:injection site edema | rel=r_associated | relid=0 | w=28
  310. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:injection site granuloma
    n1=en:drug interaction | n2=en:injection site granuloma | rel=r_associated | relid=0 | w=28
  311. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:intentional drug overdose
    n1=en:drug interaction | n2=en:intentional drug overdose | rel=r_associated | relid=0 | w=28
  312. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:interaction with other medicinal products
    n1=en:drug interaction | n2=en:interaction with other medicinal products | rel=r_associated | relid=0 | w=28
  313. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:interference laboratory test
    n1=en:drug interaction | n2=en:interference laboratory test | rel=r_associated | relid=0 | w=28
  314. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:intermittent claudication
    n1=en:drug interaction | n2=en:intermittent claudication | rel=r_associated | relid=0 | w=28
  315. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:mental and behavioral signs and symptoms
    n1=en:drug interaction | n2=en:mental and behavioral signs and symptoms | rel=r_associated | relid=0 | w=28
  316. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:pharmacological phenomena
    n1=en:drug interaction | n2=en:pharmacological phenomena | rel=r_associated | relid=0 | w=28
  317. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:photosensitive dermatitis
    n1=en:drug interaction | n2=en:photosensitive dermatitis | rel=r_associated | relid=0 | w=28
  318. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:protein modification, translational
    n1=en:drug interaction | n2=en:protein modification, translational | rel=r_associated | relid=0 | w=28
  319. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:signal transduction
    n1=en:drug interaction | n2=en:signal transduction | rel=r_associated | relid=0 | w=28
  320. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:sudden death
    n1=en:drug interaction | n2=en:sudden death | rel=r_associated | relid=0 | w=28
  321. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:synergism
    n1=en:drug interaction | n2=en:synergism | rel=r_associated | relid=0 | w=28
  322. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:tobacco interaction
    n1=en:drug interaction | n2=en:tobacco interaction | rel=r_associated | relid=0 | w=28
  323. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:urological manifestations
    n1=en:drug interaction | n2=en:urological manifestations | rel=r_associated | relid=0 | w=28
  324. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:ventilation or perfusion signs and symptoms
    n1=en:drug interaction | n2=en:ventilation or perfusion signs and symptoms | rel=r_associated | relid=0 | w=28
  325. en:drug interaction -- r_associated #0: 28 / 0.609 -> en:wound finding
    n1=en:drug interaction | n2=en:wound finding | rel=r_associated | relid=0 | w=28
  326. en:drug interaction -- r_associated #0: 28 / 0.609 -> formule
    n1=en:drug interaction | n2=formule | rel=r_associated | relid=0 | w=28
  327. en:drug interaction -- r_associated #0: 28 / 0.609 -> médicament
    n1=en:drug interaction | n2=médicament | rel=r_associated | relid=0 | w=28
  328. en:drug interaction -- r_associated #0: 28 / 0.609 -> médoc
    (médicament)
    n1=en:drug interaction | n2=médoc
    (médicament)
    | rel=r_associated | relid=0 | w=28
  329. en:drug interaction -- r_associated #0: 28 / 0.609 -> patient
    n1=en:drug interaction | n2=patient | rel=r_associated | relid=0 | w=28
  330. en:drug interaction -- r_associated #0: 28 / 0.609 -> pharmacie
    (médicaments)
    n1=en:drug interaction | n2=pharmacie
    (médicaments)
    | rel=r_associated | relid=0 | w=28
  331. en:drug interaction -- r_associated #0: 28 / 0.609 -> potentialisation
    n1=en:drug interaction | n2=potentialisation | rel=r_associated | relid=0 | w=28
  332. en:drug interaction -- r_associated #0: 28 / 0.609 -> principe actif
    n1=en:drug interaction | n2=principe actif | rel=r_associated | relid=0 | w=28
  333. en:drug interaction -- r_associated #0: 28 / 0.609 -> rhabdomyolyse
    n1=en:drug interaction | n2=rhabdomyolyse | rel=r_associated | relid=0 | w=28
  334. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:abnormal virilization
    n1=en:drug interaction | n2=en:abnormal virilization | rel=r_associated | relid=0 | w=27
  335. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:cachexia
    n1=en:drug interaction | n2=en:cachexia | rel=r_associated | relid=0 | w=27
  336. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:carcinoma
    n1=en:drug interaction | n2=en:carcinoma | rel=r_associated | relid=0 | w=27
  337. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:cardiac output, high
    n1=en:drug interaction | n2=en:cardiac output, high | rel=r_associated | relid=0 | w=27
  338. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:decarboxylation
    n1=en:drug interaction | n2=en:decarboxylation | rel=r_associated | relid=0 | w=27
  339. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:disease of mucous membrane
    n1=en:drug interaction | n2=en:disease of mucous membrane | rel=r_associated | relid=0 | w=27
  340. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:dna repair
    n1=en:drug interaction | n2=en:dna repair | rel=r_associated | relid=0 | w=27
  341. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:drug tolerance
    n1=en:drug interaction | n2=en:drug tolerance | rel=r_associated | relid=0 | w=27
  342. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:fetal disorder
    n1=en:drug interaction | n2=en:fetal disorder | rel=r_associated | relid=0 | w=27
  343. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:fetal distress
    n1=en:drug interaction | n2=en:fetal distress | rel=r_associated | relid=0 | w=27
  344. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:hyperthermia
    n1=en:drug interaction | n2=en:hyperthermia | rel=r_associated | relid=0 | w=27
  345. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:hypothermia adverse event
    n1=en:drug interaction | n2=en:hypothermia adverse event | rel=r_associated | relid=0 | w=27
  346. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:interaction with illicit drug
    n1=en:drug interaction | n2=en:interaction with illicit drug | rel=r_associated | relid=0 | w=27
  347. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:low cardiac output
    n1=en:drug interaction | n2=en:low cardiac output | rel=r_associated | relid=0 | w=27
  348. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:mobility limitation
    n1=en:drug interaction | n2=en:mobility limitation | rel=r_associated | relid=0 | w=27
  349. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:motion sickness
    n1=en:drug interaction | n2=en:motion sickness | rel=r_associated | relid=0 | w=27
  350. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:multiple congenital anomalies
    n1=en:drug interaction | n2=en:multiple congenital anomalies | rel=r_associated | relid=0 | w=27
  351. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:neurologic manifestations
    n1=en:drug interaction | n2=en:neurologic manifestations | rel=r_associated | relid=0 | w=27
  352. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:neurological signs and symptoms
    n1=en:drug interaction | n2=en:neurological signs and symptoms | rel=r_associated | relid=0 | w=27
  353. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:oral manifestations
    n1=en:drug interaction | n2=en:oral manifestations | rel=r_associated | relid=0 | w=27
  354. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:osmosis
    n1=en:drug interaction | n2=en:osmosis | rel=r_associated | relid=0 | w=27
  355. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:pollutant interaction
    n1=en:drug interaction | n2=en:pollutant interaction | rel=r_associated | relid=0 | w=27
  356. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:pseudophakia
    n1=en:drug interaction | n2=en:pseudophakia | rel=r_associated | relid=0 | w=27
  357. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:seizure
    n1=en:drug interaction | n2=en:seizure | rel=r_associated | relid=0 | w=27
  358. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:spatial orientation of specimen unknown
    n1=en:drug interaction | n2=en:spatial orientation of specimen unknown | rel=r_associated | relid=0 | w=27
  359. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:sudden infant death syndrome
    n1=en:drug interaction | n2=en:sudden infant death syndrome | rel=r_associated | relid=0 | w=27
  360. en:drug interaction -- r_associated #0: 27 / 0.587 -> en:vertigo
    n1=en:drug interaction | n2=en:vertigo | rel=r_associated | relid=0 | w=27
  361. en:drug interaction -- r_associated #0: 27 / 0.587 -> inhibiteur
    n1=en:drug interaction | n2=inhibiteur | rel=r_associated | relid=0 | w=27
  362. en:drug interaction -- r_associated #0: 27 / 0.587 -> interaction médicamenteuse
    n1=en:drug interaction | n2=interaction médicamenteuse | rel=r_associated | relid=0 | w=27
  363. en:drug interaction -- r_associated #0: 27 / 0.587 -> médecine
    n1=en:drug interaction | n2=médecine | rel=r_associated | relid=0 | w=27
  364. en:drug interaction -- r_associated #0: 27 / 0.587 -> médicaments
    n1=en:drug interaction | n2=médicaments | rel=r_associated | relid=0 | w=27
  365. en:drug interaction -- r_associated #0: 27 / 0.587 -> perte de conscience
    n1=en:drug interaction | n2=perte de conscience | rel=r_associated | relid=0 | w=27
  366. en:drug interaction -- r_associated #0: 27 / 0.587 -> pharmacocinétique
    n1=en:drug interaction | n2=pharmacocinétique | rel=r_associated | relid=0 | w=27
  367. en:drug interaction -- r_associated #0: 27 / 0.587 -> posologie
    n1=en:drug interaction | n2=posologie | rel=r_associated | relid=0 | w=27
  368. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:acylation
    n1=en:drug interaction | n2=en:acylation | rel=r_associated | relid=0 | w=26
  369. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:ascites
    n1=en:drug interaction | n2=en:ascites | rel=r_associated | relid=0 | w=26
  370. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:benign finding
    n1=en:drug interaction | n2=en:benign finding | rel=r_associated | relid=0 | w=26
  371. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:biotinylation
    n1=en:drug interaction | n2=en:biotinylation | rel=r_associated | relid=0 | w=26
  372. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:cardiovascular system signs and symptoms
    n1=en:drug interaction | n2=en:cardiovascular system signs and symptoms | rel=r_associated | relid=0 | w=26
  373. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:chills
    n1=en:drug interaction | n2=en:chills | rel=r_associated | relid=0 | w=26
  374. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:cyclization
    n1=en:drug interaction | n2=en:cyclization | rel=r_associated | relid=0 | w=26
  375. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:dna modification process
    n1=en:drug interaction | n2=en:dna modification process | rel=r_associated | relid=0 | w=26
  376. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:fibrosis
    n1=en:drug interaction | n2=en:fibrosis | rel=r_associated | relid=0 | w=26
  377. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:gene expression process
    n1=en:drug interaction | n2=en:gene expression process | rel=r_associated | relid=0 | w=26
  378. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:herb-drug interactions
    n1=en:drug interaction | n2=en:herb-drug interactions | rel=r_associated | relid=0 | w=26
  379. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:hernia
    n1=en:drug interaction | n2=en:hernia | rel=r_associated | relid=0 | w=26
  380. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:heterotrophic processes
    n1=en:drug interaction | n2=en:heterotrophic processes | rel=r_associated | relid=0 | w=26
  381. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:hyperglycemia
    n1=en:drug interaction | n2=en:hyperglycemia | rel=r_associated | relid=0 | w=26
  382. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:hyperplasia
    n1=en:drug interaction | n2=en:hyperplasia | rel=r_associated | relid=0 | w=26
  383. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:increased immunoglobulin
    n1=en:drug interaction | n2=en:increased immunoglobulin | rel=r_associated | relid=0 | w=26
  384. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:inhibitory drug interaction
    n1=en:drug interaction | n2=en:inhibitory drug interaction | rel=r_associated | relid=0 | w=26
  385. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:injection site pain
    n1=en:drug interaction | n2=en:injection site pain | rel=r_associated | relid=0 | w=26
  386. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:labelled drug-disease interaction medication error
    n1=en:drug interaction | n2=en:labelled drug-disease interaction medication error | rel=r_associated | relid=0 | w=26
  387. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:metabolic process
    n1=en:drug interaction | n2=en:metabolic process | rel=r_associated | relid=0 | w=26
  388. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:no additional pathologic finding in tumor specimen
    n1=en:drug interaction | n2=en:no additional pathologic finding in tumor specimen | rel=r_associated | relid=0 | w=26
  389. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:pathology examination findings present
    n1=en:drug interaction | n2=en:pathology examination findings present | rel=r_associated | relid=0 | w=26
  390. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:pathophysiologic finding
    n1=en:drug interaction | n2=en:pathophysiologic finding | rel=r_associated | relid=0 | w=26
  391. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:pediatric failure to thrive
    n1=en:drug interaction | n2=en:pediatric failure to thrive | rel=r_associated | relid=0 | w=26
  392. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:peptide biosynthesis
    n1=en:drug interaction | n2=en:peptide biosynthesis | rel=r_associated | relid=0 | w=26
  393. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:pneumatosis
    n1=en:drug interaction | n2=en:pneumatosis | rel=r_associated | relid=0 | w=26
  394. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:post vaccination syndrome
    n1=en:drug interaction | n2=en:post vaccination syndrome | rel=r_associated | relid=0 | w=26
  395. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:protein binding
    n1=en:drug interaction | n2=en:protein binding | rel=r_associated | relid=0 | w=26
  396. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:protein carbonylation
    n1=en:drug interaction | n2=en:protein carbonylation | rel=r_associated | relid=0 | w=26
  397. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:proteinuria
    n1=en:drug interaction | n2=en:proteinuria | rel=r_associated | relid=0 | w=26
  398. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:reversal of disease phenotype
    n1=en:drug interaction | n2=en:reversal of disease phenotype | rel=r_associated | relid=0 | w=26
  399. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:shock
    n1=en:drug interaction | n2=en:shock | rel=r_associated | relid=0 | w=26
  400. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:structure-activity relationship
    n1=en:drug interaction | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=26
  401. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:tumor lysis syndrome adverse event
    n1=en:drug interaction | n2=en:tumor lysis syndrome adverse event | rel=r_associated | relid=0 | w=26
  402. en:drug interaction -- r_associated #0: 26 / 0.565 -> en:weakness
    n1=en:drug interaction | n2=en:weakness | rel=r_associated | relid=0 | w=26
  403. en:drug interaction -- r_associated #0: 26 / 0.565 -> pharmacie
    (science)
    n1=en:drug interaction | n2=pharmacie
    (science)
    | rel=r_associated | relid=0 | w=26
  404. en:drug interaction -- r_associated #0: 26 / 0.565 -> surdosage
    n1=en:drug interaction | n2=surdosage | rel=r_associated | relid=0 | w=26
  405. en:drug interaction -- r_associated #0: 25 / 0.543 -> composition
    n1=en:drug interaction | n2=composition | rel=r_associated | relid=0 | w=25
  406. en:drug interaction -- r_associated #0: 25 / 0.543 -> effet indésirable d'un médicament
    n1=en:drug interaction | n2=effet indésirable d'un médicament | rel=r_associated | relid=0 | w=25
  407. en:drug interaction -- r_associated #0: 25 / 0.543 -> en:drug
    n1=en:drug interaction | n2=en:drug | rel=r_associated | relid=0 | w=25
  408. en:drug interaction -- r_associated #0: 25 / 0.543 -> en:drug-drug interaction
    n1=en:drug interaction | n2=en:drug-drug interaction | rel=r_associated | relid=0 | w=25
  409. en:drug interaction -- r_associated #0: 25 / 0.543 -> iatrogène
    n1=en:drug interaction | n2=iatrogène | rel=r_associated | relid=0 | w=25
  410. en:drug interaction -- r_associated #0: 25 / 0.543 -> inducteur
    n1=en:drug interaction | n2=inducteur | rel=r_associated | relid=0 | w=25
  411. en:drug interaction -- r_associated #0: 25 / 0.543 -> métabolisme
    n1=en:drug interaction | n2=métabolisme | rel=r_associated | relid=0 | w=25
  412. en:drug interaction -- r_associated #0: 25 / 0.543 -> pharmacie
    n1=en:drug interaction | n2=pharmacie | rel=r_associated | relid=0 | w=25
  413. en:drug interaction -- r_associated #0: 25 / 0.543 -> pharmacien
    n1=en:drug interaction | n2=pharmacien | rel=r_associated | relid=0 | w=25
  414. en:drug interaction -- r_associated #0: 25 / 0.543 -> pharmacologie
    n1=en:drug interaction | n2=pharmacologie | rel=r_associated | relid=0 | w=25
  415. en:drug interaction -- r_associated #0: 24 / 0.522 -> perte de connaissance
    n1=en:drug interaction | n2=perte de connaissance | rel=r_associated | relid=0 | w=24
  416. en:drug interaction -- r_associated #0: 24 / 0.522 -> trouble du système immunitaire
    n1=en:drug interaction | n2=trouble du système immunitaire | rel=r_associated | relid=0 | w=24
  417. en:drug interaction -- r_associated #0: 23 / 0.5 -> effet secondaire
    n1=en:drug interaction | n2=effet secondaire | rel=r_associated | relid=0 | w=23
  418. en:drug interaction -- r_associated #0: 23 / 0.5 -> millepertuis
    n1=en:drug interaction | n2=millepertuis | rel=r_associated | relid=0 | w=23
  419. en:drug interaction -- r_associated #0: 23 / 0.5 -> physiologie
    n1=en:drug interaction | n2=physiologie | rel=r_associated | relid=0 | w=23
  420. en:drug interaction -- r_associated #0: 22 / 0.478 -> hyperthermie
    n1=en:drug interaction | n2=hyperthermie | rel=r_associated | relid=0 | w=22
  421. en:drug interaction -- r_associated #0: 22 / 0.478 -> infection bactérienne
    n1=en:drug interaction | n2=infection bactérienne | rel=r_associated | relid=0 | w=22
  422. en:drug interaction -- r_associated #0: 22 / 0.478 -> spécialité
    n1=en:drug interaction | n2=spécialité | rel=r_associated | relid=0 | w=22
  423. en:drug interaction -- r_associated #0: 21 / 0.457 -> bouffées de chaleur
    n1=en:drug interaction | n2=bouffées de chaleur | rel=r_associated | relid=0 | w=21
  424. en:drug interaction -- r_associated #0: 21 / 0.457 -> effet indésirable
    n1=en:drug interaction | n2=effet indésirable | rel=r_associated | relid=0 | w=21
  425. en:drug interaction -- r_associated #0: 21 / 0.457 -> intéraction
    n1=en:drug interaction | n2=intéraction | rel=r_associated | relid=0 | w=21
  426. en:drug interaction -- r_associated #0: 21 / 0.457 -> médicamenteuse
    n1=en:drug interaction | n2=médicamenteuse | rel=r_associated | relid=0 | w=21
  427. en:drug interaction -- r_associated #0: 21 / 0.457 -> mélange
    n1=en:drug interaction | n2=mélange | rel=r_associated | relid=0 | w=21
  428. en:drug interaction -- r_associated #0: 21 / 0.457 -> préparation pharmaceutique
    n1=en:drug interaction | n2=préparation pharmaceutique | rel=r_associated | relid=0 | w=21
  429. en:drug interaction -- r_associated #0: 21 / 0.457 -> trouble du système immun
    n1=en:drug interaction | n2=trouble du système immun | rel=r_associated | relid=0 | w=21
  430. en:drug interaction -- r_associated #0: 20 / 0.435 -> absence de croissance
    n1=en:drug interaction | n2=absence de croissance | rel=r_associated | relid=0 | w=20
  431. en:drug interaction -- r_associated #0: 20 / 0.435 -> adénome
    n1=en:drug interaction | n2=adénome | rel=r_associated | relid=0 | w=20
  432. en:drug interaction -- r_associated #0: 20 / 0.435 -> affections du système immunitaire
    n1=en:drug interaction | n2=affections du système immunitaire | rel=r_associated | relid=0 | w=20
  433. en:drug interaction -- r_associated #0: 20 / 0.435 -> agnosie
    n1=en:drug interaction | n2=agnosie | rel=r_associated | relid=0 | w=20
  434. en:drug interaction -- r_associated #0: 20 / 0.435 -> angl. NSE
    n1=en:drug interaction | n2=angl. NSE | rel=r_associated | relid=0 | w=20
  435. en:drug interaction -- r_associated #0: 20 / 0.435 -> anomalie chromosomique
    n1=en:drug interaction | n2=anomalie chromosomique | rel=r_associated | relid=0 | w=20
  436. en:drug interaction -- r_associated #0: 20 / 0.435 -> anomalie cytogénétique
    n1=en:drug interaction | n2=anomalie cytogénétique | rel=r_associated | relid=0 | w=20
  437. en:drug interaction -- r_associated #0: 20 / 0.435 -> anomalie du développement
    n1=en:drug interaction | n2=anomalie du développement | rel=r_associated | relid=0 | w=20
  438. en:drug interaction -- r_associated #0: 20 / 0.435 -> anormalité des chromosomes
    n1=en:drug interaction | n2=anormalité des chromosomes | rel=r_associated | relid=0 | w=20
  439. en:drug interaction -- r_associated #0: 20 / 0.435 -> anti-sida
    n1=en:drug interaction | n2=anti-sida | rel=r_associated | relid=0 | w=20
  440. en:drug interaction -- r_associated #0: 20 / 0.435 -> antisida
    n1=en:drug interaction | n2=antisida | rel=r_associated | relid=0 | w=20
  441. en:drug interaction -- r_associated #0: 20 / 0.435 -> asthénie
    n1=en:drug interaction | n2=asthénie | rel=r_associated | relid=0 | w=20
  442. en:drug interaction -- r_associated #0: 20 / 0.435 -> asthénie neuro-circulatoire
    n1=en:drug interaction | n2=asthénie neuro-circulatoire | rel=r_associated | relid=0 | w=20
  443. en:drug interaction -- r_associated #0: 20 / 0.435 -> asthénie neurocirculatoire
    n1=en:drug interaction | n2=asthénie neurocirculatoire | rel=r_associated | relid=0 | w=20
  444. en:drug interaction -- r_associated #0: 20 / 0.435 -> asthénie sénile
    n1=en:drug interaction | n2=asthénie sénile | rel=r_associated | relid=0 | w=20
  445. en:drug interaction -- r_associated #0: 20 / 0.435 -> au black
    n1=en:drug interaction | n2=au black | rel=r_associated | relid=0 | w=20
  446. en:drug interaction -- r_associated #0: 20 / 0.435 -> au noir
    n1=en:drug interaction | n2=au noir | rel=r_associated | relid=0 | w=20
  447. en:drug interaction -- r_associated #0: 20 / 0.435 -> bactériémie
    n1=en:drug interaction | n2=bactériémie | rel=r_associated | relid=0 | w=20
  448. en:drug interaction -- r_associated #0: 20 / 0.435 -> Bactériémie
    n1=en:drug interaction | n2=Bactériémie | rel=r_associated | relid=0 | w=20
  449. en:drug interaction -- r_associated #0: 20 / 0.435 -> bactériémie non précisée
    n1=en:drug interaction | n2=bactériémie non précisée | rel=r_associated | relid=0 | w=20
  450. en:drug interaction -- r_associated #0: 20 / 0.435 -> bactériémies
    n1=en:drug interaction | n2=bactériémies | rel=r_associated | relid=0 | w=20
  451. en:drug interaction -- r_associated #0: 20 / 0.435 -> battement rapide du coeur
    n1=en:drug interaction | n2=battement rapide du coeur | rel=r_associated | relid=0 | w=20
  452. en:drug interaction -- r_associated #0: 20 / 0.435 -> bégaye
    n1=en:drug interaction | n2=bégaye | rel=r_associated | relid=0 | w=20
  453. en:drug interaction -- r_associated #0: 20 / 0.435 -> black-blanc-beur
    n1=en:drug interaction | n2=black-blanc-beur | rel=r_associated | relid=0 | w=20
  454. en:drug interaction -- r_associated #0: 20 / 0.435 -> black-out
    n1=en:drug interaction | n2=black-out | rel=r_associated | relid=0 | w=20
  455. en:drug interaction -- r_associated #0: 20 / 0.435 -> bruits cardiaques
    n1=en:drug interaction | n2=bruits cardiaques | rel=r_associated | relid=0 | w=20
  456. en:drug interaction -- r_associated #0: 20 / 0.435 -> cancer épithélial
    n1=en:drug interaction | n2=cancer épithélial | rel=r_associated | relid=0 | w=20
  457. en:drug interaction -- r_associated #0: 20 / 0.435 -> carcinoma
    n1=en:drug interaction | n2=carcinoma | rel=r_associated | relid=0 | w=20
  458. en:drug interaction -- r_associated #0: 20 / 0.435 -> carcinome
    n1=en:drug interaction | n2=carcinome | rel=r_associated | relid=0 | w=20
  459. en:drug interaction -- r_associated #0: 20 / 0.435 -> carcinôme
    n1=en:drug interaction | n2=carcinôme | rel=r_associated | relid=0 | w=20
  460. en:drug interaction -- r_associated #0: 20 / 0.435 -> chlamydiose
    n1=en:drug interaction | n2=chlamydiose | rel=r_associated | relid=0 | w=20
  461. en:drug interaction -- r_associated #0: 20 / 0.435 -> choc cardiogène
    n1=en:drug interaction | n2=choc cardiogène | rel=r_associated | relid=0 | w=20
  462. en:drug interaction -- r_associated #0: 20 / 0.435 -> choc cardiogénique
    n1=en:drug interaction | n2=choc cardiogénique | rel=r_associated | relid=0 | w=20
  463. en:drug interaction -- r_associated #0: 20 / 0.435 -> choc compliquant ou consécutif à travail et accouchement
    n1=en:drug interaction | n2=choc compliquant ou consécutif à travail et accouchement | rel=r_associated | relid=0 | w=20
  464. en:drug interaction -- r_associated #0: 20 / 0.435 -> claudication
    n1=en:drug interaction | n2=claudication | rel=r_associated | relid=0 | w=20
  465. en:drug interaction -- r_associated #0: 20 / 0.435 -> coupure d'alimentation
    n1=en:drug interaction | n2=coupure d'alimentation | rel=r_associated | relid=0 | w=20
  466. en:drug interaction -- r_associated #0: 20 / 0.435 -> coupure d'électricité
    n1=en:drug interaction | n2=coupure d'électricité | rel=r_associated | relid=0 | w=20
  467. en:drug interaction -- r_associated #0: 20 / 0.435 -> coupure de courant
    n1=en:drug interaction | n2=coupure de courant | rel=r_associated | relid=0 | w=20
  468. en:drug interaction -- r_associated #0: 20 / 0.435 -> débilité sénile
    n1=en:drug interaction | n2=débilité sénile | rel=r_associated | relid=0 | w=20
  469. en:drug interaction -- r_associated #0: 20 / 0.435 -> déficience congénitale
    n1=en:drug interaction | n2=déficience congénitale | rel=r_associated | relid=0 | w=20
  470. en:drug interaction -- r_associated #0: 20 / 0.435 -> déformation congénitale
    n1=en:drug interaction | n2=déformation congénitale | rel=r_associated | relid=0 | w=20
  471. en:drug interaction -- r_associated #0: 20 / 0.435 -> démence (sémiologie)
    n1=en:drug interaction | n2=démence (sémiologie) | rel=r_associated | relid=0 | w=20
  472. en:drug interaction -- r_associated #0: 20 / 0.435 -> démence dégénérative primaire
    n1=en:drug interaction | n2=démence dégénérative primaire | rel=r_associated | relid=0 | w=20
  473. en:drug interaction -- r_associated #0: 20 / 0.435 -> démence forme dépressive ou délirante
    n1=en:drug interaction | n2=démence forme dépressive ou délirante | rel=r_associated | relid=0 | w=20
  474. en:drug interaction -- r_associated #0: 20 / 0.435 -> démence présénile
    n1=en:drug interaction | n2=démence présénile | rel=r_associated | relid=0 | w=20
  475. en:drug interaction -- r_associated #0: 20 / 0.435 -> démence sénile
    n1=en:drug interaction | n2=démence sénile | rel=r_associated | relid=0 | w=20
  476. en:drug interaction -- r_associated #0: 20 / 0.435 -> démence sénile avec delirium ou état confusionnel aigu
    n1=en:drug interaction | n2=démence sénile avec delirium ou état confusionnel aigu | rel=r_associated | relid=0 | w=20
  477. en:drug interaction -- r_associated #0: 20 / 0.435 -> des bouffées de chaleur
    n1=en:drug interaction | n2=des bouffées de chaleur | rel=r_associated | relid=0 | w=20
  478. en:drug interaction -- r_associated #0: 20 / 0.435 -> détresse foetale
    n1=en:drug interaction | n2=détresse foetale | rel=r_associated | relid=0 | w=20
  479. en:drug interaction -- r_associated #0: 20 / 0.435 -> difformité congénitale
    n1=en:drug interaction | n2=difformité congénitale | rel=r_associated | relid=0 | w=20
  480. en:drug interaction -- r_associated #0: 20 / 0.435 -> disease
    n1=en:drug interaction | n2=disease | rel=r_associated | relid=0 | w=20
  481. en:drug interaction -- r_associated #0: 20 / 0.435 -> disorder
    n1=en:drug interaction | n2=disorder | rel=r_associated | relid=0 | w=20
  482. en:drug interaction -- r_associated #0: 20 / 0.435 -> dose excessive
    n1=en:drug interaction | n2=dose excessive | rel=r_associated | relid=0 | w=20
  483. en:drug interaction -- r_associated #0: 20 / 0.435 -> dyspnée
    n1=en:drug interaction | n2=dyspnée | rel=r_associated | relid=0 | w=20
  484. en:drug interaction -- r_associated #0: 20 / 0.435 -> dyspnoee
    n1=en:drug interaction | n2=dyspnoee | rel=r_associated | relid=0 | w=20
  485. en:drug interaction -- r_associated #0: 20 / 0.435 -> ectromélie
    n1=en:drug interaction | n2=ectromélie | rel=r_associated | relid=0 | w=20
  486. en:drug interaction -- r_associated #0: 20 / 0.435 -> élévation de la température corporelle
    n1=en:drug interaction | n2=élévation de la température corporelle | rel=r_associated | relid=0 | w=20
  487. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:aconuresis
    n1=en:drug interaction | n2=en:aconuresis | rel=r_associated | relid=0 | w=20
  488. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:adenomata
    n1=en:drug interaction | n2=en:adenomata | rel=r_associated | relid=0 | w=20
  489. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:age-related physical debility
    n1=en:drug interaction | n2=en:age-related physical debility | rel=r_associated | relid=0 | w=20
  490. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:aids
    n1=en:drug interaction | n2=en:aids | rel=r_associated | relid=0 | w=20
  491. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:AIDS
    n1=en:drug interaction | n2=en:AIDS | rel=r_associated | relid=0 | w=20
  492. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:AIDS awareness
    n1=en:drug interaction | n2=en:AIDS awareness | rel=r_associated | relid=0 | w=20
  493. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:anti-AIDS
    n1=en:drug interaction | n2=en:anti-AIDS | rel=r_associated | relid=0 | w=20
  494. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:atrophia
    n1=en:drug interaction | n2=en:atrophia | rel=r_associated | relid=0 | w=20
  495. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:bacteraemia
    n1=en:drug interaction | n2=en:bacteraemia | rel=r_associated | relid=0 | w=20
  496. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:bacteremia
    n1=en:drug interaction | n2=en:bacteremia | rel=r_associated | relid=0 | w=20
  497. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:bacterial infections
    n1=en:drug interaction | n2=en:bacterial infections | rel=r_associated | relid=0 | w=20
  498. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:bactieremia
    n1=en:drug interaction | n2=en:bactieremia | rel=r_associated | relid=0 | w=20
  499. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:bad break
    n1=en:drug interaction | n2=en:bad break | rel=r_associated | relid=0 | w=20
  500. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:balance problem
    n1=en:drug interaction | n2=en:balance problem | rel=r_associated | relid=0 | w=20
  501. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:birth defect
    n1=en:drug interaction | n2=en:birth defect | rel=r_associated | relid=0 | w=20
  502. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:black-white-arab
    n1=en:drug interaction | n2=en:black-white-arab | rel=r_associated | relid=0 | w=20
  503. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:blackout
    n1=en:drug interaction | n2=en:blackout | rel=r_associated | relid=0 | w=20
  504. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:blackout - symptom
    n1=en:drug interaction | n2=en:blackout - symptom | rel=r_associated | relid=0 | w=20
  505. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:blood-poisoning
    n1=en:drug interaction | n2=en:blood-poisoning | rel=r_associated | relid=0 | w=20
  506. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:cardiac shock
    n1=en:drug interaction | n2=en:cardiac shock | rel=r_associated | relid=0 | w=20
  507. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:cardiogenic shock
    n1=en:drug interaction | n2=en:cardiogenic shock | rel=r_associated | relid=0 | w=20
  508. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:cardioneurosis
    n1=en:drug interaction | n2=en:cardioneurosis | rel=r_associated | relid=0 | w=20
  509. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:child's sudden death
    n1=en:drug interaction | n2=en:child's sudden death | rel=r_associated | relid=0 | w=20
  510. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:chlamydia infection
    n1=en:drug interaction | n2=en:chlamydia infection | rel=r_associated | relid=0 | w=20
  511. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:chlamydial infection
    n1=en:drug interaction | n2=en:chlamydial infection | rel=r_associated | relid=0 | w=20
  512. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:chromosomal aberration
    n1=en:drug interaction | n2=en:chromosomal aberration | rel=r_associated | relid=0 | w=20
  513. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:chromosomal abnormality
    n1=en:drug interaction | n2=en:chromosomal abnormality | rel=r_associated | relid=0 | w=20
  514. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:cognitive deficit in psychomotor function
    n1=en:drug interaction | n2=en:cognitive deficit in psychomotor function | rel=r_associated | relid=0 | w=20
  515. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:communications blackout
    n1=en:drug interaction | n2=en:communications blackout | rel=r_associated | relid=0 | w=20
  516. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:congenital anomaly
    n1=en:drug interaction | n2=en:congenital anomaly | rel=r_associated | relid=0 | w=20
  517. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:congenital defect
    n1=en:drug interaction | n2=en:congenital defect | rel=r_associated | relid=0 | w=20
  518. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:congenital malformation
    n1=en:drug interaction | n2=en:congenital malformation | rel=r_associated | relid=0 | w=20
  519. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:cot death
    n1=en:drug interaction | n2=en:cot death | rel=r_associated | relid=0 | w=20
  520. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:crib death
    n1=en:drug interaction | n2=en:crib death | rel=r_associated | relid=0 | w=20
  521. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:developmental anomaly
    n1=en:drug interaction | n2=en:developmental anomaly | rel=r_associated | relid=0 | w=20
  522. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:developmental fault
    n1=en:drug interaction | n2=en:developmental fault | rel=r_associated | relid=0 | w=20
  523. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:disease
    n1=en:drug interaction | n2=en:disease | rel=r_associated | relid=0 | w=20
  524. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:disease aids
    n1=en:drug interaction | n2=en:disease aids | rel=r_associated | relid=0 | w=20
  525. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:disorder
    n1=en:drug interaction | n2=en:disorder | rel=r_associated | relid=0 | w=20
  526. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:disorder of equilibrium
    n1=en:drug interaction | n2=en:disorder of equilibrium | rel=r_associated | relid=0 | w=20
  527. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:disturbance of equilibrium
    n1=en:drug interaction | n2=en:disturbance of equilibrium | rel=r_associated | relid=0 | w=20
  528. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:dizziness
    n1=en:drug interaction | n2=en:dizziness | rel=r_associated | relid=0 | w=20
  529. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:drug overdose
    n1=en:drug interaction | n2=en:drug overdose | rel=r_associated | relid=0 | w=20
  530. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:dyspnoea
    n1=en:drug interaction | n2=en:dyspnoea | rel=r_associated | relid=0 | w=20
  531. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:effort syndrome
    n1=en:drug interaction | n2=en:effort syndrome | rel=r_associated | relid=0 | w=20
  532. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:electricity cut
    n1=en:drug interaction | n2=en:electricity cut | rel=r_associated | relid=0 | w=20
  533. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:encopresis
    n1=en:drug interaction | n2=en:encopresis | rel=r_associated | relid=0 | w=20
  534. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:enlarged spleen
    n1=en:drug interaction | n2=en:enlarged spleen | rel=r_associated | relid=0 | w=20
  535. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:excessive thirst
    n1=en:drug interaction | n2=en:excessive thirst | rel=r_associated | relid=0 | w=20
  536. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:faecal incontinence
    n1=en:drug interaction | n2=en:faecal incontinence | rel=r_associated | relid=0 | w=20
  537. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:feebleness
    n1=en:drug interaction | n2=en:feebleness | rel=r_associated | relid=0 | w=20
  538. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:fervescence
    n1=en:drug interaction | n2=en:fervescence | rel=r_associated | relid=0 | w=20
  539. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:flu
    n1=en:drug interaction | n2=en:flu | rel=r_associated | relid=0 | w=20
  540. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:Flushing
    n1=en:drug interaction | n2=en:Flushing | rel=r_associated | relid=0 | w=20
  541. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:foetal distress
    n1=en:drug interaction | n2=en:foetal distress | rel=r_associated | relid=0 | w=20
  542. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:fungus disease
    n1=en:drug interaction | n2=en:fungus disease | rel=r_associated | relid=0 | w=20
  543. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:fungus infection
    n1=en:drug interaction | n2=en:fungus infection | rel=r_associated | relid=0 | w=20
  544. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:heat-stroke
    n1=en:drug interaction | n2=en:heat-stroke | rel=r_associated | relid=0 | w=20
  545. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:hot flushes
    n1=en:drug interaction | n2=en:hot flushes | rel=r_associated | relid=0 | w=20
  546. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:hypersplenism
    n1=en:drug interaction | n2=en:hypersplenism | rel=r_associated | relid=0 | w=20
  547. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:hyperthermy
    n1=en:drug interaction | n2=en:hyperthermy | rel=r_associated | relid=0 | w=20
  548. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:ichoremia
    n1=en:drug interaction | n2=en:ichoremia | rel=r_associated | relid=0 | w=20
  549. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:illicitly
    n1=en:drug interaction | n2=en:illicitly | rel=r_associated | relid=0 | w=20
  550. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:immune deficiency syndrome
    n1=en:drug interaction | n2=en:immune deficiency syndrome | rel=r_associated | relid=0 | w=20
  551. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:immune system diseases
    n1=en:drug interaction | n2=en:immune system diseases | rel=r_associated | relid=0 | w=20
  552. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:incontinentia urinae
    n1=en:drug interaction | n2=en:incontinentia urinae | rel=r_associated | relid=0 | w=20
  553. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:macies
    n1=en:drug interaction | n2=en:macies | rel=r_associated | relid=0 | w=20
  554. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:major physical defect
    n1=en:drug interaction | n2=en:major physical defect | rel=r_associated | relid=0 | w=20
  555. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:media blackout
    n1=en:drug interaction | n2=en:media blackout | rel=r_associated | relid=0 | w=20
  556. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:multiracial
    n1=en:drug interaction | n2=en:multiracial | rel=r_associated | relid=0 | w=20
  557. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:mycosis
    n1=en:drug interaction | n2=en:mycosis | rel=r_associated | relid=0 | w=20
  558. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:neonatal distress
    n1=en:drug interaction | n2=en:neonatal distress | rel=r_associated | relid=0 | w=20
  559. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:neurocirculatory astheny
    n1=en:drug interaction | n2=en:neurocirculatory astheny | rel=r_associated | relid=0 | w=20
  560. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:OD
    n1=en:drug interaction | n2=en:OD | rel=r_associated | relid=0 | w=20
  561. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:oedema
    n1=en:drug interaction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  562. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:off the books
    n1=en:drug interaction | n2=en:off the books | rel=r_associated | relid=0 | w=20
  563. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:oncoma
    n1=en:drug interaction | n2=en:oncoma | rel=r_associated | relid=0 | w=20
  564. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:oncosis
    n1=en:drug interaction | n2=en:oncosis | rel=r_associated | relid=0 | w=20
  565. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:orthostatic low blood pressure
    n1=en:drug interaction | n2=en:orthostatic low blood pressure | rel=r_associated | relid=0 | w=20
  566. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:overdosing
    n1=en:drug interaction | n2=en:overdosing | rel=r_associated | relid=0 | w=20
  567. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:physical defect
    n1=en:drug interaction | n2=en:physical defect | rel=r_associated | relid=0 | w=20
  568. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:power black out
    n1=en:drug interaction | n2=en:power black out | rel=r_associated | relid=0 | w=20
  569. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:power cut
    n1=en:drug interaction | n2=en:power cut | rel=r_associated | relid=0 | w=20
  570. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:power failure
    n1=en:drug interaction | n2=en:power failure | rel=r_associated | relid=0 | w=20
  571. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:power loss
    n1=en:drug interaction | n2=en:power loss | rel=r_associated | relid=0 | w=20
  572. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:power outage
    n1=en:drug interaction | n2=en:power outage | rel=r_associated | relid=0 | w=20
  573. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:presenile dementia
    n1=en:drug interaction | n2=en:presenile dementia | rel=r_associated | relid=0 | w=20
  574. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:problem with balance
    n1=en:drug interaction | n2=en:problem with balance | rel=r_associated | relid=0 | w=20
  575. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:proptosis
    n1=en:drug interaction | n2=en:proptosis | rel=r_associated | relid=0 | w=20
  576. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:protopsis
    n1=en:drug interaction | n2=en:protopsis | rel=r_associated | relid=0 | w=20
  577. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:rotary vertigo
    n1=en:drug interaction | n2=en:rotary vertigo | rel=r_associated | relid=0 | w=20
  578. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:senile asthenia
    n1=en:drug interaction | n2=en:senile asthenia | rel=r_associated | relid=0 | w=20
  579. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:senile dementia
    n1=en:drug interaction | n2=en:senile dementia | rel=r_associated | relid=0 | w=20
  580. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:senility
    n1=en:drug interaction | n2=en:senility | rel=r_associated | relid=0 | w=20
  581. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:septic infection
    n1=en:drug interaction | n2=en:septic infection | rel=r_associated | relid=0 | w=20
  582. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:septicaema
    n1=en:drug interaction | n2=en:septicaema | rel=r_associated | relid=0 | w=20
  583. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:septicaemia
    n1=en:drug interaction | n2=en:septicaemia | rel=r_associated | relid=0 | w=20
  584. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:septicemia
    n1=en:drug interaction | n2=en:septicemia | rel=r_associated | relid=0 | w=20
  585. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:severe neonatal distress
    n1=en:drug interaction | n2=en:severe neonatal distress | rel=r_associated | relid=0 | w=20
  586. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:side effects of drug
    n1=en:drug interaction | n2=en:side effects of drug | rel=r_associated | relid=0 | w=20
  587. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:sids
    n1=en:drug interaction | n2=en:sids | rel=r_associated | relid=0 | w=20
  588. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:SIDS
    n1=en:drug interaction | n2=en:SIDS | rel=r_associated | relid=0 | w=20
  589. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:synchopexia
    n1=en:drug interaction | n2=en:synchopexia | rel=r_associated | relid=0 | w=20
  590. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:systemic infection
    n1=en:drug interaction | n2=en:systemic infection | rel=r_associated | relid=0 | w=20
  591. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:tachyrhythmia
    n1=en:drug interaction | n2=en:tachyrhythmia | rel=r_associated | relid=0 | w=20
  592. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:tachysystole
    n1=en:drug interaction | n2=en:tachysystole | rel=r_associated | relid=0 | w=20
  593. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:tendinitis
    n1=en:drug interaction | n2=en:tendinitis | rel=r_associated | relid=0 | w=20
  594. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:tendinosis
    n1=en:drug interaction | n2=en:tendinosis | rel=r_associated | relid=0 | w=20
  595. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:teratosis
    n1=en:drug interaction | n2=en:teratosis | rel=r_associated | relid=0 | w=20
  596. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:unintentional voiding of urine
    n1=en:drug interaction | n2=en:unintentional voiding of urine | rel=r_associated | relid=0 | w=20
  597. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:unspecified senile psychotic condition
    n1=en:drug interaction | n2=en:unspecified senile psychotic condition | rel=r_associated | relid=0 | w=20
  598. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:uracratia
    n1=en:drug interaction | n2=en:uracratia | rel=r_associated | relid=0 | w=20
  599. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:viremia
    n1=en:drug interaction | n2=en:viremia | rel=r_associated | relid=0 | w=20
  600. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:virose
    n1=en:drug interaction | n2=en:virose | rel=r_associated | relid=0 | w=20
  601. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:virosis
    n1=en:drug interaction | n2=en:virosis | rel=r_associated | relid=0 | w=20
  602. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:water thesaurismosis
    n1=en:drug interaction | n2=en:water thesaurismosis | rel=r_associated | relid=0 | w=20
  603. en:drug interaction -- r_associated #0: 20 / 0.435 -> en:yeast infection
    n1=en:drug interaction | n2=en:yeast infection | rel=r_associated | relid=0 | w=20
  604. en:drug interaction -- r_associated #0: 20 / 0.435 -> encoprésie
    n1=en:drug interaction | n2=encoprésie | rel=r_associated | relid=0 | w=20
  605. en:drug interaction -- r_associated #0: 20 / 0.435 -> enflé
    n1=en:drug interaction | n2=enflé | rel=r_associated | relid=0 | w=20
  606. en:drug interaction -- r_associated #0: 20 / 0.435 -> énophtalmie
    n1=en:drug interaction | n2=énophtalmie | rel=r_associated | relid=0 | w=20
  607. en:drug interaction -- r_associated #0: 20 / 0.435 -> énurésie
    n1=en:drug interaction | n2=énurésie | rel=r_associated | relid=0 | w=20
  608. en:drug interaction -- r_associated #0: 20 / 0.435 -> erreur de médication
    n1=en:drug interaction | n2=erreur de médication | rel=r_associated | relid=0 | w=20
  609. en:drug interaction -- r_associated #0: 20 / 0.435 -> erythema
    n1=en:drug interaction | n2=erythema | rel=r_associated | relid=0 | w=20
  610. en:drug interaction -- r_associated #0: 20 / 0.435 -> érythème
    n1=en:drug interaction | n2=érythème | rel=r_associated | relid=0 | w=20
  611. en:drug interaction -- r_associated #0: 20 / 0.435 -> État infectieux
    n1=en:drug interaction | n2=État infectieux | rel=r_associated | relid=0 | w=20
  612. en:drug interaction -- r_associated #0: 20 / 0.435 -> état nébuleux
    n1=en:drug interaction | n2=état nébuleux | rel=r_associated | relid=0 | w=20
  613. en:drug interaction -- r_associated #0: 20 / 0.435 -> état septique
    n1=en:drug interaction | n2=état septique | rel=r_associated | relid=0 | w=20
  614. en:drug interaction -- r_associated #0: 20 / 0.435 -> État septique
    n1=en:drug interaction | n2=État septique | rel=r_associated | relid=0 | w=20
  615. en:drug interaction -- r_associated #0: 20 / 0.435 -> état vertigineux
    n1=en:drug interaction | n2=état vertigineux | rel=r_associated | relid=0 | w=20
  616. en:drug interaction -- r_associated #0: 20 / 0.435 -> ethnologique
    n1=en:drug interaction | n2=ethnologique | rel=r_associated | relid=0 | w=20
  617. en:drug interaction -- r_associated #0: 20 / 0.435 -> étourdissement
    n1=en:drug interaction | n2=étourdissement | rel=r_associated | relid=0 | w=20
  618. en:drug interaction -- r_associated #0: 20 / 0.435 -> exophtalmie
    n1=en:drug interaction | n2=exophtalmie | rel=r_associated | relid=0 | w=20
  619. en:drug interaction -- r_associated #0: 20 / 0.435 -> exophthalmie
    n1=en:drug interaction | n2=exophthalmie | rel=r_associated | relid=0 | w=20
  620. en:drug interaction -- r_associated #0: 20 / 0.435 -> fever
    n1=en:drug interaction | n2=fever | rel=r_associated | relid=0 | w=20
  621. en:drug interaction -- r_associated #0: 20 / 0.435 -> flu
    n1=en:drug interaction | n2=flu | rel=r_associated | relid=0 | w=20
  622. en:drug interaction -- r_associated #0: 20 / 0.435 -> fréquence cardiaque élevée
    n1=en:drug interaction | n2=fréquence cardiaque élevée | rel=r_associated | relid=0 | w=20
  623. en:drug interaction -- r_associated #0: 20 / 0.435 -> gêne respiratoire
    n1=en:drug interaction | n2=gêne respiratoire | rel=r_associated | relid=0 | w=20
  624. en:drug interaction -- r_associated #0: 20 / 0.435 -> gonflement
    n1=en:drug interaction | n2=gonflement | rel=r_associated | relid=0 | w=20
  625. en:drug interaction -- r_associated #0: 20 / 0.435 -> granulome inflammatoire
    n1=en:drug interaction | n2=granulome inflammatoire | rel=r_associated | relid=0 | w=20
  626. en:drug interaction -- r_associated #0: 20 / 0.435 -> halitose
    n1=en:drug interaction | n2=halitose | rel=r_associated | relid=0 | w=20
  627. en:drug interaction -- r_associated #0: 20 / 0.435 -> hæmorrhagie
    n1=en:drug interaction | n2=hæmorrhagie | rel=r_associated | relid=0 | w=20
  628. en:drug interaction -- r_associated #0: 20 / 0.435 -> hématurie
    n1=en:drug interaction | n2=hématurie | rel=r_associated | relid=0 | w=20
  629. en:drug interaction -- r_associated #0: 20 / 0.435 -> hématurie macroscopique
    n1=en:drug interaction | n2=hématurie macroscopique | rel=r_associated | relid=0 | w=20
  630. en:drug interaction -- r_associated #0: 20 / 0.435 -> hémorragie
    n1=en:drug interaction | n2=hémorragie | rel=r_associated | relid=0 | w=20
  631. en:drug interaction -- r_associated #0: 20 / 0.435 -> hemorragie
    n1=en:drug interaction | n2=hemorragie | rel=r_associated | relid=0 | w=20
  632. en:drug interaction -- r_associated #0: 20 / 0.435 -> hémorragie au point d'injection
    n1=en:drug interaction | n2=hémorragie au point d'injection | rel=r_associated | relid=0 | w=20
  633. en:drug interaction -- r_associated #0: 20 / 0.435 -> hémorragie d'un point d'injection
    n1=en:drug interaction | n2=hémorragie d'un point d'injection | rel=r_associated | relid=0 | w=20
  634. en:drug interaction -- r_associated #0: 20 / 0.435 -> hémorrhagie
    n1=en:drug interaction | n2=hémorrhagie | rel=r_associated | relid=0 | w=20
  635. en:drug interaction -- r_associated #0: 20 / 0.435 -> hypersplénisme
    n1=en:drug interaction | n2=hypersplénisme | rel=r_associated | relid=0 | w=20
  636. en:drug interaction -- r_associated #0: 20 / 0.435 -> hypotension orthostatique
    n1=en:drug interaction | n2=hypotension orthostatique | rel=r_associated | relid=0 | w=20
  637. en:drug interaction -- r_associated #0: 20 / 0.435 -> hypotension orthostatique neurogène
    n1=en:drug interaction | n2=hypotension orthostatique neurogène | rel=r_associated | relid=0 | w=20
  638. en:drug interaction -- r_associated #0: 20 / 0.435 -> illicitement
    n1=en:drug interaction | n2=illicitement | rel=r_associated | relid=0 | w=20
  639. en:drug interaction -- r_associated #0: 20 / 0.435 -> immunopathies
    n1=en:drug interaction | n2=immunopathies | rel=r_associated | relid=0 | w=20
  640. en:drug interaction -- r_associated #0: 20 / 0.435 -> incontinence d'urine
    n1=en:drug interaction | n2=incontinence d'urine | rel=r_associated | relid=0 | w=20
  641. en:drug interaction -- r_associated #0: 20 / 0.435 -> incontinence fécale
    n1=en:drug interaction | n2=incontinence fécale | rel=r_associated | relid=0 | w=20
  642. en:drug interaction -- r_associated #0: 20 / 0.435 -> incontinence paradoxale
    n1=en:drug interaction | n2=incontinence paradoxale | rel=r_associated | relid=0 | w=20
  643. en:drug interaction -- r_associated #0: 20 / 0.435 -> incontinence urinaire
    n1=en:drug interaction | n2=incontinence urinaire | rel=r_associated | relid=0 | w=20
  644. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection à Chlamydia
    n1=en:drug interaction | n2=infection à Chlamydia | rel=r_associated | relid=0 | w=20
  645. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection à chlamydia
    n1=en:drug interaction | n2=infection à chlamydia | rel=r_associated | relid=0 | w=20
  646. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection à rickettsies
    n1=en:drug interaction | n2=infection à rickettsies | rel=r_associated | relid=0 | w=20
  647. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection à spirochètes
    n1=en:drug interaction | n2=infection à spirochètes | rel=r_associated | relid=0 | w=20
  648. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection due au rétrovirus
    n1=en:drug interaction | n2=infection due au rétrovirus | rel=r_associated | relid=0 | w=20
  649. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection généralisée
    n1=en:drug interaction | n2=infection généralisée | rel=r_associated | relid=0 | w=20
  650. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection méningococcique
    n1=en:drug interaction | n2=infection méningococcique | rel=r_associated | relid=0 | w=20
  651. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection surajoutée
    n1=en:drug interaction | n2=infection surajoutée | rel=r_associated | relid=0 | w=20
  652. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection systémique
    n1=en:drug interaction | n2=infection systémique | rel=r_associated | relid=0 | w=20
  653. en:drug interaction -- r_associated #0: 20 / 0.435 -> infection virale
    n1=en:drug interaction | n2=infection virale | rel=r_associated | relid=0 | w=20
  654. en:drug interaction -- r_associated #0: 20 / 0.435 -> infections bactériennes
    n1=en:drug interaction | n2=infections bactériennes | rel=r_associated | relid=0 | w=20
  655. en:drug interaction -- r_associated #0: 20 / 0.435 -> infections virales
    n1=en:drug interaction | n2=infections virales | rel=r_associated | relid=0 | w=20
  656. en:drug interaction -- r_associated #0: 20 / 0.435 -> influenza
    n1=en:drug interaction | n2=influenza | rel=r_associated | relid=0 | w=20
  657. en:drug interaction -- r_associated #0: 20 / 0.435 -> interaction en épidémiologie
    n1=en:drug interaction | n2=interaction en épidémiologie | rel=r_associated | relid=0 | w=20
  658. en:drug interaction -- r_associated #0: 20 / 0.435 -> intumescence
    n1=en:drug interaction | n2=intumescence | rel=r_associated | relid=0 | w=20
  659. en:drug interaction -- r_associated #0: 20 / 0.435 -> lymphoedème non filarien
    n1=en:drug interaction | n2=lymphoedème non filarien | rel=r_associated | relid=0 | w=20
  660. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie à cytomégalovirus
    n1=en:drug interaction | n2=maladie à cytomégalovirus | rel=r_associated | relid=0 | w=20
  661. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie causée par des bactéries
    n1=en:drug interaction | n2=maladie causée par des bactéries | rel=r_associated | relid=0 | w=20
  662. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie causée par une bactérie
    n1=en:drug interaction | n2=maladie causée par une bactérie | rel=r_associated | relid=0 | w=20
  663. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie congénitale
    n1=en:drug interaction | n2=maladie congénitale | rel=r_associated | relid=0 | w=20
  664. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie de Pierce
    n1=en:drug interaction | n2=maladie de Pierce | rel=r_associated | relid=0 | w=20
  665. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie due à un virus
    n1=en:drug interaction | n2=maladie due à un virus | rel=r_associated | relid=0 | w=20
  666. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie infectieuse bactérienne
    n1=en:drug interaction | n2=maladie infectieuse bactérienne | rel=r_associated | relid=0 | w=20
  667. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie infectieuse virale
    n1=en:drug interaction | n2=maladie infectieuse virale | rel=r_associated | relid=0 | w=20
  668. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladie virale
    n1=en:drug interaction | n2=maladie virale | rel=r_associated | relid=0 | w=20
  669. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies bactériennes
    n1=en:drug interaction | n2=maladies bactériennes | rel=r_associated | relid=0 | w=20
  670. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies causées par des bactéries
    n1=en:drug interaction | n2=maladies causées par des bactéries | rel=r_associated | relid=0 | w=20
  671. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies causées par une bactérie
    n1=en:drug interaction | n2=maladies causées par une bactérie | rel=r_associated | relid=0 | w=20
  672. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies du système immunitaire
    n1=en:drug interaction | n2=maladies du système immunitaire | rel=r_associated | relid=0 | w=20
  673. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies immunitaires
    n1=en:drug interaction | n2=maladies immunitaires | rel=r_associated | relid=0 | w=20
  674. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies immunologiques
    n1=en:drug interaction | n2=maladies immunologiques | rel=r_associated | relid=0 | w=20
  675. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies infectieuses bactériennes
    n1=en:drug interaction | n2=maladies infectieuses bactériennes | rel=r_associated | relid=0 | w=20
  676. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies infectieuses virales
    n1=en:drug interaction | n2=maladies infectieuses virales | rel=r_associated | relid=0 | w=20
  677. en:drug interaction -- r_associated #0: 20 / 0.435 -> maladies virales
    n1=en:drug interaction | n2=maladies virales | rel=r_associated | relid=0 | w=20
  678. en:drug interaction -- r_associated #0: 20 / 0.435 -> malformation
    n1=en:drug interaction | n2=malformation | rel=r_associated | relid=0 | w=20
  679. en:drug interaction -- r_associated #0: 20 / 0.435 -> malformation congénitale
    n1=en:drug interaction | n2=malformation congénitale | rel=r_associated | relid=0 | w=20
  680. en:drug interaction -- r_associated #0: 20 / 0.435 -> mauvaise haleine
    n1=en:drug interaction | n2=mauvaise haleine | rel=r_associated | relid=0 | w=20
  681. en:drug interaction -- r_associated #0: 20 / 0.435 -> métaplasie
    n1=en:drug interaction | n2=métaplasie | rel=r_associated | relid=0 | w=20
  682. en:drug interaction -- r_associated #0: 20 / 0.435 -> mort subite du nourrisson
    n1=en:drug interaction | n2=mort subite du nourrisson | rel=r_associated | relid=0 | w=20
  683. en:drug interaction -- r_associated #0: 20 / 0.435 -> multiracial
    n1=en:drug interaction | n2=multiracial | rel=r_associated | relid=0 | w=20
  684. en:drug interaction -- r_associated #0: 20 / 0.435 -> murmure cardiaque
    n1=en:drug interaction | n2=murmure cardiaque | rel=r_associated | relid=0 | w=20
  685. en:drug interaction -- r_associated #0: 20 / 0.435 -> mycose
    n1=en:drug interaction | n2=mycose | rel=r_associated | relid=0 | w=20
  686. en:drug interaction -- r_associated #0: 20 / 0.435 -> mycosis
    n1=en:drug interaction | n2=mycosis | rel=r_associated | relid=0 | w=20
  687. en:drug interaction -- r_associated #0: 20 / 0.435 -> non précisée, bactériémie
    n1=en:drug interaction | n2=non précisée, bactériémie | rel=r_associated | relid=0 | w=20
  688. en:drug interaction -- r_associated #0: 20 / 0.435 -> oedème
    n1=en:drug interaction | n2=oedème | rel=r_associated | relid=0 | w=20
  689. en:drug interaction -- r_associated #0: 20 / 0.435 -> Oedème
    n1=en:drug interaction | n2=Oedème | rel=r_associated | relid=0 | w=20
  690. en:drug interaction -- r_associated #0: 20 / 0.435 -> œdème
    n1=en:drug interaction | n2=œdème | rel=r_associated | relid=0 | w=20
  691. en:drug interaction -- r_associated #0: 20 / 0.435 -> overdoses
    n1=en:drug interaction | n2=overdoses | rel=r_associated | relid=0 | w=20
  692. en:drug interaction -- r_associated #0: 20 / 0.435 -> pâmoison
    n1=en:drug interaction | n2=pâmoison | rel=r_associated | relid=0 | w=20
  693. en:drug interaction -- r_associated #0: 20 / 0.435 -> panne d'électricité
    n1=en:drug interaction | n2=panne d'électricité | rel=r_associated | relid=0 | w=20
  694. en:drug interaction -- r_associated #0: 20 / 0.435 -> panne de courant
    n1=en:drug interaction | n2=panne de courant | rel=r_associated | relid=0 | w=20
  695. en:drug interaction -- r_associated #0: 20 / 0.435 -> pathologie congénitale
    n1=en:drug interaction | n2=pathologie congénitale | rel=r_associated | relid=0 | w=20
  696. en:drug interaction -- r_associated #0: 20 / 0.435 -> Perte de connaissance
    n1=en:drug interaction | n2=Perte de connaissance | rel=r_associated | relid=0 | w=20
  697. en:drug interaction -- r_associated #0: 20 / 0.435 -> poids corporel
    n1=en:drug interaction | n2=poids corporel | rel=r_associated | relid=0 | w=20
  698. en:drug interaction -- r_associated #0: 20 / 0.435 -> point saignant au site d'injection
    n1=en:drug interaction | n2=point saignant au site d'injection | rel=r_associated | relid=0 | w=20
  699. en:drug interaction -- r_associated #0: 20 / 0.435 -> polydipsie
    n1=en:drug interaction | n2=polydipsie | rel=r_associated | relid=0 | w=20
  700. en:drug interaction -- r_associated #0: 20 / 0.435 -> présentation sacro-iliaque droite antérieure
    n1=en:drug interaction | n2=présentation sacro-iliaque droite antérieure | rel=r_associated | relid=0 | w=20
  701. en:drug interaction -- r_associated #0: 20 / 0.435 -> proptose
    n1=en:drug interaction | n2=proptose | rel=r_associated | relid=0 | w=20
  702. en:drug interaction -- r_associated #0: 20 / 0.435 -> proptosis
    n1=en:drug interaction | n2=proptosis | rel=r_associated | relid=0 | w=20
  703. en:drug interaction -- r_associated #0: 20 / 0.435 -> psychose présénile
    n1=en:drug interaction | n2=psychose présénile | rel=r_associated | relid=0 | w=20
  704. en:drug interaction -- r_associated #0: 20 / 0.435 -> psychose sénile
    n1=en:drug interaction | n2=psychose sénile | rel=r_associated | relid=0 | w=20
  705. en:drug interaction -- r_associated #0: 20 / 0.435 -> retard de croissance
    n1=en:drug interaction | n2=retard de croissance | rel=r_associated | relid=0 | w=20
  706. en:drug interaction -- r_associated #0: 20 / 0.435 -> retard de croissance staturo-pondérale
    n1=en:drug interaction | n2=retard de croissance staturo-pondérale | rel=r_associated | relid=0 | w=20
  707. en:drug interaction -- r_associated #0: 20 / 0.435 -> Retard de croissance staturo-pondérale
    n1=en:drug interaction | n2=Retard de croissance staturo-pondérale | rel=r_associated | relid=0 | w=20
  708. en:drug interaction -- r_associated #0: 20 / 0.435 -> S.I.D.A.
    n1=en:drug interaction | n2=S.I.D.A. | rel=r_associated | relid=0 | w=20
  709. en:drug interaction -- r_associated #0: 20 / 0.435 -> sarcome
    n1=en:drug interaction | n2=sarcome | rel=r_associated | relid=0 | w=20
  710. en:drug interaction -- r_associated #0: 20 / 0.435 -> sénescence sans mention de psychose
    n1=en:drug interaction | n2=sénescence sans mention de psychose | rel=r_associated | relid=0 | w=20
  711. en:drug interaction -- r_associated #0: 20 / 0.435 -> sénilité
    n1=en:drug interaction | n2=sénilité | rel=r_associated | relid=0 | w=20
  712. en:drug interaction -- r_associated #0: 20 / 0.435 -> sensation de rotation
    n1=en:drug interaction | n2=sensation de rotation | rel=r_associated | relid=0 | w=20
  713. en:drug interaction -- r_associated #0: 20 / 0.435 -> sensation de tournoiement
    n1=en:drug interaction | n2=sensation de tournoiement | rel=r_associated | relid=0 | w=20
  714. en:drug interaction -- r_associated #0: 20 / 0.435 -> sensation rotatoire
    n1=en:drug interaction | n2=sensation rotatoire | rel=r_associated | relid=0 | w=20
  715. en:drug interaction -- r_associated #0: 20 / 0.435 -> sensation vertigineuse
    n1=en:drug interaction | n2=sensation vertigineuse | rel=r_associated | relid=0 | w=20
  716. en:drug interaction -- r_associated #0: 20 / 0.435 -> sepsis
    n1=en:drug interaction | n2=sepsis | rel=r_associated | relid=0 | w=20
  717. en:drug interaction -- r_associated #0: 20 / 0.435 -> septicémie
    n1=en:drug interaction | n2=septicémie | rel=r_associated | relid=0 | w=20
  718. en:drug interaction -- r_associated #0: 20 / 0.435 -> SIDA
    n1=en:drug interaction | n2=SIDA | rel=r_associated | relid=0 | w=20
  719. en:drug interaction -- r_associated #0: 20 / 0.435 -> soif excessive
    n1=en:drug interaction | n2=soif excessive | rel=r_associated | relid=0 | w=20
  720. en:drug interaction -- r_associated #0: 20 / 0.435 -> souffle au coeur
    n1=en:drug interaction | n2=souffle au coeur | rel=r_associated | relid=0 | w=20
  721. en:drug interaction -- r_associated #0: 20 / 0.435 -> souffrance foetale
    n1=en:drug interaction | n2=souffrance foetale | rel=r_associated | relid=0 | w=20
  722. en:drug interaction -- r_associated #0: 20 / 0.435 -> sous la table
    n1=en:drug interaction | n2=sous la table | rel=r_associated | relid=0 | w=20
  723. en:drug interaction -- r_associated #0: 20 / 0.435 -> splénomégalie
    n1=en:drug interaction | n2=splénomégalie | rel=r_associated | relid=0 | w=20
  724. en:drug interaction -- r_associated #0: 20 / 0.435 -> splénomégalie congénitale
    n1=en:drug interaction | n2=splénomégalie congénitale | rel=r_associated | relid=0 | w=20
  725. en:drug interaction -- r_associated #0: 20 / 0.435 -> stutter
    n1=en:drug interaction | n2=stutter | rel=r_associated | relid=0 | w=20
  726. en:drug interaction -- r_associated #0: 20 / 0.435 -> superinfection
    n1=en:drug interaction | n2=superinfection | rel=r_associated | relid=0 | w=20
  727. en:drug interaction -- r_associated #0: 20 / 0.435 -> surdosage de médicament ou de drogue
    n1=en:drug interaction | n2=surdosage de médicament ou de drogue | rel=r_associated | relid=0 | w=20
  728. en:drug interaction -- r_associated #0: 20 / 0.435 -> surdosage médicamenteux
    n1=en:drug interaction | n2=surdosage médicamenteux | rel=r_associated | relid=0 | w=20
  729. en:drug interaction -- r_associated #0: 20 / 0.435 -> surdose
    n1=en:drug interaction | n2=surdose | rel=r_associated | relid=0 | w=20
  730. en:drug interaction -- r_associated #0: 20 / 0.435 -> surdoser
    n1=en:drug interaction | n2=surdoser | rel=r_associated | relid=0 | w=20
  731. en:drug interaction -- r_associated #0: 20 / 0.435 -> surinfection
    n1=en:drug interaction | n2=surinfection | rel=r_associated | relid=0 | w=20
  732. en:drug interaction -- r_associated #0: 20 / 0.435 -> syncope blanche
    n1=en:drug interaction | n2=syncope blanche | rel=r_associated | relid=0 | w=20
  733. en:drug interaction -- r_associated #0: 20 / 0.435 -> syncope bleue
    n1=en:drug interaction | n2=syncope bleue | rel=r_associated | relid=0 | w=20
  734. en:drug interaction -- r_associated #0: 20 / 0.435 -> syncope due à la chaleur
    n1=en:drug interaction | n2=syncope due à la chaleur | rel=r_associated | relid=0 | w=20
  735. en:drug interaction -- r_associated #0: 20 / 0.435 -> syncope et collapsus
    n1=en:drug interaction | n2=syncope et collapsus | rel=r_associated | relid=0 | w=20
  736. en:drug interaction -- r_associated #0: 20 / 0.435 -> syncope psychogène
    n1=en:drug interaction | n2=syncope psychogène | rel=r_associated | relid=0 | w=20
  737. en:drug interaction -- r_associated #0: 20 / 0.435 -> syndrome d'immunodéficience acquise
    n1=en:drug interaction | n2=syndrome d'immunodéficience acquise | rel=r_associated | relid=0 | w=20
  738. en:drug interaction -- r_associated #0: 20 / 0.435 -> syndrome de glissement
    n1=en:drug interaction | n2=syndrome de glissement | rel=r_associated | relid=0 | w=20
  739. en:drug interaction -- r_associated #0: 20 / 0.435 -> syndrome de l'immunodéficience acquise
    n1=en:drug interaction | n2=syndrome de l'immunodéficience acquise | rel=r_associated | relid=0 | w=20
  740. en:drug interaction -- r_associated #0: 20 / 0.435 -> syndrome de la mort subite du nourrisson
    n1=en:drug interaction | n2=syndrome de la mort subite du nourrisson | rel=r_associated | relid=0 | w=20
  741. en:drug interaction -- r_associated #0: 20 / 0.435 -> syndrome du retard de développement
    n1=en:drug interaction | n2=syndrome du retard de développement | rel=r_associated | relid=0 | w=20
  742. en:drug interaction -- r_associated #0: 20 / 0.435 -> syndrome du sinus carotidien
    n1=en:drug interaction | n2=syndrome du sinus carotidien | rel=r_associated | relid=0 | w=20
  743. en:drug interaction -- r_associated #0: 20 / 0.435 -> tachycardie
    n1=en:drug interaction | n2=tachycardie | rel=r_associated | relid=0 | w=20
  744. en:drug interaction -- r_associated #0: 20 / 0.435 -> tachycardie, hypertension, microphtalmie et hyperglycinurie
    n1=en:drug interaction | n2=tachycardie, hypertension, microphtalmie et hyperglycinurie | rel=r_associated | relid=0 | w=20
  745. en:drug interaction -- r_associated #0: 20 / 0.435 -> tampane
    n1=en:drug interaction | n2=tampane | rel=r_associated | relid=0 | w=20
  746. en:drug interaction -- r_associated #0: 20 / 0.435 -> tare congénitale
    n1=en:drug interaction | n2=tare congénitale | rel=r_associated | relid=0 | w=20
  747. en:drug interaction -- r_associated #0: 20 / 0.435 -> tendinite
    n1=en:drug interaction | n2=tendinite | rel=r_associated | relid=0 | w=20
  748. en:drug interaction -- r_associated #0: 20 / 0.435 -> tendinites
    n1=en:drug interaction | n2=tendinites | rel=r_associated | relid=0 | w=20
  749. en:drug interaction -- r_associated #0: 20 / 0.435 -> tendinose
    n1=en:drug interaction | n2=tendinose | rel=r_associated | relid=0 | w=20
  750. en:drug interaction -- r_associated #0: 20 / 0.435 -> tête pivotante
    n1=en:drug interaction | n2=tête pivotante | rel=r_associated | relid=0 | w=20
  751. en:drug interaction -- r_associated #0: 20 / 0.435 -> transcription
    n1=en:drug interaction | n2=transcription | rel=r_associated | relid=0 | w=20
  752. en:drug interaction -- r_associated #0: 20 / 0.435 -> trouble bactérien infectieux
    n1=en:drug interaction | n2=trouble bactérien infectieux | rel=r_associated | relid=0 | w=20
  753. en:drug interaction -- r_associated #0: 20 / 0.435 -> trouble chromosomique
    n1=en:drug interaction | n2=trouble chromosomique | rel=r_associated | relid=0 | w=20
  754. en:drug interaction -- r_associated #0: 20 / 0.435 -> trouble de l'équilibre
    n1=en:drug interaction | n2=trouble de l'équilibre | rel=r_associated | relid=0 | w=20
  755. en:drug interaction -- r_associated #0: 20 / 0.435 -> trouble psychotique sénile non précisé
    n1=en:drug interaction | n2=trouble psychotique sénile non précisé | rel=r_associated | relid=0 | w=20
  756. en:drug interaction -- r_associated #0: 20 / 0.435 -> troubles bactériens infectieux
    n1=en:drug interaction | n2=troubles bactériens infectieux | rel=r_associated | relid=0 | w=20
  757. en:drug interaction -- r_associated #0: 20 / 0.435 -> troubles immunitaires
    n1=en:drug interaction | n2=troubles immunitaires | rel=r_associated | relid=0 | w=20
  758. en:drug interaction -- r_associated #0: 20 / 0.435 -> TULV
    n1=en:drug interaction | n2=TULV | rel=r_associated | relid=0 | w=20
  759. en:drug interaction -- r_associated #0: 20 / 0.435 -> tuméfaction
    n1=en:drug interaction | n2=tuméfaction | rel=r_associated | relid=0 | w=20
  760. en:drug interaction -- r_associated #0: 20 / 0.435 -> tuméfié
    n1=en:drug interaction | n2=tuméfié | rel=r_associated | relid=0 | w=20
  761. en:drug interaction -- r_associated #0: 20 / 0.435 -> tumescence
    n1=en:drug interaction | n2=tumescence | rel=r_associated | relid=0 | w=20
  762. en:drug interaction -- r_associated #0: 20 / 0.435 -> tumeur cancéreuse
    n1=en:drug interaction | n2=tumeur cancéreuse | rel=r_associated | relid=0 | w=20
  763. en:drug interaction -- r_associated #0: 20 / 0.435 -> une anomalie congénitale
    n1=en:drug interaction | n2=une anomalie congénitale | rel=r_associated | relid=0 | w=20
  764. en:drug interaction -- r_associated #0: 20 / 0.435 -> vertige
    n1=en:drug interaction | n2=vertige | rel=r_associated | relid=0 | w=20
  765. en:drug interaction -- r_associated #0: 20 / 0.435 -> vertige rotatoire
    n1=en:drug interaction | n2=vertige rotatoire | rel=r_associated | relid=0 | w=20
  766. en:drug interaction -- r_associated #0: 20 / 0.435 -> vertige subjectif
    n1=en:drug interaction | n2=vertige subjectif | rel=r_associated | relid=0 | w=20
  767. en:drug interaction -- r_associated #0: 20 / 0.435 -> vertigo
    n1=en:drug interaction | n2=vertigo | rel=r_associated | relid=0 | w=20
  768. en:drug interaction -- r_associated #0: 20 / 0.435 -> vertigo rotatoire
    n1=en:drug interaction | n2=vertigo rotatoire | rel=r_associated | relid=0 | w=20
  769. en:drug interaction -- r_associated #0: 20 / 0.435 -> vice de conformation
    n1=en:drug interaction | n2=vice de conformation | rel=r_associated | relid=0 | w=20
  770. en:drug interaction -- r_associated #0: 20 / 0.435 -> vieillesse sans mention de psychose
    n1=en:drug interaction | n2=vieillesse sans mention de psychose | rel=r_associated | relid=0 | w=20
  771. en:drug interaction -- r_associated #0: 20 / 0.435 -> viémies
    n1=en:drug interaction | n2=viémies | rel=r_associated | relid=0 | w=20
  772. en:drug interaction -- r_associated #0: 20 / 0.435 -> virémie
    n1=en:drug interaction | n2=virémie | rel=r_associated | relid=0 | w=20
  773. en:drug interaction -- r_associated #0: 20 / 0.435 -> virose
    n1=en:drug interaction | n2=virose | rel=r_associated | relid=0 | w=20
  774. en:drug interaction -- r_associated #0: 20 / 0.435 -> viroses
    n1=en:drug interaction | n2=viroses | rel=r_associated | relid=0 | w=20
  775. en:drug interaction -- r_associated #0: 20 / 0.435 -> voies biosynthétiques
    n1=en:drug interaction | n2=voies biosynthétiques | rel=r_associated | relid=0 | w=20
  776. en:drug interaction -- r_associated #0: 20 / 0.435 -> Voile noir
    n1=en:drug interaction | n2=Voile noir | rel=r_associated | relid=0 | w=20
  777. en:drug interaction -- r_associated #0: 20 / 0.435 -> voile noir
    n1=en:drug interaction | n2=voile noir | rel=r_associated | relid=0 | w=20
  778. en:drug interaction -- r_associated #0: 10 / 0.217 -> en:medicine
    n1=en:drug interaction | n2=en:medicine | rel=r_associated | relid=0 | w=10
  779. en:drug interaction -- r_associated #0: 10 / 0.217 -> en:pharmacology
    n1=en:drug interaction | n2=en:pharmacology | rel=r_associated | relid=0 | w=10
  780. en:drug interaction -- r_associated #0: 10 / 0.217 -> interaction avec d'autres médicaments
    n1=en:drug interaction | n2=interaction avec d'autres médicaments | rel=r_associated | relid=0 | w=10
≈ 1130 relations entrantes

  1. bactériémie --- r_associated #0: 828.68 --> en:drug interaction
    n1=bactériémie | n2=en:drug interaction | rel=r_associated | relid=0 | w=828.68
  2. en:bacterial infection --- r_associated #0: 825.59 --> en:drug interaction
    n1=en:bacterial infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=825.59
  3. en:hemorrhage --- r_associated #0: 705 --> en:drug interaction
    n1=en:hemorrhage | n2=en:drug interaction | rel=r_associated | relid=0 | w=705
  4. hémorragie --- r_associated #0: 702 --> en:drug interaction
    n1=hémorragie | n2=en:drug interaction | rel=r_associated | relid=0 | w=702
  5. infection bactérienne --- r_associated #0: 665 --> en:drug interaction
    n1=infection bactérienne | n2=en:drug interaction | rel=r_associated | relid=0 | w=665
  6. en:bacterial infections --- r_associated #0: 642 --> en:drug interaction
    n1=en:bacterial infections | n2=en:drug interaction | rel=r_associated | relid=0 | w=642
  7. en:bacteremia --- r_associated #0: 633 --> en:drug interaction
    n1=en:bacteremia | n2=en:drug interaction | rel=r_associated | relid=0 | w=633
  8. en:loss of consciousness --- r_associated #0: 591 --> en:drug interaction
    n1=en:loss of consciousness | n2=en:drug interaction | rel=r_associated | relid=0 | w=591
  9. perte de conscience --- r_associated #0: 587 --> en:drug interaction
    n1=perte de conscience | n2=en:drug interaction | rel=r_associated | relid=0 | w=587
  10. perte de connaissance --- r_associated #0: 538 --> en:drug interaction
    n1=perte de connaissance | n2=en:drug interaction | rel=r_associated | relid=0 | w=538
  11. démence sénile avec delirium ou état confusionnel aigu --- r_associated #0: 525 --> en:drug interaction
    n1=démence sénile avec delirium ou état confusionnel aigu | n2=en:drug interaction | rel=r_associated | relid=0 | w=525
  12. trouble psychotique sénile non précisé --- r_associated #0: 525 --> en:drug interaction
    n1=trouble psychotique sénile non précisé | n2=en:drug interaction | rel=r_associated | relid=0 | w=525
  13. asthénie sénile --- r_associated #0: 523 --> en:drug interaction
    n1=asthénie sénile | n2=en:drug interaction | rel=r_associated | relid=0 | w=523
  14. démence forme dépressive ou délirante --- r_associated #0: 520 --> en:drug interaction
    n1=démence forme dépressive ou délirante | n2=en:drug interaction | rel=r_associated | relid=0 | w=520
  15. sénescence sans mention de psychose --- r_associated #0: 520 --> en:drug interaction
    n1=sénescence sans mention de psychose | n2=en:drug interaction | rel=r_associated | relid=0 | w=520
  16. débilité sénile --- r_associated #0: 515 --> en:drug interaction
    n1=débilité sénile | n2=en:drug interaction | rel=r_associated | relid=0 | w=515
  17. psychose présénile --- r_associated #0: 515 --> en:drug interaction
    n1=psychose présénile | n2=en:drug interaction | rel=r_associated | relid=0 | w=515
  18. démence dégénérative primaire --- r_associated #0: 505 --> en:drug interaction
    n1=démence dégénérative primaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=505
  19. psychose sénile --- r_associated #0: 498 --> en:drug interaction
    n1=psychose sénile | n2=en:drug interaction | rel=r_associated | relid=0 | w=498
  20. en:senility --- r_associated #0: 480 --> en:drug interaction
    n1=en:senility | n2=en:drug interaction | rel=r_associated | relid=0 | w=480
  21. en:unspecified senile psychotic condition --- r_associated #0: 480 --> en:drug interaction
    n1=en:unspecified senile psychotic condition | n2=en:drug interaction | rel=r_associated | relid=0 | w=480
  22. vieillesse sans mention de psychose --- r_associated #0: 479 --> en:drug interaction
    n1=vieillesse sans mention de psychose | n2=en:drug interaction | rel=r_associated | relid=0 | w=479
  23. en:senile asthenia --- r_associated #0: 475 --> en:drug interaction
    n1=en:senile asthenia | n2=en:drug interaction | rel=r_associated | relid=0 | w=475
  24. maladie infectieuse bactérienne --- r_associated #0: 465 --> en:drug interaction
    n1=maladie infectieuse bactérienne | n2=en:drug interaction | rel=r_associated | relid=0 | w=465
  25. démence présénile --- r_associated #0: 461 --> en:drug interaction
    n1=démence présénile | n2=en:drug interaction | rel=r_associated | relid=0 | w=461
  26. en:age-related physical debility --- r_associated #0: 455 --> en:drug interaction
    n1=en:age-related physical debility | n2=en:drug interaction | rel=r_associated | relid=0 | w=455
  27. maladie causée par des bactéries --- r_associated #0: 455 --> en:drug interaction
    n1=maladie causée par des bactéries | n2=en:drug interaction | rel=r_associated | relid=0 | w=455
  28. maladie causée par une bactérie --- r_associated #0: 451 --> en:drug interaction
    n1=maladie causée par une bactérie | n2=en:drug interaction | rel=r_associated | relid=0 | w=451
  29. syndrome de glissement --- r_associated #0: 450 --> en:drug interaction
    n1=syndrome de glissement | n2=en:drug interaction | rel=r_associated | relid=0 | w=450
  30. trouble bactérien infectieux --- r_associated #0: 450 --> en:drug interaction
    n1=trouble bactérien infectieux | n2=en:drug interaction | rel=r_associated | relid=0 | w=450
  31. démence sénile --- r_associated #0: 445 --> en:drug interaction
    n1=démence sénile | n2=en:drug interaction | rel=r_associated | relid=0 | w=445
  32. en:chlamydia infection --- r_associated #0: 445 --> en:drug interaction
    n1=en:chlamydia infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=445
  33. choc cardiogénique --- r_associated #0: 444 --> en:drug interaction
    n1=choc cardiogénique | n2=en:drug interaction | rel=r_associated | relid=0 | w=444
  34. bactériémie non précisée --- r_associated #0: 440 --> en:drug interaction
    n1=bactériémie non précisée | n2=en:drug interaction | rel=r_associated | relid=0 | w=440
  35. non précisée, bactériémie --- r_associated #0: 440 --> en:drug interaction
    n1=non précisée, bactériémie | n2=en:drug interaction | rel=r_associated | relid=0 | w=440
  36. fièvre
    (médecine)
     --- r_associated #0: 438 --> en:drug interaction
    n1=fièvre
    (médecine)
    | n2=en:drug interaction | rel=r_associated | relid=0 | w=438
  37. en:presenile dementia --- r_associated #0: 435 --> en:drug interaction
    n1=en:presenile dementia | n2=en:drug interaction | rel=r_associated | relid=0 | w=435
  38. en:fever --- r_associated #0: 434 --> en:drug interaction
    n1=en:fever | n2=en:drug interaction | rel=r_associated | relid=0 | w=434
  39. sénilité --- r_associated #0: 434 --> en:drug interaction
    n1=sénilité | n2=en:drug interaction | rel=r_associated | relid=0 | w=434
  40. en:adverse reaction to drug --- r_associated #0: 433 --> en:drug interaction
    n1=en:adverse reaction to drug | n2=en:drug interaction | rel=r_associated | relid=0 | w=433
  41. effet indésirable d'un médicament --- r_associated #0: 432 --> en:drug interaction
    n1=effet indésirable d'un médicament | n2=en:drug interaction | rel=r_associated | relid=0 | w=432
  42. en:blackout - symptom --- r_associated #0: 430 --> en:drug interaction
    n1=en:blackout - symptom | n2=en:drug interaction | rel=r_associated | relid=0 | w=430
  43. infection méningococcique --- r_associated #0: 425 --> en:drug interaction
    n1=infection méningococcique | n2=en:drug interaction | rel=r_associated | relid=0 | w=425
  44. en:cardiogenic shock --- r_associated #0: 415 --> en:drug interaction
    n1=en:cardiogenic shock | n2=en:drug interaction | rel=r_associated | relid=0 | w=415
  45. asthénie neuro-circulatoire --- r_associated #0: 400 --> en:drug interaction
    n1=asthénie neuro-circulatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=400
  46. hypotension orthostatique neurogène --- r_associated #0: 400 --> en:drug interaction
    n1=hypotension orthostatique neurogène | n2=en:drug interaction | rel=r_associated | relid=0 | w=400
  47. syncope due à la chaleur --- r_associated #0: 400 --> en:drug interaction
    n1=syncope due à la chaleur | n2=en:drug interaction | rel=r_associated | relid=0 | w=400
  48. syncope psychogène --- r_associated #0: 400 --> en:drug interaction
    n1=syncope psychogène | n2=en:drug interaction | rel=r_associated | relid=0 | w=400
  49. choc compliquant ou consécutif à travail et accouchement --- r_associated #0: 395 --> en:drug interaction
    n1=choc compliquant ou consécutif à travail et accouchement | n2=en:drug interaction | rel=r_associated | relid=0 | w=395
  50. syndrome du sinus carotidien --- r_associated #0: 391 --> en:drug interaction
    n1=syndrome du sinus carotidien | n2=en:drug interaction | rel=r_associated | relid=0 | w=391
  51. voile noir --- r_associated #0: 384 --> en:drug interaction
    n1=voile noir | n2=en:drug interaction | rel=r_associated | relid=0 | w=384
  52. hypotension orthostatique --- r_associated #0: 375 --> en:drug interaction
    n1=hypotension orthostatique | n2=en:drug interaction | rel=r_associated | relid=0 | w=375
  53. choc cardiogène --- r_associated #0: 360 --> en:drug interaction
    n1=choc cardiogène | n2=en:drug interaction | rel=r_associated | relid=0 | w=360
  54. asthénie neurocirculatoire --- r_associated #0: 340 --> en:drug interaction
    n1=asthénie neurocirculatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=340
  55. anomalie congénitale --- r_associated #0: 334 --> en:drug interaction
    n1=anomalie congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=334
  56. en:congenital abnormality --- r_associated #0: 330 --> en:drug interaction
    n1=en:congenital abnormality | n2=en:drug interaction | rel=r_associated | relid=0 | w=330
  57. malformation congénitale --- r_associated #0: 311 --> en:drug interaction
    n1=malformation congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=311
  58. en:congenital defect --- r_associated #0: 310 --> en:drug interaction
    n1=en:congenital defect | n2=en:drug interaction | rel=r_associated | relid=0 | w=310
  59. hemorragie --- r_associated #0: 310 --> en:drug interaction
    n1=hemorragie | n2=en:drug interaction | rel=r_associated | relid=0 | w=310
  60. infections bactériennes --- r_associated #0: 310 --> en:drug interaction
    n1=infections bactériennes | n2=en:drug interaction | rel=r_associated | relid=0 | w=310
  61. en:congenital anomaly --- r_associated #0: 309 --> en:drug interaction
    n1=en:congenital anomaly | n2=en:drug interaction | rel=r_associated | relid=0 | w=309
  62. maladies bactériennes --- r_associated #0: 305 --> en:drug interaction
    n1=maladies bactériennes | n2=en:drug interaction | rel=r_associated | relid=0 | w=305
  63. maladies infectieuses bactériennes --- r_associated #0: 305 --> en:drug interaction
    n1=maladies infectieuses bactériennes | n2=en:drug interaction | rel=r_associated | relid=0 | w=305
  64. déformation congénitale --- r_associated #0: 286 --> en:drug interaction
    n1=déformation congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=286
  65. en:immune system disorder --- r_associated #0: 280 --> en:drug interaction
    n1=en:immune system disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=280
  66. infection à Chlamydia --- r_associated #0: 280 --> en:drug interaction
    n1=infection à Chlamydia | n2=en:drug interaction | rel=r_associated | relid=0 | w=280
  67. maladie du système immunitaire --- r_associated #0: 276 --> en:drug interaction
    n1=maladie du système immunitaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=276
  68. trouble du système immun --- r_associated #0: 276 --> en:drug interaction
    n1=trouble du système immun | n2=en:drug interaction | rel=r_associated | relid=0 | w=276
  69. trouble du système immunitaire --- r_associated #0: 276 --> en:drug interaction
    n1=trouble du système immunitaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=276
  70. déficience congénitale --- r_associated #0: 275 --> en:drug interaction
    n1=déficience congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=275
  71. infection à rickettsies --- r_associated #0: 275 --> en:drug interaction
    n1=infection à rickettsies | n2=en:drug interaction | rel=r_associated | relid=0 | w=275
  72. infection à spirochètes --- r_associated #0: 260 --> en:drug interaction
    n1=infection à spirochètes | n2=en:drug interaction | rel=r_associated | relid=0 | w=260
  73. en:bacteraemia --- r_associated #0: 240 --> en:drug interaction
    n1=en:bacteraemia | n2=en:drug interaction | rel=r_associated | relid=0 | w=240
  74. en:bactieremia --- r_associated #0: 240 --> en:drug interaction
    n1=en:bactieremia | n2=en:drug interaction | rel=r_associated | relid=0 | w=240
  75. atrophie --- r_associated #0: 237 --> en:drug interaction
    n1=atrophie | n2=en:drug interaction | rel=r_associated | relid=0 | w=237
  76. en:atrophy --- r_associated #0: 235 --> en:drug interaction
    n1=en:atrophy | n2=en:drug interaction | rel=r_associated | relid=0 | w=235
  77. infection à chlamydia --- r_associated #0: 235 --> en:drug interaction
    n1=infection à chlamydia | n2=en:drug interaction | rel=r_associated | relid=0 | w=235
  78. vertige rotatoire --- r_associated #0: 235 --> en:drug interaction
    n1=vertige rotatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=235
  79. vertige subjectif --- r_associated #0: 235 --> en:drug interaction
    n1=vertige subjectif | n2=en:drug interaction | rel=r_associated | relid=0 | w=235
  80. vertigo rotatoire --- r_associated #0: 235 --> en:drug interaction
    n1=vertigo rotatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=235
  81. sensation de tournoiement --- r_associated #0: 231 --> en:drug interaction
    n1=sensation de tournoiement | n2=en:drug interaction | rel=r_associated | relid=0 | w=231
  82. hémorrhagie --- r_associated #0: 230 --> en:drug interaction
    n1=hémorrhagie | n2=en:drug interaction | rel=r_associated | relid=0 | w=230
  83. infection généralisée --- r_associated #0: 230 --> en:drug interaction
    n1=infection généralisée | n2=en:drug interaction | rel=r_associated | relid=0 | w=230
  84. sepsis --- r_associated #0: 230 --> en:drug interaction
    n1=sepsis | n2=en:drug interaction | rel=r_associated | relid=0 | w=230
  85. en:sepsis --- r_associated #0: 226 --> en:drug interaction
    n1=en:sepsis | n2=en:drug interaction | rel=r_associated | relid=0 | w=226
  86. en:sarcoma --- r_associated #0: 225 --> en:drug interaction
    n1=en:sarcoma | n2=en:drug interaction | rel=r_associated | relid=0 | w=225
  87. en:septicemia --- r_associated #0: 223 --> en:drug interaction
    n1=en:septicemia | n2=en:drug interaction | rel=r_associated | relid=0 | w=223
  88. sensation de rotation --- r_associated #0: 222 --> en:drug interaction
    n1=sensation de rotation | n2=en:drug interaction | rel=r_associated | relid=0 | w=222
  89. sarcome --- r_associated #0: 221 --> en:drug interaction
    n1=sarcome | n2=en:drug interaction | rel=r_associated | relid=0 | w=221
  90. Bactériémie --- r_associated #0: 220 --> en:drug interaction
    n1=Bactériémie | n2=en:drug interaction | rel=r_associated | relid=0 | w=220
  91. état nébuleux --- r_associated #0: 220 --> en:drug interaction
    n1=état nébuleux | n2=en:drug interaction | rel=r_associated | relid=0 | w=220
  92. état vertigineux --- r_associated #0: 220 --> en:drug interaction
    n1=état vertigineux | n2=en:drug interaction | rel=r_associated | relid=0 | w=220
  93. tête pivotante --- r_associated #0: 215 --> en:drug interaction
    n1=tête pivotante | n2=en:drug interaction | rel=r_associated | relid=0 | w=215
  94. bactériémies --- r_associated #0: 210 --> en:drug interaction
    n1=bactériémies | n2=en:drug interaction | rel=r_associated | relid=0 | w=210
  95. troubles bactériens infectieux --- r_associated #0: 210 --> en:drug interaction
    n1=troubles bactériens infectieux | n2=en:drug interaction | rel=r_associated | relid=0 | w=210
  96. maladies causées par des bactéries --- r_associated #0: 206 --> en:drug interaction
    n1=maladies causées par des bactéries | n2=en:drug interaction | rel=r_associated | relid=0 | w=206
  97. maladie congénitale --- r_associated #0: 203 --> en:drug interaction
    n1=maladie congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=203
  98. sensation rotatoire --- r_associated #0: 203 --> en:drug interaction
    n1=sensation rotatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=203
  99. septicémie --- r_associated #0: 201 --> en:drug interaction
    n1=septicémie | n2=en:drug interaction | rel=r_associated | relid=0 | w=201
  100. maladies causées par une bactérie --- r_associated #0: 200 --> en:drug interaction
    n1=maladies causées par une bactérie | n2=en:drug interaction | rel=r_associated | relid=0 | w=200
  101. difformité congénitale --- r_associated #0: 195 --> en:drug interaction
    n1=difformité congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=195
  102. pathologie congénitale --- r_associated #0: 195 --> en:drug interaction
    n1=pathologie congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=195
  103. maladies immunitaires --- r_associated #0: 190 --> en:drug interaction
    n1=maladies immunitaires | n2=en:drug interaction | rel=r_associated | relid=0 | w=190
  104. oedème --- r_associated #0: 190 --> en:drug interaction
    n1=oedème | n2=en:drug interaction | rel=r_associated | relid=0 | w=190
  105. sensation vertigineuse --- r_associated #0: 190 --> en:drug interaction
    n1=sensation vertigineuse | n2=en:drug interaction | rel=r_associated | relid=0 | w=190
  106. en:edema --- r_associated #0: 186 --> en:drug interaction
    n1=en:edema | n2=en:drug interaction | rel=r_associated | relid=0 | w=186
  107. affections du système immunitaire --- r_associated #0: 185 --> en:drug interaction
    n1=affections du système immunitaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=185
  108. en:overdose --- r_associated #0: 182 --> en:drug interaction
    n1=en:overdose | n2=en:drug interaction | rel=r_associated | relid=0 | w=182
  109. troubles immunitaires --- r_associated #0: 180 --> en:drug interaction
    n1=troubles immunitaires | n2=en:drug interaction | rel=r_associated | relid=0 | w=180
  110. surdosage médicamenteux --- r_associated #0: 178 --> en:drug interaction
    n1=surdosage médicamenteux | n2=en:drug interaction | rel=r_associated | relid=0 | w=178
  111. infection systémique --- r_associated #0: 177 --> en:drug interaction
    n1=infection systémique | n2=en:drug interaction | rel=r_associated | relid=0 | w=177
  112. en:immune system diseases --- r_associated #0: 171 --> en:drug interaction
    n1=en:immune system diseases | n2=en:drug interaction | rel=r_associated | relid=0 | w=171
  113. maladies du système immunitaire --- r_associated #0: 170 --> en:drug interaction
    n1=maladies du système immunitaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=170
  114. maladies immunologiques --- r_associated #0: 170 --> en:drug interaction
    n1=maladies immunologiques | n2=en:drug interaction | rel=r_associated | relid=0 | w=170
  115. pâmoison --- r_associated #0: 170 --> en:drug interaction
    n1=pâmoison | n2=en:drug interaction | rel=r_associated | relid=0 | w=170
  116. maladie due à un virus --- r_associated #0: 169 --> en:drug interaction
    n1=maladie due à un virus | n2=en:drug interaction | rel=r_associated | relid=0 | w=169
  117. anomalie chromosomique --- r_associated #0: 168 --> en:drug interaction
    n1=anomalie chromosomique | n2=en:drug interaction | rel=r_associated | relid=0 | w=168
  118. détresse foetale --- r_associated #0: 165 --> en:drug interaction
    n1=détresse foetale | n2=en:drug interaction | rel=r_associated | relid=0 | w=165
  119. en:chromosomal abnormality --- r_associated #0: 165 --> en:drug interaction
    n1=en:chromosomal abnormality | n2=en:drug interaction | rel=r_associated | relid=0 | w=165
  120. immunopathies --- r_associated #0: 165 --> en:drug interaction
    n1=immunopathies | n2=en:drug interaction | rel=r_associated | relid=0 | w=165
  121. en:fetal distress --- r_associated #0: 164 --> en:drug interaction
    n1=en:fetal distress | n2=en:drug interaction | rel=r_associated | relid=0 | w=164
  122. en:vertigo --- r_associated #0: 164 --> en:drug interaction
    n1=en:vertigo | n2=en:drug interaction | rel=r_associated | relid=0 | w=164
  123. maladie à cytomégalovirus --- r_associated #0: 163 --> en:drug interaction
    n1=maladie à cytomégalovirus | n2=en:drug interaction | rel=r_associated | relid=0 | w=163
  124. splénomégalie congénitale --- r_associated #0: 161 --> en:drug interaction
    n1=splénomégalie congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=161
  125. en:dizziness --- r_associated #0: 160 --> en:drug interaction
    n1=en:dizziness | n2=en:drug interaction | rel=r_associated | relid=0 | w=160
  126. en:hypersplenism --- r_associated #0: 160 --> en:drug interaction
    n1=en:hypersplenism | n2=en:drug interaction | rel=r_associated | relid=0 | w=160
  127. maladie infectieuse virale --- r_associated #0: 158 --> en:drug interaction
    n1=maladie infectieuse virale | n2=en:drug interaction | rel=r_associated | relid=0 | w=158
  128. splénomégalie --- r_associated #0: 157 --> en:drug interaction
    n1=splénomégalie | n2=en:drug interaction | rel=r_associated | relid=0 | w=157
  129. en:viremia --- r_associated #0: 154 --> en:drug interaction
    n1=en:viremia | n2=en:drug interaction | rel=r_associated | relid=0 | w=154
  130. infection due au rétrovirus --- r_associated #0: 153 --> en:drug interaction
    n1=infection due au rétrovirus | n2=en:drug interaction | rel=r_associated | relid=0 | w=153
  131. en:viral infection --- r_associated #0: 152 --> en:drug interaction
    n1=en:viral infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=152
  132. en:hot flashes --- r_associated #0: 149 --> en:drug interaction
    n1=en:hot flashes | n2=en:drug interaction | rel=r_associated | relid=0 | w=149
  133. hypersplénisme --- r_associated #0: 149 --> en:drug interaction
    n1=hypersplénisme | n2=en:drug interaction | rel=r_associated | relid=0 | w=149
  134. bouffées de chaleur --- r_associated #0: 148 --> en:drug interaction
    n1=bouffées de chaleur | n2=en:drug interaction | rel=r_associated | relid=0 | w=148
  135. incontinence paradoxale --- r_associated #0: 145 --> en:drug interaction
    n1=incontinence paradoxale | n2=en:drug interaction | rel=r_associated | relid=0 | w=145
  136. infection virale --- r_associated #0: 143 --> en:drug interaction
    n1=infection virale | n2=en:drug interaction | rel=r_associated | relid=0 | w=143
  137. retard de croissance staturo-pondérale --- r_associated #0: 141 --> en:drug interaction
    n1=retard de croissance staturo-pondérale | n2=en:drug interaction | rel=r_associated | relid=0 | w=141
  138. en:pediatric failure to thrive --- r_associated #0: 140 --> en:drug interaction
    n1=en:pediatric failure to thrive | n2=en:drug interaction | rel=r_associated | relid=0 | w=140
  139. en:heart murmur --- r_associated #0: 138 --> en:drug interaction
    n1=en:heart murmur | n2=en:drug interaction | rel=r_associated | relid=0 | w=138
  140. maladie virale --- r_associated #0: 138 --> en:drug interaction
    n1=maladie virale | n2=en:drug interaction | rel=r_associated | relid=0 | w=138
  141. virose --- r_associated #0: 138 --> en:drug interaction
    n1=virose | n2=en:drug interaction | rel=r_associated | relid=0 | w=138
  142. Oedème --- r_associated #0: 136 --> en:drug interaction
    n1=Oedème | n2=en:drug interaction | rel=r_associated | relid=0 | w=136
  143. Retard de croissance staturo-pondérale --- r_associated #0: 135 --> en:drug interaction
    n1=Retard de croissance staturo-pondérale | n2=en:drug interaction | rel=r_associated | relid=0 | w=135
  144. absence de croissance --- r_associated #0: 135 --> en:drug interaction
    n1=absence de croissance | n2=en:drug interaction | rel=r_associated | relid=0 | w=135
  145. en:virose --- r_associated #0: 135 --> en:drug interaction
    n1=en:virose | n2=en:drug interaction | rel=r_associated | relid=0 | w=135
  146. syndrome du retard de développement --- r_associated #0: 135 --> en:drug interaction
    n1=syndrome du retard de développement | n2=en:drug interaction | rel=r_associated | relid=0 | w=135
  147. murmure cardiaque --- r_associated #0: 134 --> en:drug interaction
    n1=murmure cardiaque | n2=en:drug interaction | rel=r_associated | relid=0 | w=134
  148. en:splenomegaly --- r_associated #0: 132 --> en:drug interaction
    n1=en:splenomegaly | n2=en:drug interaction | rel=r_associated | relid=0 | w=132
  149. en:congenital malformation --- r_associated #0: 130 --> en:drug interaction
    n1=en:congenital malformation | n2=en:drug interaction | rel=r_associated | relid=0 | w=130
  150. overdoses --- r_associated #0: 127 --> en:drug interaction
    n1=overdoses | n2=en:drug interaction | rel=r_associated | relid=0 | w=127
  151. surdosage de médicament ou de drogue --- r_associated #0: 126 --> en:drug interaction
    n1=surdosage de médicament ou de drogue | n2=en:drug interaction | rel=r_associated | relid=0 | w=126
  152. chlamydiose --- r_associated #0: 125 --> en:drug interaction
    n1=chlamydiose | n2=en:drug interaction | rel=r_associated | relid=0 | w=125
  153. souffrance foetale --- r_associated #0: 125 --> en:drug interaction
    n1=souffrance foetale | n2=en:drug interaction | rel=r_associated | relid=0 | w=125
  154. surdose --- r_associated #0: 125 --> en:drug interaction
    n1=surdose | n2=en:drug interaction | rel=r_associated | relid=0 | w=125
  155. vertigo --- r_associated #0: 124 --> en:drug interaction
    n1=vertigo | n2=en:drug interaction | rel=r_associated | relid=0 | w=124
  156. en:balance problem --- r_associated #0: 120 --> en:drug interaction
    n1=en:balance problem | n2=en:drug interaction | rel=r_associated | relid=0 | w=120
  157. en:birth defect --- r_associated #0: 120 --> en:drug interaction
    n1=en:birth defect | n2=en:drug interaction | rel=r_associated | relid=0 | w=120
  158. en:disorder of equilibrium --- r_associated #0: 120 --> en:drug interaction
    n1=en:disorder of equilibrium | n2=en:drug interaction | rel=r_associated | relid=0 | w=120
  159. en:drug overdose --- r_associated #0: 120 --> en:drug interaction
    n1=en:drug overdose | n2=en:drug interaction | rel=r_associated | relid=0 | w=120
  160. en:problem with balance --- r_associated #0: 120 --> en:drug interaction
    n1=en:problem with balance | n2=en:drug interaction | rel=r_associated | relid=0 | w=120
  161. trouble de l'équilibre --- r_associated #0: 120 --> en:drug interaction
    n1=trouble de l'équilibre | n2=en:drug interaction | rel=r_associated | relid=0 | w=120
  162. surdosage --- r_associated #0: 117 --> en:drug interaction
    n1=surdosage | n2=en:drug interaction | rel=r_associated | relid=0 | w=117
  163. maladie de Pierce --- r_associated #0: 115 --> en:drug interaction
    n1=maladie de Pierce | n2=en:drug interaction | rel=r_associated | relid=0 | w=115
  164. lymphoedème non filarien --- r_associated #0: 111 --> en:drug interaction
    n1=lymphoedème non filarien | n2=en:drug interaction | rel=r_associated | relid=0 | w=111
  165. proptose --- r_associated #0: 111 --> en:drug interaction
    n1=proptose | n2=en:drug interaction | rel=r_associated | relid=0 | w=111
  166. œdème --- r_associated #0: 110 --> en:drug interaction
    n1=œdème | n2=en:drug interaction | rel=r_associated | relid=0 | w=110
  167. dose excessive --- r_associated #0: 110 --> en:drug interaction
    n1=dose excessive | n2=en:drug interaction | rel=r_associated | relid=0 | w=110
  168. en:exophthalmos --- r_associated #0: 110 --> en:drug interaction
    n1=en:exophthalmos | n2=en:drug interaction | rel=r_associated | relid=0 | w=110
  169. exophthalmie --- r_associated #0: 110 --> en:drug interaction
    n1=exophthalmie | n2=en:drug interaction | rel=r_associated | relid=0 | w=110
  170. tendinose --- r_associated #0: 110 --> en:drug interaction
    n1=tendinose | n2=en:drug interaction | rel=r_associated | relid=0 | w=110
  171. en:hyperthermia --- r_associated #0: 109 --> en:drug interaction
    n1=en:hyperthermia | n2=en:drug interaction | rel=r_associated | relid=0 | w=109
  172. hyperthermie --- r_associated #0: 106 --> en:drug interaction
    n1=hyperthermie | n2=en:drug interaction | rel=r_associated | relid=0 | w=106
  173. surinfection --- r_associated #0: 106 --> en:drug interaction
    n1=surinfection | n2=en:drug interaction | rel=r_associated | relid=0 | w=106
  174. œdème --- r_associated #0: 106 --> en:drug interaction
    n1=œdème | n2=en:drug interaction | rel=r_associated | relid=0 | w=106
  175. en:superinfection --- r_associated #0: 103 --> en:drug interaction
    n1=en:superinfection | n2=en:drug interaction | rel=r_associated | relid=0 | w=103
  176. exophtalmie --- r_associated #0: 100 --> en:drug interaction
    n1=exophtalmie | n2=en:drug interaction | rel=r_associated | relid=0 | w=100
  177. en:chromosome disorder --- r_associated #0: 95 --> en:drug interaction
    n1=en:chromosome disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=95
  178. superinfection --- r_associated #0: 95 --> en:drug interaction
    n1=superinfection | n2=en:drug interaction | rel=r_associated | relid=0 | w=95
  179. trouble chromosomique --- r_associated #0: 95 --> en:drug interaction
    n1=trouble chromosomique | n2=en:drug interaction | rel=r_associated | relid=0 | w=95
  180. tumeur cancéreuse --- r_associated #0: 95 --> en:drug interaction
    n1=tumeur cancéreuse | n2=en:drug interaction | rel=r_associated | relid=0 | w=95
  181. vertige --- r_associated #0: 95 --> en:drug interaction
    n1=vertige | n2=en:drug interaction | rel=r_associated | relid=0 | w=95
  182. élévation de la température corporelle --- r_associated #0: 95 --> en:drug interaction
    n1=élévation de la température corporelle | n2=en:drug interaction | rel=r_associated | relid=0 | w=95
  183. tampane --- r_associated #0: 94 --> en:drug interaction
    n1=tampane | n2=en:drug interaction | rel=r_associated | relid=0 | w=94
  184. viroses --- r_associated #0: 94 --> en:drug interaction
    n1=viroses | n2=en:drug interaction | rel=r_associated | relid=0 | w=94
  185. en:carcinoma --- r_associated #0: 92 --> en:drug interaction
    n1=en:carcinoma | n2=en:drug interaction | rel=r_associated | relid=0 | w=92
  186. état septique --- r_associated #0: 91 --> en:drug interaction
    n1=état septique | n2=en:drug interaction | rel=r_associated | relid=0 | w=91
  187. anormalité des chromosomes --- r_associated #0: 90 --> en:drug interaction
    n1=anormalité des chromosomes | n2=en:drug interaction | rel=r_associated | relid=0 | w=90
  188. syndrome de l'immunodéficience acquise --- r_associated #0: 90 --> en:drug interaction
    n1=syndrome de l'immunodéficience acquise | n2=en:drug interaction | rel=r_associated | relid=0 | w=90
  189. en:acquired immunodeficiency syndrome --- r_associated #0: 89 --> en:drug interaction
    n1=en:acquired immunodeficiency syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=89
  190. collapsus cardiovasculaire --- r_associated #0: 87 --> en:drug interaction
    n1=collapsus cardiovasculaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=87
  191. asthénie --- r_associated #0: 86 --> en:drug interaction
    n1=asthénie | n2=en:drug interaction | rel=r_associated | relid=0 | w=86
  192. maladies virales --- r_associated #0: 86 --> en:drug interaction
    n1=maladies virales | n2=en:drug interaction | rel=r_associated | relid=0 | w=86
  193. défaillance circulatoire périphérique --- r_associated #0: 85 --> en:drug interaction
    n1=défaillance circulatoire périphérique | n2=en:drug interaction | rel=r_associated | relid=0 | w=85
  194. infections virales --- r_associated #0: 85 --> en:drug interaction
    n1=infections virales | n2=en:drug interaction | rel=r_associated | relid=0 | w=85
  195. syndrome d'immunodéficience acquise --- r_associated #0: 85 --> en:drug interaction
    n1=syndrome d'immunodéficience acquise | n2=en:drug interaction | rel=r_associated | relid=0 | w=85
  196. tare congénitale --- r_associated #0: 85 --> en:drug interaction
    n1=tare congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=85
  197. en:asthenia --- r_associated #0: 84 --> en:drug interaction
    n1=en:asthenia | n2=en:drug interaction | rel=r_associated | relid=0 | w=84
  198. en:polydipsia --- r_associated #0: 81 --> en:drug interaction
    n1=en:polydipsia | n2=en:drug interaction | rel=r_associated | relid=0 | w=81
  199. au black --- r_associated #0: 80 --> en:drug interaction
    n1=au black | n2=en:drug interaction | rel=r_associated | relid=0 | w=80
  200. black-out --- r_associated #0: 80 --> en:drug interaction
    n1=black-out | n2=en:drug interaction | rel=r_associated | relid=0 | w=80
  201. en:blackout --- r_associated #0: 80 --> en:drug interaction
    n1=en:blackout | n2=en:drug interaction | rel=r_associated | relid=0 | w=80
  202. en:cardiac shock --- r_associated #0: 80 --> en:drug interaction
    n1=en:cardiac shock | n2=en:drug interaction | rel=r_associated | relid=0 | w=80
  203. panne d'électricité --- r_associated #0: 80 --> en:drug interaction
    n1=panne d'électricité | n2=en:drug interaction | rel=r_associated | relid=0 | w=80
  204. souffle au coeur --- r_associated #0: 80 --> en:drug interaction
    n1=souffle au coeur | n2=en:drug interaction | rel=r_associated | relid=0 | w=80
  205. étourdissement --- r_associated #0: 80 --> en:drug interaction
    n1=étourdissement | n2=en:drug interaction | rel=r_associated | relid=0 | w=80
  206. soif excessive --- r_associated #0: 78 --> en:drug interaction
    n1=soif excessive | n2=en:drug interaction | rel=r_associated | relid=0 | w=78
  207. maladies infectieuses virales --- r_associated #0: 77 --> en:drug interaction
    n1=maladies infectieuses virales | n2=en:drug interaction | rel=r_associated | relid=0 | w=77
  208. stutter --- r_associated #0: 77 --> en:drug interaction
    n1=stutter | n2=en:drug interaction | rel=r_associated | relid=0 | w=77
  209. en:disease or disorder --- r_associated #0: 76 --> en:drug interaction
    n1=en:disease or disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=76
  210. SIDA --- r_associated #0: 75 --> en:drug interaction
    n1=SIDA | n2=en:drug interaction | rel=r_associated | relid=0 | w=75
  211. collapsus de la circulation périphérique --- r_associated #0: 75 --> en:drug interaction
    n1=collapsus de la circulation périphérique | n2=en:drug interaction | rel=r_associated | relid=0 | w=75
  212. collapsus vasculaire --- r_associated #0: 75 --> en:drug interaction
    n1=collapsus vasculaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=75
  213. disorder --- r_associated #0: 75 --> en:drug interaction
    n1=disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=75
  214. défaillance de la circulation périphérique --- r_associated #0: 75 --> en:drug interaction
    n1=défaillance de la circulation périphérique | n2=en:drug interaction | rel=r_associated | relid=0 | w=75
  215. en:stutter --- r_associated #0: 75 --> en:drug interaction
    n1=en:stutter | n2=en:drug interaction | rel=r_associated | relid=0 | w=75
  216. non précisé, choc --- r_associated #0: 75 --> en:drug interaction
    n1=non précisé, choc | n2=en:drug interaction | rel=r_associated | relid=0 | w=75
  217. polydipsie --- r_associated #0: 75 --> en:drug interaction
    n1=polydipsie | n2=en:drug interaction | rel=r_associated | relid=0 | w=75
  218. en:flu --- r_associated #0: 71 --> en:drug interaction
    n1=en:flu | n2=en:drug interaction | rel=r_associated | relid=0 | w=71
  219. hæmorrhagie --- r_associated #0: 71 --> en:drug interaction
    n1=hæmorrhagie | n2=en:drug interaction | rel=r_associated | relid=0 | w=71
  220. viémies --- r_associated #0: 71 --> en:drug interaction
    n1=viémies | n2=en:drug interaction | rel=r_associated | relid=0 | w=71
  221. bruits cardiaques --- r_associated #0: 70 --> en:drug interaction
    n1=bruits cardiaques | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  222. coupure d'électricité --- r_associated #0: 70 --> en:drug interaction
    n1=coupure d'électricité | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  223. disease --- r_associated #0: 70 --> en:drug interaction
    n1=disease | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  224. défaillance circulatoire --- r_associated #0: 70 --> en:drug interaction
    n1=défaillance circulatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  225. en:communications blackout --- r_associated #0: 70 --> en:drug interaction
    n1=en:communications blackout | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  226. en:dyspnea --- r_associated #0: 70 --> en:drug interaction
    n1=en:dyspnea | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  227. en:media blackout --- r_associated #0: 70 --> en:drug interaction
    n1=en:media blackout | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  228. en:multiracial --- r_associated #0: 70 --> en:drug interaction
    n1=en:multiracial | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  229. en:power cut --- r_associated #0: 70 --> en:drug interaction
    n1=en:power cut | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  230. en:power outage --- r_associated #0: 70 --> en:drug interaction
    n1=en:power outage | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  231. infection à Bedsonia --- r_associated #0: 70 --> en:drug interaction
    n1=infection à Bedsonia | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  232. retard de croissance --- r_associated #0: 70 --> en:drug interaction
    n1=retard de croissance | n2=en:drug interaction | rel=r_associated | relid=0 | w=70
  233. au noir --- r_associated #0: 69 --> en:drug interaction
    n1=au noir | n2=en:drug interaction | rel=r_associated | relid=0 | w=69
  234. en:biosynthetic pathways --- r_associated #0: 69 --> en:drug interaction
    n1=en:biosynthetic pathways | n2=en:drug interaction | rel=r_associated | relid=0 | w=69
  235. en:chlamydiosis --- r_associated #0: 68 --> en:drug interaction
    n1=en:chlamydiosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=68
  236. influenza --- r_associated #0: 68 --> en:drug interaction
    n1=influenza | n2=en:drug interaction | rel=r_associated | relid=0 | w=68
  237. anti-sida --- r_associated #0: 67 --> en:drug interaction
    n1=anti-sida | n2=en:drug interaction | rel=r_associated | relid=0 | w=67
  238. dyspnée --- r_associated #0: 66 --> en:drug interaction
    n1=dyspnée | n2=en:drug interaction | rel=r_associated | relid=0 | w=66
  239. flu --- r_associated #0: 66 --> en:drug interaction
    n1=flu | n2=en:drug interaction | rel=r_associated | relid=0 | w=66
  240. voies biosynthétiques --- r_associated #0: 66 --> en:drug interaction
    n1=voies biosynthétiques | n2=en:drug interaction | rel=r_associated | relid=0 | w=66
  241. en:AIDS --- r_associated #0: 65 --> en:drug interaction
    n1=en:AIDS | n2=en:drug interaction | rel=r_associated | relid=0 | w=65
  242. en:off the books --- r_associated #0: 65 --> en:drug interaction
    n1=en:off the books | n2=en:drug interaction | rel=r_associated | relid=0 | w=65
  243. antisida --- r_associated #0: 64 --> en:drug interaction
    n1=antisida | n2=en:drug interaction | rel=r_associated | relid=0 | w=64
  244. carcinoma --- r_associated #0: 63 --> en:drug interaction
    n1=carcinoma | n2=en:drug interaction | rel=r_associated | relid=0 | w=63
  245. en:excessive thirst --- r_associated #0: 63 --> en:drug interaction
    n1=en:excessive thirst | n2=en:drug interaction | rel=r_associated | relid=0 | w=63
  246. en:black-white-arab --- r_associated #0: 61 --> en:drug interaction
    n1=en:black-white-arab | n2=en:drug interaction | rel=r_associated | relid=0 | w=61
  247. en:chlamydial infection --- r_associated #0: 61 --> en:drug interaction
    n1=en:chlamydial infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=61
  248. en:power failure --- r_associated #0: 61 --> en:drug interaction
    n1=en:power failure | n2=en:drug interaction | rel=r_associated | relid=0 | w=61
  249. en:septicaemia --- r_associated #0: 61 --> en:drug interaction
    n1=en:septicaemia | n2=en:drug interaction | rel=r_associated | relid=0 | w=61
  250. anomalie cytogénétique --- r_associated #0: 60 --> en:drug interaction
    n1=anomalie cytogénétique | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  251. black-blanc-beur --- r_associated #0: 60 --> en:drug interaction
    n1=black-blanc-beur | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  252. choc d'origine vasculaire --- r_associated #0: 60 --> en:drug interaction
    n1=choc d'origine vasculaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  253. coupure de courant --- r_associated #0: 60 --> en:drug interaction
    n1=coupure de courant | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  254. en:illicitly --- r_associated #0: 60 --> en:drug interaction
    n1=en:illicitly | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  255. en:immune deficiency syndrome --- r_associated #0: 60 --> en:drug interaction
    n1=en:immune deficiency syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  256. panne de courant --- r_associated #0: 60 --> en:drug interaction
    n1=panne de courant | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  257. sous la table --- r_associated #0: 60 --> en:drug interaction
    n1=sous la table | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  258. transcription --- r_associated #0: 60 --> en:drug interaction
    n1=transcription | n2=en:drug interaction | rel=r_associated | relid=0 | w=60
  259. coupure d'alimentation --- r_associated #0: 58 --> en:drug interaction
    n1=coupure d'alimentation | n2=en:drug interaction | rel=r_associated | relid=0 | w=58
  260. tachycardie, hypertension, microphtalmie et hyperglycinurie --- r_associated #0: 58 --> en:drug interaction
    n1=tachycardie, hypertension, microphtalmie et hyperglycinurie | n2=en:drug interaction | rel=r_associated | relid=0 | w=58
  261. battement rapide du coeur --- r_associated #0: 56 --> en:drug interaction
    n1=battement rapide du coeur | n2=en:drug interaction | rel=r_associated | relid=0 | w=56
  262. fréquence cardiaque élevée --- r_associated #0: 56 --> en:drug interaction
    n1=fréquence cardiaque élevée | n2=en:drug interaction | rel=r_associated | relid=0 | w=56
  263. cachexie maligne --- r_associated #0: 55 --> en:drug interaction
    n1=cachexie maligne | n2=en:drug interaction | rel=r_associated | relid=0 | w=55
  264. dyspnœe --- r_associated #0: 55 --> en:drug interaction
    n1=dyspnœe | n2=en:drug interaction | rel=r_associated | relid=0 | w=55
  265. en:disease aids --- r_associated #0: 55 --> en:drug interaction
    n1=en:disease aids | n2=en:drug interaction | rel=r_associated | relid=0 | w=55
  266. en:tachycardia --- r_associated #0: 55 --> en:drug interaction
    n1=en:tachycardia | n2=en:drug interaction | rel=r_associated | relid=0 | w=55
  267. insuffisance cardiovasculaire aiguë --- r_associated #0: 55 --> en:drug interaction
    n1=insuffisance cardiovasculaire aiguë | n2=en:drug interaction | rel=r_associated | relid=0 | w=55
  268. insuffisance circulatoire périphérique --- r_associated #0: 55 --> en:drug interaction
    n1=insuffisance circulatoire périphérique | n2=en:drug interaction | rel=r_associated | relid=0 | w=55
  269. tachycardie --- r_associated #0: 55 --> en:drug interaction
    n1=tachycardie | n2=en:drug interaction | rel=r_associated | relid=0 | w=55
  270. dyspnoee --- r_associated #0: 54 --> en:drug interaction
    n1=dyspnoee | n2=en:drug interaction | rel=r_associated | relid=0 | w=54
  271. en:tendinosis --- r_associated #0: 54 --> en:drug interaction
    n1=en:tendinosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=54
  272. fièvre --- r_associated #0: 54 --> en:drug interaction
    n1=fièvre | n2=en:drug interaction | rel=r_associated | relid=0 | w=54
  273. vice de conformation --- r_associated #0: 54 --> en:drug interaction
    n1=vice de conformation | n2=en:drug interaction | rel=r_associated | relid=0 | w=54
  274. en:transcription --- r_associated #0: 53 --> en:drug interaction
    n1=en:transcription | n2=en:drug interaction | rel=r_associated | relid=0 | w=53
  275. État septique --- r_associated #0: 53 --> en:drug interaction
    n1=État septique | n2=en:drug interaction | rel=r_associated | relid=0 | w=53
  276. en:proptosis --- r_associated #0: 52 --> en:drug interaction
    n1=en:proptosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=52
  277. en:foetal distress --- r_associated #0: 51 --> en:drug interaction
    n1=en:foetal distress | n2=en:drug interaction | rel=r_associated | relid=0 | w=51
  278. S.I.D.A. --- r_associated #0: 50 --> en:drug interaction
    n1=S.I.D.A. | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  279. amaigrissement pathologique --- r_associated #0: 50 --> en:drug interaction
    n1=amaigrissement pathologique | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  280. en:AIDS awareness --- r_associated #0: 50 --> en:drug interaction
    n1=en:AIDS awareness | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  281. en:blood-poisoning --- r_associated #0: 50 --> en:drug interaction
    n1=en:blood-poisoning | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  282. en:cardioneurosis --- r_associated #0: 50 --> en:drug interaction
    n1=en:cardioneurosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  283. en:effort syndrome --- r_associated #0: 50 --> en:drug interaction
    n1=en:effort syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  284. en:mycosis --- r_associated #0: 50 --> en:drug interaction
    n1=en:mycosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  285. hémorragie d'un point d'injection --- r_associated #0: 50 --> en:drug interaction
    n1=hémorragie d'un point d'injection | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  286. marasme nutritionnel --- r_associated #0: 50 --> en:drug interaction
    n1=marasme nutritionnel | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  287. mycose --- r_associated #0: 50 --> en:drug interaction
    n1=mycose | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  288. tendinite --- r_associated #0: 50 --> en:drug interaction
    n1=tendinite | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  289. tendinites --- r_associated #0: 50 --> en:drug interaction
    n1=tendinites | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  290. érythème --- r_associated #0: 50 --> en:drug interaction
    n1=érythème | n2=en:drug interaction | rel=r_associated | relid=0 | w=50
  291. en:erythema --- r_associated #0: 49 --> en:drug interaction
    n1=en:erythema | n2=en:drug interaction | rel=r_associated | relid=0 | w=49
  292. en:overdosing --- r_associated #0: 49 --> en:drug interaction
    n1=en:overdosing | n2=en:drug interaction | rel=r_associated | relid=0 | w=49
  293. en:swelling --- r_associated #0: 49 --> en:drug interaction
    n1=en:swelling | n2=en:drug interaction | rel=r_associated | relid=0 | w=49
  294. syncope bleue --- r_associated #0: 49 --> en:drug interaction
    n1=syncope bleue | n2=en:drug interaction | rel=r_associated | relid=0 | w=49
  295. cancer épithélial --- r_associated #0: 48 --> en:drug interaction
    n1=cancer épithélial | n2=en:drug interaction | rel=r_associated | relid=0 | w=48
  296. en:physical defect --- r_associated #0: 48 --> en:drug interaction
    n1=en:physical defect | n2=en:drug interaction | rel=r_associated | relid=0 | w=48
  297. mycosis --- r_associated #0: 48 --> en:drug interaction
    n1=mycosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=48
  298. en:fungal infection --- r_associated #0: 47 --> en:drug interaction
    n1=en:fungal infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=47
  299. en:major physical defect --- r_associated #0: 47 --> en:drug interaction
    n1=en:major physical defect | n2=en:drug interaction | rel=r_associated | relid=0 | w=47
  300. en:tachyrhythmia --- r_associated #0: 47 --> en:drug interaction
    n1=en:tachyrhythmia | n2=en:drug interaction | rel=r_associated | relid=0 | w=47
  301. gêne respiratoire --- r_associated #0: 47 --> en:drug interaction
    n1=gêne respiratoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=47
  302. syndrome de l'acide rétinoïque --- r_associated #0: 47 --> en:drug interaction
    n1=syndrome de l'acide rétinoïque | n2=en:drug interaction | rel=r_associated | relid=0 | w=47
  303. claudication --- r_associated #0: 46 --> en:drug interaction
    n1=claudication | n2=en:drug interaction | rel=r_associated | relid=0 | w=46
  304. en:oedema --- r_associated #0: 46 --> en:drug interaction
    n1=en:oedema | n2=en:drug interaction | rel=r_associated | relid=0 | w=46
  305. erythema --- r_associated #0: 46 --> en:drug interaction
    n1=erythema | n2=en:drug interaction | rel=r_associated | relid=0 | w=46
  306. point saignant au site d'injection --- r_associated #0: 46 --> en:drug interaction
    n1=point saignant au site d'injection | n2=en:drug interaction | rel=r_associated | relid=0 | w=46
  307. énophtalmie --- r_associated #0: 46 --> en:drug interaction
    n1=énophtalmie | n2=en:drug interaction | rel=r_associated | relid=0 | w=46
  308. en:disorder --- r_associated #0: 45 --> en:drug interaction
    n1=en:disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=45
  309. en:injection site hemorrhage --- r_associated #0: 45 --> en:drug interaction
    n1=en:injection site hemorrhage | n2=en:drug interaction | rel=r_associated | relid=0 | w=45
  310. enflé --- r_associated #0: 45 --> en:drug interaction
    n1=enflé | n2=en:drug interaction | rel=r_associated | relid=0 | w=45
  311. hémorragie au point d'injection --- r_associated #0: 45 --> en:drug interaction
    n1=hémorragie au point d'injection | n2=en:drug interaction | rel=r_associated | relid=0 | w=45
  312. multiracial --- r_associated #0: 45 --> en:drug interaction
    n1=multiracial | n2=en:drug interaction | rel=r_associated | relid=0 | w=45
  313. syndrome de dépérissement --- r_associated #0: 45 --> en:drug interaction
    n1=syndrome de dépérissement | n2=en:drug interaction | rel=r_associated | relid=0 | w=45
  314. tuméfié --- r_associated #0: 45 --> en:drug interaction
    n1=tuméfié | n2=en:drug interaction | rel=r_associated | relid=0 | w=45
  315. État infectieux --- r_associated #0: 45 --> en:drug interaction
    n1=État infectieux | n2=en:drug interaction | rel=r_associated | relid=0 | w=45
  316. agnosie --- r_associated #0: 44 --> en:drug interaction
    n1=agnosie | n2=en:drug interaction | rel=r_associated | relid=0 | w=44
  317. en:rotary vertigo --- r_associated #0: 44 --> en:drug interaction
    n1=en:rotary vertigo | n2=en:drug interaction | rel=r_associated | relid=0 | w=44
  318. syncope blanche --- r_associated #0: 44 --> en:drug interaction
    n1=syncope blanche | n2=en:drug interaction | rel=r_associated | relid=0 | w=44
  319. en:claudication --- r_associated #0: 43 --> en:drug interaction
    n1=en:claudication | n2=en:drug interaction | rel=r_associated | relid=0 | w=43
  320. en:feebleness --- r_associated #0: 43 --> en:drug interaction
    n1=en:feebleness | n2=en:drug interaction | rel=r_associated | relid=0 | w=43
  321. en:immunology aspects --- r_associated #0: 43 --> en:drug interaction
    n1=en:immunology aspects | n2=en:drug interaction | rel=r_associated | relid=0 | w=43
  322. en:physiological aspects --- r_associated #0: 43 --> en:drug interaction
    n1=en:physiological aspects | n2=en:drug interaction | rel=r_associated | relid=0 | w=43
  323. fever --- r_associated #0: 43 --> en:drug interaction
    n1=fever | n2=en:drug interaction | rel=r_associated | relid=0 | w=43
  324. en:enophthalmos --- r_associated #0: 42 --> en:drug interaction
    n1=en:enophthalmos | n2=en:drug interaction | rel=r_associated | relid=0 | w=42
  325. en:hypothermia adverse event --- r_associated #0: 42 --> en:drug interaction
    n1=en:hypothermia adverse event | n2=en:drug interaction | rel=r_associated | relid=0 | w=42
  326. en:ichoremia --- r_associated #0: 42 --> en:drug interaction
    n1=en:ichoremia | n2=en:drug interaction | rel=r_associated | relid=0 | w=42
  327. en:septic infection --- r_associated #0: 42 --> en:drug interaction
    n1=en:septic infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=42
  328. en:synchopexia --- r_associated #0: 42 --> en:drug interaction
    n1=en:synchopexia | n2=en:drug interaction | rel=r_associated | relid=0 | w=42
  329. Perte de connaissance --- r_associated #0: 41 --> en:drug interaction
    n1=Perte de connaissance | n2=en:drug interaction | rel=r_associated | relid=0 | w=41
  330. adénome --- r_associated #0: 41 --> en:drug interaction
    n1=adénome | n2=en:drug interaction | rel=r_associated | relid=0 | w=41
  331. anomalie du développement --- r_associated #0: 41 --> en:drug interaction
    n1=anomalie du développement | n2=en:drug interaction | rel=r_associated | relid=0 | w=41
  332. carcinôme --- r_associated #0: 41 --> en:drug interaction
    n1=carcinôme | n2=en:drug interaction | rel=r_associated | relid=0 | w=41
  333. en:agnosia --- r_associated #0: 41 --> en:drug interaction
    n1=en:agnosia | n2=en:drug interaction | rel=r_associated | relid=0 | w=41
  334. en:halitosis --- r_associated #0: 41 --> en:drug interaction
    n1=en:halitosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=41
  335. en:septicaema --- r_associated #0: 41 --> en:drug interaction
    n1=en:septicaema | n2=en:drug interaction | rel=r_associated | relid=0 | w=41
  336. en:teratosis --- r_associated #0: 41 --> en:drug interaction
    n1=en:teratosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=41
  337. carcinome --- r_associated #0: 40 --> en:drug interaction
    n1=carcinome | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  338. en:adenoma --- r_associated #0: 40 --> en:drug interaction
    n1=en:adenoma | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  339. en:cachexia --- r_associated #0: 40 --> en:drug interaction
    n1=en:cachexia | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  340. en:disease --- r_associated #0: 40 --> en:drug interaction
    n1=en:disease | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  341. en:hot flushes --- r_associated #0: 40 --> en:drug interaction
    n1=en:hot flushes | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  342. en:senile dementia --- r_associated #0: 40 --> en:drug interaction
    n1=en:senile dementia | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  343. infection surajoutée --- r_associated #0: 40 --> en:drug interaction
    n1=infection surajoutée | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  344. insuffisance circulatoire aiguë --- r_associated #0: 40 --> en:drug interaction
    n1=insuffisance circulatoire aiguë | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  345. souffle au cœur --- r_associated #0: 40 --> en:drug interaction
    n1=souffle au cœur | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  346. syndrome cachectique dû au vih --- r_associated #0: 40 --> en:drug interaction
    n1=syndrome cachectique dû au vih | n2=en:drug interaction | rel=r_associated | relid=0 | w=40
  347. Voile noir --- r_associated #0: 39 --> en:drug interaction
    n1=Voile noir | n2=en:drug interaction | rel=r_associated | relid=0 | w=39
  348. en:atrophia --- r_associated #0: 39 --> en:drug interaction
    n1=en:atrophia | n2=en:drug interaction | rel=r_associated | relid=0 | w=39
  349. en:digestive system signs and symptoms --- r_associated #0: 39 --> en:drug interaction
    n1=en:digestive system signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=39
  350. en:fungus infection --- r_associated #0: 39 --> en:drug interaction
    n1=en:fungus infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=39
  351. en:low cardiac output --- r_associated #0: 39 --> en:drug interaction
    n1=en:low cardiac output | n2=en:drug interaction | rel=r_associated | relid=0 | w=39
  352. en:macies --- r_associated #0: 39 --> en:drug interaction
    n1=en:macies | n2=en:drug interaction | rel=r_associated | relid=0 | w=39
  353. en:sign --- r_associated #0: 39 --> en:drug interaction
    n1=en:sign | n2=en:drug interaction | rel=r_associated | relid=0 | w=39
  354. en:tachysystole --- r_associated #0: 39 --> en:drug interaction
    n1=en:tachysystole | n2=en:drug interaction | rel=r_associated | relid=0 | w=39
  355. en:overdose accidental --- r_associated #0: 38 --> en:drug interaction
    n1=en:overdose accidental | n2=en:drug interaction | rel=r_associated | relid=0 | w=38
  356. en:severe neonatal distress --- r_associated #0: 38 --> en:drug interaction
    n1=en:severe neonatal distress | n2=en:drug interaction | rel=r_associated | relid=0 | w=38
  357. en:side effects of drug --- r_associated #0: 38 --> en:drug interaction
    n1=en:side effects of drug | n2=en:drug interaction | rel=r_associated | relid=0 | w=38
  358. granulome inflammatoire --- r_associated #0: 38 --> en:drug interaction
    n1=granulome inflammatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=38
  359. hématurie macroscopique --- r_associated #0: 38 --> en:drug interaction
    n1=hématurie macroscopique | n2=en:drug interaction | rel=r_associated | relid=0 | w=38
  360. en:apraxias --- r_associated #0: 37 --> en:drug interaction
    n1=en:apraxias | n2=en:drug interaction | rel=r_associated | relid=0 | w=37
  361. en:influenza --- r_associated #0: 37 --> en:drug interaction
    n1=en:influenza | n2=en:drug interaction | rel=r_associated | relid=0 | w=37
  362. en:virosis --- r_associated #0: 37 --> en:drug interaction
    n1=en:virosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=37
  363. maladie mycotique --- r_associated #0: 37 --> en:drug interaction
    n1=maladie mycotique | n2=en:drug interaction | rel=r_associated | relid=0 | w=37
  364. en:neonatal distress --- r_associated #0: 36 --> en:drug interaction
    n1=en:neonatal distress | n2=en:drug interaction | rel=r_associated | relid=0 | w=36
  365. en:radiation interaction --- r_associated #0: 36 --> en:drug interaction
    n1=en:radiation interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=36
  366. incontinence urinaire --- r_associated #0: 36 --> en:drug interaction
    n1=incontinence urinaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=36
  367. poids corporel --- r_associated #0: 36 --> en:drug interaction
    n1=poids corporel | n2=en:drug interaction | rel=r_associated | relid=0 | w=36
  368. tumescence --- r_associated #0: 36 --> en:drug interaction
    n1=tumescence | n2=en:drug interaction | rel=r_associated | relid=0 | w=36
  369. collapsus cardio-vasculaire --- r_associated #0: 35 --> en:drug interaction
    n1=collapsus cardio-vasculaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  370. collapsus circulatoire --- r_associated #0: 35 --> en:drug interaction
    n1=collapsus circulatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  371. en:SIDS --- r_associated #0: 35 --> en:drug interaction
    n1=en:SIDS | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  372. en:allergic reaction --- r_associated #0: 35 --> en:drug interaction
    n1=en:allergic reaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  373. en:altered hormone level (nos) --- r_associated #0: 35 --> en:drug interaction
    n1=en:altered hormone level (nos) | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  374. en:body weight --- r_associated #0: 35 --> en:drug interaction
    n1=en:body weight | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  375. en:cot death --- r_associated #0: 35 --> en:drug interaction
    n1=en:cot death | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  376. en:crib death --- r_associated #0: 35 --> en:drug interaction
    n1=en:crib death | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  377. en:decreased immunoglobulin --- r_associated #0: 35 --> en:drug interaction
    n1=en:decreased immunoglobulin | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  378. en:depression, chemical --- r_associated #0: 35 --> en:drug interaction
    n1=en:depression, chemical | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  379. en:drug effect disorder --- r_associated #0: 35 --> en:drug interaction
    n1=en:drug effect disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  380. en:drug inverse agonism --- r_associated #0: 35 --> en:drug interaction
    n1=en:drug inverse agonism | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  381. en:drug physiologic incompatibility --- r_associated #0: 35 --> en:drug interaction
    n1=en:drug physiologic incompatibility | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  382. en:ectromelia --- r_associated #0: 35 --> en:drug interaction
    n1=en:ectromelia | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  383. en:effect of exposure to physical force --- r_associated #0: 35 --> en:drug interaction
    n1=en:effect of exposure to physical force | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  384. en:encopresis --- r_associated #0: 35 --> en:drug interaction
    n1=en:encopresis | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  385. en:ethnologic --- r_associated #0: 35 --> en:drug interaction
    n1=en:ethnologic | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  386. en:fever chills --- r_associated #0: 35 --> en:drug interaction
    n1=en:fever chills | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  387. en:gangrene --- r_associated #0: 35 --> en:drug interaction
    n1=en:gangrene | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  388. en:herb-drug interactions --- r_associated #0: 35 --> en:drug interaction
    n1=en:herb-drug interactions | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  389. en:injection site cyst --- r_associated #0: 35 --> en:drug interaction
    n1=en:injection site cyst | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  390. en:injection site edema --- r_associated #0: 35 --> en:drug interaction
    n1=en:injection site edema | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  391. en:injection site hypersensitivity --- r_associated #0: 35 --> en:drug interaction
    n1=en:injection site hypersensitivity | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  392. en:labelled drug-disease interaction medication error --- r_associated #0: 35 --> en:drug interaction
    n1=en:labelled drug-disease interaction medication error | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  393. en:metabolic process --- r_associated #0: 35 --> en:drug interaction
    n1=en:metabolic process | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  394. en:neurologic manifestations --- r_associated #0: 35 --> en:drug interaction
    n1=en:neurologic manifestations | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  395. en:oral manifestations --- r_associated #0: 35 --> en:drug interaction
    n1=en:oral manifestations | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  396. en:pollutant interaction --- r_associated #0: 35 --> en:drug interaction
    n1=en:pollutant interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  397. en:potentiating drug interaction --- r_associated #0: 35 --> en:drug interaction
    n1=en:potentiating drug interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  398. en:skin manifestations --- r_associated #0: 35 --> en:drug interaction
    n1=en:skin manifestations | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  399. en:sudden infant death syndrome --- r_associated #0: 35 --> en:drug interaction
    n1=en:sudden infant death syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  400. en:transport process --- r_associated #0: 35 --> en:drug interaction
    n1=en:transport process | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  401. en:unexpected therapeutic effect --- r_associated #0: 35 --> en:drug interaction
    n1=en:unexpected therapeutic effect | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  402. gonflement --- r_associated #0: 35 --> en:drug interaction
    n1=gonflement | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  403. intumescence --- r_associated #0: 35 --> en:drug interaction
    n1=intumescence | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  404. mort subite du nourrisson --- r_associated #0: 35 --> en:drug interaction
    n1=mort subite du nourrisson | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  405. syncope et collapsus --- r_associated #0: 35 --> en:drug interaction
    n1=syncope et collapsus | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  406. syndrome de la mort subite du nourrisson --- r_associated #0: 35 --> en:drug interaction
    n1=syndrome de la mort subite du nourrisson | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  407. tuméfaction --- r_associated #0: 35 --> en:drug interaction
    n1=tuméfaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=35
  408. en:disease of mucous membrane --- r_associated #0: 34 --> en:drug interaction
    n1=en:disease of mucous membrane | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  409. en:enzyme activity finding --- r_associated #0: 34 --> en:drug interaction
    n1=en:enzyme activity finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  410. en:granuloma --- r_associated #0: 34 --> en:drug interaction
    n1=en:granuloma | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  411. en:hematuria --- r_associated #0: 34 --> en:drug interaction
    n1=en:hematuria | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  412. en:infection --- r_associated #0: 34 --> en:drug interaction
    n1=en:infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  413. en:injection site granuloma --- r_associated #0: 34 --> en:drug interaction
    n1=en:injection site granuloma | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  414. en:injection site pain --- r_associated #0: 34 --> en:drug interaction
    n1=en:injection site pain | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  415. en:intentional trauma --- r_associated #0: 34 --> en:drug interaction
    n1=en:intentional trauma | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  416. en:malignant hyperthermia syndrome --- r_associated #0: 34 --> en:drug interaction
    n1=en:malignant hyperthermia syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  417. en:nervous system finding --- r_associated #0: 34 --> en:drug interaction
    n1=en:nervous system finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  418. en:orthostatic low blood pressure --- r_associated #0: 34 --> en:drug interaction
    n1=en:orthostatic low blood pressure | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  419. en:osmosis --- r_associated #0: 34 --> en:drug interaction
    n1=en:osmosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  420. en:pneumatosis --- r_associated #0: 34 --> en:drug interaction
    n1=en:pneumatosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  421. en:tobacco interaction --- r_associated #0: 34 --> en:drug interaction
    n1=en:tobacco interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  422. interaction --- r_associated #0: 34 --> en:drug interaction
    n1=interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  423. interaction en épidémiologie --- r_associated #0: 34 --> en:drug interaction
    n1=interaction en épidémiologie | n2=en:drug interaction | rel=r_associated | relid=0 | w=34
  424. en:fungus disease --- r_associated #0: 33 --> en:drug interaction
    n1=en:fungus disease | n2=en:drug interaction | rel=r_associated | relid=0 | w=33
  425. en:incontinence --- r_associated #0: 33 --> en:drug interaction
    n1=en:incontinence | n2=en:drug interaction | rel=r_associated | relid=0 | w=33
  426. en:systemic infection --- r_associated #0: 33 --> en:drug interaction
    n1=en:systemic infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=33
  427. erreur de médication --- r_associated #0: 33 --> en:drug interaction
    n1=erreur de médication | n2=en:drug interaction | rel=r_associated | relid=0 | w=33
  428. en:abnormal virilization --- r_associated #0: 32 --> en:drug interaction
    n1=en:abnormal virilization | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  429. en:aerobiosis --- r_associated #0: 32 --> en:drug interaction
    n1=en:aerobiosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  430. en:body odor --- r_associated #0: 32 --> en:drug interaction
    n1=en:body odor | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  431. en:child's sudden death --- r_associated #0: 32 --> en:drug interaction
    n1=en:child's sudden death | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  432. en:cyst --- r_associated #0: 32 --> en:drug interaction
    n1=en:cyst | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  433. en:drug-drug pharmacodynamic interaction --- r_associated #0: 32 --> en:drug interaction
    n1=en:drug-drug pharmacodynamic interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  434. en:finding of measures of urine output --- r_associated #0: 32 --> en:drug interaction
    n1=en:finding of measures of urine output | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  435. en:jaundice --- r_associated #0: 32 --> en:drug interaction
    n1=en:jaundice | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  436. en:medication error --- r_associated #0: 32 --> en:drug interaction
    n1=en:medication error | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  437. en:metaplasia --- r_associated #0: 32 --> en:drug interaction
    n1=en:metaplasia | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  438. en:reticulocytosis --- r_associated #0: 32 --> en:drug interaction
    n1=en:reticulocytosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  439. encoprésie --- r_associated #0: 32 --> en:drug interaction
    n1=encoprésie | n2=en:drug interaction | rel=r_associated | relid=0 | w=32
  440. ectromélie --- r_associated #0: 31 --> en:drug interaction
    n1=ectromélie | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  441. en:alcohol interaction --- r_associated #0: 31 --> en:drug interaction
    n1=en:alcohol interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  442. en:calculus finding --- r_associated #0: 31 --> en:drug interaction
    n1=en:calculus finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  443. en:chemical exposure --- r_associated #0: 31 --> en:drug interaction
    n1=en:chemical exposure | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  444. en:fecal incontinence --- r_associated #0: 31 --> en:drug interaction
    n1=en:fecal incontinence | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  445. en:food interaction --- r_associated #0: 31 --> en:drug interaction
    n1=en:food interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  446. en:food-drug interactions --- r_associated #0: 31 --> en:drug interaction
    n1=en:food-drug interactions | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  447. en:general clinical state finding --- r_associated #0: 31 --> en:drug interaction
    n1=en:general clinical state finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  448. en:hangover from any alcohol or other drugs substance --- r_associated #0: 31 --> en:drug interaction
    n1=en:hangover from any alcohol or other drugs substance | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  449. en:interaction --- r_associated #0: 31 --> en:drug interaction
    n1=en:interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  450. en:protopsis --- r_associated #0: 31 --> en:drug interaction
    n1=en:protopsis | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  451. en:radiation damage --- r_associated #0: 31 --> en:drug interaction
    n1=en:radiation damage | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  452. en:reaction aggravation --- r_associated #0: 31 --> en:drug interaction
    n1=en:reaction aggravation | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  453. en:tuberculosis aggravated --- r_associated #0: 31 --> en:drug interaction
    n1=en:tuberculosis aggravated | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  454. en:withdrawal and rebound effects --- r_associated #0: 31 --> en:drug interaction
    n1=en:withdrawal and rebound effects | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  455. enophtalmie --- r_associated #0: 31 --> en:drug interaction
    n1=enophtalmie | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  456. halitose --- r_associated #0: 31 --> en:drug interaction
    n1=halitose | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  457. métaplasie --- r_associated #0: 31 --> en:drug interaction
    n1=métaplasie | n2=en:drug interaction | rel=r_associated | relid=0 | w=31
  458. Infection bactérienne --- r_associated #0: 30 --> en:drug interaction
    n1=Infection bactérienne | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  459. bégaye --- r_associated #0: 30 --> en:drug interaction
    n1=bégaye | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  460. choc circulatoire --- r_associated #0: 30 --> en:drug interaction
    n1=choc circulatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  461. démence (sémiologie) --- r_associated #0: 30 --> en:drug interaction
    n1=démence (sémiologie) | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  462. en:abscess --- r_associated #0: 30 --> en:drug interaction
    n1=en:abscess | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  463. en:aconuresis --- r_associated #0: 30 --> en:drug interaction
    n1=en:aconuresis | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  464. en:aids --- r_associated #0: 30 --> en:drug interaction
    n1=en:aids | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  465. en:altered neurotransmitter level (nos) --- r_associated #0: 30 --> en:drug interaction
    n1=en:altered neurotransmitter level (nos) | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  466. en:anti-AIDS --- r_associated #0: 30 --> en:drug interaction
    n1=en:anti-AIDS | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  467. en:biocatalysis --- r_associated #0: 30 --> en:drug interaction
    n1=en:biocatalysis | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  468. en:chills --- r_associated #0: 30 --> en:drug interaction
    n1=en:chills | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  469. en:chromosomal aberration --- r_associated #0: 30 --> en:drug interaction
    n1=en:chromosomal aberration | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  470. en:cognitive deficit in psychomotor function --- r_associated #0: 30 --> en:drug interaction
    n1=en:cognitive deficit in psychomotor function | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  471. en:decreased drug level --- r_associated #0: 30 --> en:drug interaction
    n1=en:decreased drug level | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  472. en:developmental fault --- r_associated #0: 30 --> en:drug interaction
    n1=en:developmental fault | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  473. en:device interaction --- r_associated #0: 30 --> en:drug interaction
    n1=en:device interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  474. en:drug resistance process --- r_associated #0: 30 --> en:drug interaction
    n1=en:drug resistance process | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  475. en:drug therapeutic incompatibility --- r_associated #0: 30 --> en:drug interaction
    n1=en:drug therapeutic incompatibility | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  476. en:drug-drug interaction --- r_associated #0: 30 --> en:drug interaction
    n1=en:drug-drug interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  477. en:dyspnoea --- r_associated #0: 30 --> en:drug interaction
    n1=en:dyspnoea | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  478. en:evaluation finding --- r_associated #0: 30 --> en:drug interaction
    n1=en:evaluation finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  479. en:finding by site --- r_associated #0: 30 --> en:drug interaction
    n1=en:finding by site | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  480. en:low birth weight --- r_associated #0: 30 --> en:drug interaction
    n1=en:low birth weight | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  481. en:potentiation, drug --- r_associated #0: 30 --> en:drug interaction
    n1=en:potentiation, drug | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  482. en:power black out --- r_associated #0: 30 --> en:drug interaction
    n1=en:power black out | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  483. en:power loss --- r_associated #0: 30 --> en:drug interaction
    n1=en:power loss | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  484. en:sids --- r_associated #0: 30 --> en:drug interaction
    n1=en:sids | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  485. en:tendinitis --- r_associated #0: 30 --> en:drug interaction
    n1=en:tendinitis | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  486. en:wasting syndrome --- r_associated #0: 30 --> en:drug interaction
    n1=en:wasting syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  487. incontinence d'urine --- r_associated #0: 30 --> en:drug interaction
    n1=incontinence d'urine | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  488. mauvaise haleine --- r_associated #0: 30 --> en:drug interaction
    n1=mauvaise haleine | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  489. proptosis --- r_associated #0: 30 --> en:drug interaction
    n1=proptosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  490. présentation sacro-iliaque droite antérieure --- r_associated #0: 30 --> en:drug interaction
    n1=présentation sacro-iliaque droite antérieure | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  491. surdoser --- r_associated #0: 30 --> en:drug interaction
    n1=surdoser | n2=en:drug interaction | rel=r_associated | relid=0 | w=30
  492. en:adverse drug interaction --- r_associated #0: 29 --> en:drug interaction
    n1=en:adverse drug interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  493. en:bad break --- r_associated #0: 29 --> en:drug interaction
    n1=en:bad break | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  494. en:cardiovascular system signs and symptoms --- r_associated #0: 29 --> en:drug interaction
    n1=en:cardiovascular system signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  495. en:congenital or acquired anatomic abnormality --- r_associated #0: 29 --> en:drug interaction
    n1=en:congenital or acquired anatomic abnormality | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  496. en:drug-drug pharmacokinetic interaction --- r_associated #0: 29 --> en:drug interaction
    n1=en:drug-drug pharmacokinetic interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  497. en:enlarged spleen --- r_associated #0: 29 --> en:drug interaction
    n1=en:enlarged spleen | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  498. en:fervescence --- r_associated #0: 29 --> en:drug interaction
    n1=en:fervescence | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  499. en:heat stroke --- r_associated #0: 29 --> en:drug interaction
    n1=en:heat stroke | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  500. en:hyperthermy --- r_associated #0: 29 --> en:drug interaction
    n1=en:hyperthermy | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  501. en:increased immunoglobulin --- r_associated #0: 29 --> en:drug interaction
    n1=en:increased immunoglobulin | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  502. en:masked infection --- r_associated #0: 29 --> en:drug interaction
    n1=en:masked infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  503. en:pain --- r_associated #0: 29 --> en:drug interaction
    n1=en:pain | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  504. en:prodromal symptoms --- r_associated #0: 29 --> en:drug interaction
    n1=en:prodromal symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  505. en:stimulation, chemical --- r_associated #0: 29 --> en:drug interaction
    n1=en:stimulation, chemical | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  506. en:ventilation or perfusion signs and symptoms --- r_associated #0: 29 --> en:drug interaction
    n1=en:ventilation or perfusion signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  507. en:yeast infection --- r_associated #0: 29 --> en:drug interaction
    n1=en:yeast infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  508. illicitement --- r_associated #0: 29 --> en:drug interaction
    n1=illicitement | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  509. virémie --- r_associated #0: 29 --> en:drug interaction
    n1=virémie | n2=en:drug interaction | rel=r_associated | relid=0 | w=29
  510. angl. NSE --- r_associated #0: 28 --> en:drug interaction
    n1=angl. NSE | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  511. des bouffées de chaleur --- r_associated #0: 28 --> en:drug interaction
    n1=des bouffées de chaleur | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  512. en:drug action increased --- r_associated #0: 28 --> en:drug interaction
    n1=en:drug action increased | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  513. en:drug tolerance --- r_associated #0: 28 --> en:drug interaction
    n1=en:drug tolerance | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  514. en:electricity cut --- r_associated #0: 28 --> en:drug interaction
    n1=en:electricity cut | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  515. en:feminization --- r_associated #0: 28 --> en:drug interaction
    n1=en:feminization | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  516. en:fever, sweat, and hot flashes --- r_associated #0: 28 --> en:drug interaction
    n1=en:fever, sweat, and hot flashes | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  517. en:finding reported by subject or history provider --- r_associated #0: 28 --> en:drug interaction
    n1=en:finding reported by subject or history provider | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  518. en:incontinentia urinae --- r_associated #0: 28 --> en:drug interaction
    n1=en:incontinentia urinae | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  519. en:injection site fibrosis --- r_associated #0: 28 --> en:drug interaction
    n1=en:injection site fibrosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  520. en:necrotic process --- r_associated #0: 28 --> en:drug interaction
    n1=en:necrotic process | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  521. en:oncosis --- r_associated #0: 28 --> en:drug interaction
    n1=en:oncosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  522. en:perinatal disorder --- r_associated #0: 28 --> en:drug interaction
    n1=en:perinatal disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  523. en:symptom --- r_associated #0: 28 --> en:drug interaction
    n1=en:symptom | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  524. en:tumor lysis syndrome adverse event --- r_associated #0: 28 --> en:drug interaction
    n1=en:tumor lysis syndrome adverse event | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  525. en:unintentional voiding of urine --- r_associated #0: 28 --> en:drug interaction
    n1=en:unintentional voiding of urine | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  526. malformation --- r_associated #0: 28 --> en:drug interaction
    n1=malformation | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  527. température corporelle élevée --- r_associated #0: 28 --> en:drug interaction
    n1=température corporelle élevée | n2=en:drug interaction | rel=r_associated | relid=0 | w=28
  528. TULV --- r_associated #0: 27 --> en:drug interaction
    n1=TULV | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  529. en:OD --- r_associated #0: 27 --> en:drug interaction
    n1=en:OD | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  530. en:adenomata --- r_associated #0: 27 --> en:drug interaction
    n1=en:adenomata | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  531. en:bacterial resistance --- r_associated #0: 27 --> en:drug interaction
    n1=en:bacterial resistance | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  532. en:cancerous tumour --- r_associated #0: 27 --> en:drug interaction
    n1=en:cancerous tumour | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  533. en:disturbance of equilibrium --- r_associated #0: 27 --> en:drug interaction
    n1=en:disturbance of equilibrium | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  534. en:faecal incontinence --- r_associated #0: 27 --> en:drug interaction
    n1=en:faecal incontinence | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  535. en:flushing --- r_associated #0: 27 --> en:drug interaction
    n1=en:flushing | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  536. en:heat-stroke --- r_associated #0: 27 --> en:drug interaction
    n1=en:heat-stroke | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  537. en:injection site necrosis --- r_associated #0: 27 --> en:drug interaction
    n1=en:injection site necrosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  538. en:labelled drug-drug interaction medication error --- r_associated #0: 27 --> en:drug interaction
    n1=en:labelled drug-drug interaction medication error | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  539. en:labelled drug-food interaction medication error --- r_associated #0: 27 --> en:drug interaction
    n1=en:labelled drug-food interaction medication error | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  540. en:neurocirculatory astheny --- r_associated #0: 27 --> en:drug interaction
    n1=en:neurocirculatory astheny | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  541. en:photosensitive dermatitis --- r_associated #0: 27 --> en:drug interaction
    n1=en:photosensitive dermatitis | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  542. en:premature aging syndrome --- r_associated #0: 27 --> en:drug interaction
    n1=en:premature aging syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  543. en:synergism --- r_associated #0: 27 --> en:drug interaction
    n1=en:synergism | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  544. en:therapeutic and nontherapeutic responses --- r_associated #0: 27 --> en:drug interaction
    n1=en:therapeutic and nontherapeutic responses | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  545. en:unevaluable reaction --- r_associated #0: 27 --> en:drug interaction
    n1=en:unevaluable reaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  546. en:urinary incontinence --- r_associated #0: 27 --> en:drug interaction
    n1=en:urinary incontinence | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  547. en:water thesaurismosis --- r_associated #0: 27 --> en:drug interaction
    n1=en:water thesaurismosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  548. en:wound finding --- r_associated #0: 27 --> en:drug interaction
    n1=en:wound finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  549. ethnologique --- r_associated #0: 27 --> en:drug interaction
    n1=ethnologique | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  550. hématurie --- r_associated #0: 27 --> en:drug interaction
    n1=hématurie | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  551. interactions --- r_associated #0: 27 --> en:drug interaction
    n1=interactions | n2=en:drug interaction | rel=r_associated | relid=0 | w=27
  552. Maladie congénitale --- r_associated #0: 26 --> en:drug interaction
    n1=Maladie congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  553. en:Flushing --- r_associated #0: 26 --> en:drug interaction
    n1=en:Flushing | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  554. en:accidental injury --- r_associated #0: 26 --> en:drug interaction
    n1=en:accidental injury | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  555. en:adverse incident outcome categories --- r_associated #0: 26 --> en:drug interaction
    n1=en:adverse incident outcome categories | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  556. en:clinical history and observation findings --- r_associated #0: 26 --> en:drug interaction
    n1=en:clinical history and observation findings | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  557. en:developmental anomaly --- r_associated #0: 26 --> en:drug interaction
    n1=en:developmental anomaly | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  558. en:injection site abscess --- r_associated #0: 26 --> en:drug interaction
    n1=en:injection site abscess | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  559. en:medication --- r_associated #0: 26 --> en:drug interaction
    n1=en:medication | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  560. en:oncoma --- r_associated #0: 26 --> en:drug interaction
    n1=en:oncoma | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  561. en:post vaccination syndrome --- r_associated #0: 26 --> en:drug interaction
    n1=en:post vaccination syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  562. en:respiratory system signs and symptoms --- r_associated #0: 26 --> en:drug interaction
    n1=en:respiratory system signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  563. en:reversal of disease phenotype --- r_associated #0: 26 --> en:drug interaction
    n1=en:reversal of disease phenotype | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  564. en:therapeutic and nontherapeutic effects (excl toxicity) --- r_associated #0: 26 --> en:drug interaction
    n1=en:therapeutic and nontherapeutic effects (excl toxicity) | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  565. en:toxicant interaction --- r_associated #0: 26 --> en:drug interaction
    n1=en:toxicant interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  566. en:uracratia --- r_associated #0: 26 --> en:drug interaction
    n1=en:uracratia | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  567. incontinence fécale --- r_associated #0: 26 --> en:drug interaction
    n1=incontinence fécale | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  568. interaction médicamenteuse --- r_associated #0: 26 --> en:drug interaction
    n1=interaction médicamenteuse | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  569. interactions médicamenteuses --- r_associated #0: 26 --> en:drug interaction
    n1=interactions médicamenteuses | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  570. préparation pharmaceutique --- r_associated #0: 26 --> en:drug interaction
    n1=préparation pharmaceutique | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  571. une anomalie congénitale --- r_associated #0: 26 --> en:drug interaction
    n1=une anomalie congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  572. énurésie --- r_associated #0: 26 --> en:drug interaction
    n1=énurésie | n2=en:drug interaction | rel=r_associated | relid=0 | w=26
  573. S.I.D.A --- r_associated #0: 25 --> en:drug interaction
    n1=S.I.D.A | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  574. coup de chaleur --- r_associated #0: 25 --> en:drug interaction
    n1=coup de chaleur | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  575. en:adenoid tumor --- r_associated #0: 25 --> en:drug interaction
    n1=en:adenoid tumor | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  576. en:enuresis --- r_associated #0: 25 --> en:drug interaction
    n1=en:enuresis | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  577. en:orthostatic hypotension --- r_associated #0: 25 --> en:drug interaction
    n1=en:orthostatic hypotension | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  578. en:roll-head --- r_associated #0: 25 --> en:drug interaction
    n1=en:roll-head | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  579. en:sudden infant death --- r_associated #0: 25 --> en:drug interaction
    n1=en:sudden infant death | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  580. en:tumentia --- r_associated #0: 25 --> en:drug interaction
    n1=en:tumentia | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  581. en:uroclepsia --- r_associated #0: 25 --> en:drug interaction
    n1=en:uroclepsia | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  582. infection --- r_associated #0: 25 --> en:drug interaction
    n1=infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  583. multiraciale --- r_associated #0: 25 --> en:drug interaction
    n1=multiraciale | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  584. multiraciaux --- r_associated #0: 25 --> en:drug interaction
    n1=multiraciaux | n2=en:drug interaction | rel=r_associated | relid=0 | w=25
  585. Flushing --- r_associated #0: 24 --> en:drug interaction
    n1=Flushing | n2=en:drug interaction | rel=r_associated | relid=0 | w=24
  586. empourpré --- r_associated #0: 24 --> en:drug interaction
    n1=empourpré | n2=en:drug interaction | rel=r_associated | relid=0 | w=24
  587. en:epithelial carcinoma --- r_associated #0: 24 --> en:drug interaction
    n1=en:epithelial carcinoma | n2=en:drug interaction | rel=r_associated | relid=0 | w=24
  588. en:hypertension --- r_associated #0: 24 --> en:drug interaction
    n1=en:hypertension | n2=en:drug interaction | rel=r_associated | relid=0 | w=24
  589. fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique --- r_associated #0: 24 --> en:drug interaction
    n1=fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique | n2=en:drug interaction | rel=r_associated | relid=0 | w=24
  590. haleine fétide --- r_associated #0: 24 --> en:drug interaction
    n1=haleine fétide | n2=en:drug interaction | rel=r_associated | relid=0 | w=24
  591. panne électrique --- r_associated #0: 24 --> en:drug interaction
    n1=panne électrique | n2=en:drug interaction | rel=r_associated | relid=0 | w=24
  592. en:and hyperglycinuria --- r_associated #0: 23 --> en:drug interaction
    n1=en:and hyperglycinuria | n2=en:drug interaction | rel=r_associated | relid=0 | w=23
  593. en:blood poisoning --- r_associated #0: 23 --> en:drug interaction
    n1=en:blood poisoning | n2=en:drug interaction | rel=r_associated | relid=0 | w=23
  594. en:power blackout --- r_associated #0: 23 --> en:drug interaction
    n1=en:power blackout | n2=en:drug interaction | rel=r_associated | relid=0 | w=23
  595. en:short windedness --- r_associated #0: 23 --> en:drug interaction
    n1=en:short windedness | n2=en:drug interaction | rel=r_associated | relid=0 | w=23
  596. réaction allergique --- r_associated #0: 23 --> en:drug interaction
    n1=réaction allergique | n2=en:drug interaction | rel=r_associated | relid=0 | w=23
  597. septicité --- r_associated #0: 23 --> en:drug interaction
    n1=septicité | n2=en:drug interaction | rel=r_associated | relid=0 | w=23
  598. en:cancerous tumor --- r_associated #0: 22 --> en:drug interaction
    n1=en:cancerous tumor | n2=en:drug interaction | rel=r_associated | relid=0 | w=22
  599. en:secondary infection --- r_associated #0: 22 --> en:drug interaction
    n1=en:secondary infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=22
  600. en:tumefied --- r_associated #0: 22 --> en:drug interaction
    n1=en:tumefied | n2=en:drug interaction | rel=r_associated | relid=0 | w=22
  601. incontinence (cure endoscopique de l') --- r_associated #0: 22 --> en:drug interaction
    n1=incontinence (cure endoscopique de l') | n2=en:drug interaction | rel=r_associated | relid=0 | w=22
  602. proptose oculaire --- r_associated #0: 22 --> en:drug interaction
    n1=proptose oculaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=22
  603. souffle cardiaque --- r_associated #0: 22 --> en:drug interaction
    n1=souffle cardiaque | n2=en:drug interaction | rel=r_associated | relid=0 | w=22
  604. vireux --- r_associated #0: 22 --> en:drug interaction
    n1=vireux | n2=en:drug interaction | rel=r_associated | relid=0 | w=22
  605. apraxie --- r_associated #0: 21 --> en:drug interaction
    n1=apraxie | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  606. aérobiose --- r_associated #0: 21 --> en:drug interaction
    n1=aérobiose | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  607. bouffées de chaleur accompagnée de sueurs --- r_associated #0: 21 --> en:drug interaction
    n1=bouffées de chaleur accompagnée de sueurs | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  608. en:cancerous growth --- r_associated #0: 21 --> en:drug interaction
    n1=en:cancerous growth | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  609. en:chest tightness --- r_associated #0: 21 --> en:drug interaction
    n1=en:chest tightness | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  610. en:cytomegalovirus infection --- r_associated #0: 21 --> en:drug interaction
    n1=en:cytomegalovirus infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  611. en:interaction with other medicinal products --- r_associated #0: 21 --> en:drug interaction
    n1=en:interaction with other medicinal products | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  612. en:loss of bowel control --- r_associated #0: 21 --> en:drug interaction
    n1=en:loss of bowel control | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  613. en:microphtalmia --- r_associated #0: 21 --> en:drug interaction
    n1=en:microphtalmia | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  614. en:power shutdown --- r_associated #0: 21 --> en:drug interaction
    n1=en:power shutdown | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  615. grippal --- r_associated #0: 21 --> en:drug interaction
    n1=grippal | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  616. overdose --- r_associated #0: 21 --> en:drug interaction
    n1=overdose | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  617. syndrome cachectique --- r_associated #0: 21 --> en:drug interaction
    n1=syndrome cachectique | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  618. voies de biosynthèse --- r_associated #0: 21 --> en:drug interaction
    n1=voies de biosynthèse | n2=en:drug interaction | rel=r_associated | relid=0 | w=21
  619. Malformation congénitale --- r_associated #0: 20 --> en:drug interaction
    n1=Malformation congénitale | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  620. Perte de conscience --- r_associated #0: 20 --> en:drug interaction
    n1=Perte de conscience | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  621. Septicémie --- r_associated #0: 20 --> en:drug interaction
    n1=Septicémie | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  622. Splénomégalie --- r_associated #0: 20 --> en:drug interaction
    n1=Splénomégalie | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  623. Surdosage --- r_associated #0: 20 --> en:drug interaction
    n1=Surdosage | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  624. Surdose --- r_associated #0: 20 --> en:drug interaction
    n1=Surdose | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  625. Sénilité --- r_associated #0: 20 --> en:drug interaction
    n1=Sénilité | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  626. Tachycardie --- r_associated #0: 20 --> en:drug interaction
    n1=Tachycardie | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  627. Tendinite --- r_associated #0: 20 --> en:drug interaction
    n1=Tendinite | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  628. aliments --- r_associated #0: 20 --> en:drug interaction
    n1=aliments | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  629. atrophie généralisée --- r_associated #0: 20 --> en:drug interaction
    n1=atrophie généralisée | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  630. ciclosporine --- r_associated #0: 20 --> en:drug interaction
    n1=ciclosporine | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  631. clairance --- r_associated #0: 20 --> en:drug interaction
    n1=clairance | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  632. collapsus cardiaque --- r_associated #0: 20 --> en:drug interaction
    n1=collapsus cardiaque | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  633. contre-indication --- r_associated #0: 20 --> en:drug interaction
    n1=contre-indication | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  634. dosage --- r_associated #0: 20 --> en:drug interaction
    n1=dosage | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  635. doser --- r_associated #0: 20 --> en:drug interaction
    n1=doser | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  636. effets indésirables --- r_associated #0: 20 --> en:drug interaction
    n1=effets indésirables | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  637. en:abnormal laboratory test result --- r_associated #0: 20 --> en:drug interaction
    n1=en:abnormal laboratory test result | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  638. en:abnormal vision --- r_associated #0: 20 --> en:drug interaction
    n1=en:abnormal vision | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  639. en:absence of signs or symptoms --- r_associated #0: 20 --> en:drug interaction
    n1=en:absence of signs or symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  640. en:acylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:acylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  641. en:additive drug interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:additive drug interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  642. en:administrative drug regulation --- r_associated #0: 20 --> en:drug interaction
    n1=en:administrative drug regulation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  643. en:administrative statuses --- r_associated #0: 20 --> en:drug interaction
    n1=en:administrative statuses | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  644. en:adverse event associated with death --- r_associated #0: 20 --> en:drug interaction
    n1=en:adverse event associated with death | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  645. en:agglutination --- r_associated #0: 20 --> en:drug interaction
    n1=en:agglutination | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  646. en:alkylation process --- r_associated #0: 20 --> en:drug interaction
    n1=en:alkylation process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  647. en:allosteric regulation --- r_associated #0: 20 --> en:drug interaction
    n1=en:allosteric regulation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  648. en:amination --- r_associated #0: 20 --> en:drug interaction
    n1=en:amination | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  649. en:anaerobiosis --- r_associated #0: 20 --> en:drug interaction
    n1=en:anaerobiosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  650. en:antagonistic drug interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:antagonistic drug interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  651. en:aod abuse and dependence potential --- r_associated #0: 20 --> en:drug interaction
    n1=en:aod abuse and dependence potential | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  652. en:aphasia --- r_associated #0: 20 --> en:drug interaction
    n1=en:aphasia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  653. en:ascites --- r_associated #0: 20 --> en:drug interaction
    n1=en:ascites | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  654. en:aspects of radiation effects --- r_associated #0: 20 --> en:drug interaction
    n1=en:aspects of radiation effects | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  655. en:autotrophic processes --- r_associated #0: 20 --> en:drug interaction
    n1=en:autotrophic processes | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  656. en:benign finding --- r_associated #0: 20 --> en:drug interaction
    n1=en:benign finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  657. en:binding, competitive --- r_associated #0: 20 --> en:drug interaction
    n1=en:binding, competitive | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  658. en:biotinylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:biotinylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  659. en:body temperature changes --- r_associated #0: 20 --> en:drug interaction
    n1=en:body temperature changes | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  660. en:candidiasis --- r_associated #0: 20 --> en:drug interaction
    n1=en:candidiasis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  661. en:carbohydrate metabolic process --- r_associated #0: 20 --> en:drug interaction
    n1=en:carbohydrate metabolic process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  662. en:cardiac output, high --- r_associated #0: 20 --> en:drug interaction
    n1=en:cardiac output, high | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  663. en:cellulitis --- r_associated #0: 20 --> en:drug interaction
    n1=en:cellulitis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  664. en:chemistry --- r_associated #0: 20 --> en:drug interaction
    n1=en:chemistry | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  665. en:chromatin structural process --- r_associated #0: 20 --> en:drug interaction
    n1=en:chromatin structural process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  666. en:citric acid cycle --- r_associated #0: 20 --> en:drug interaction
    n1=en:citric acid cycle | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  667. en:clinical stage finding --- r_associated #0: 20 --> en:drug interaction
    n1=en:clinical stage finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  668. en:cyanosis --- r_associated #0: 20 --> en:drug interaction
    n1=en:cyanosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  669. en:cyclization --- r_associated #0: 20 --> en:drug interaction
    n1=en:cyclization | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  670. en:cytoprotection --- r_associated #0: 20 --> en:drug interaction
    n1=en:cytoprotection | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  671. en:dealkylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:dealkylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  672. en:deamination --- r_associated #0: 20 --> en:drug interaction
    n1=en:deamination | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  673. en:decarboxylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:decarboxylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  674. en:decreased core body temperature --- r_associated #0: 20 --> en:drug interaction
    n1=en:decreased core body temperature | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  675. en:decreased tolerance --- r_associated #0: 20 --> en:drug interaction
    n1=en:decreased tolerance | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  676. en:disorders, general, functional and nec --- r_associated #0: 20 --> en:drug interaction
    n1=en:disorders, general, functional and nec | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  677. en:distance of tumor from anal verge unknown --- r_associated #0: 20 --> en:drug interaction
    n1=en:distance of tumor from anal verge unknown | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  678. en:dna cleavage --- r_associated #0: 20 --> en:drug interaction
    n1=en:dna cleavage | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  679. en:dna maintenance process --- r_associated #0: 20 --> en:drug interaction
    n1=en:dna maintenance process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  680. en:dna methylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:dna methylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  681. en:dna modification process --- r_associated #0: 20 --> en:drug interaction
    n1=en:dna modification process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  682. en:dna repair --- r_associated #0: 20 --> en:drug interaction
    n1=en:dna repair | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  683. en:dna replication --- r_associated #0: 20 --> en:drug interaction
    n1=en:dna replication | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  684. en:dose-response relationship, drug --- r_associated #0: 20 --> en:drug interaction
    n1=en:dose-response relationship, drug | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  685. en:drug agonism --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug agonism | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  686. en:drug antagonism --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug antagonism | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  687. en:drug by legal status --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug by legal status | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  688. en:drug chemical incompatibility --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug chemical incompatibility | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  689. en:drug evaluation --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug evaluation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  690. en:drug interaction with drug --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug interaction with drug | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  691. en:drug purity --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug purity | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  692. en:drug synergism --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug synergism | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  693. en:drug-disease interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:drug-disease interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  694. en:dysarthria --- r_associated #0: 20 --> en:drug interaction
    n1=en:dysarthria | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  695. en:edema, generalized --- r_associated #0: 20 --> en:drug interaction
    n1=en:edema, generalized | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  696. en:electron transport --- r_associated #0: 20 --> en:drug interaction
    n1=en:electron transport | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  697. en:endocrine system signs and symptoms --- r_associated #0: 20 --> en:drug interaction
    n1=en:endocrine system signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  698. en:energy transfer --- r_associated #0: 20 --> en:drug interaction
    n1=en:energy transfer | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  699. en:enzyme activation --- r_associated #0: 20 --> en:drug interaction
    n1=en:enzyme activation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  700. en:enzyme activity alteration --- r_associated #0: 20 --> en:drug interaction
    n1=en:enzyme activity alteration | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  701. en:esterification --- r_associated #0: 20 --> en:drug interaction
    n1=en:esterification | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  702. en:eye manifestations --- r_associated #0: 20 --> en:drug interaction
    n1=en:eye manifestations | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  703. en:fatigue --- r_associated #0: 20 --> en:drug interaction
    n1=en:fatigue | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  704. en:fetal disorder --- r_associated #0: 20 --> en:drug interaction
    n1=en:fetal disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  705. en:fetal finding --- r_associated #0: 20 --> en:drug interaction
    n1=en:fetal finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  706. en:fibrosis --- r_associated #0: 20 --> en:drug interaction
    n1=en:fibrosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  707. en:finding by method --- r_associated #0: 20 --> en:drug interaction
    n1=en:finding by method | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  708. en:finding of grade --- r_associated #0: 20 --> en:drug interaction
    n1=en:finding of grade | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  709. en:finding of histologic grading differentiation and/or behavior --- r_associated #0: 20 --> en:drug interaction
    n1=en:finding of histologic grading differentiation and/or behavior | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  710. en:finding related to physiologic substance --- r_associated #0: 20 --> en:drug interaction
    n1=en:finding related to physiologic substance | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  711. en:gene expression process --- r_associated #0: 20 --> en:drug interaction
    n1=en:gene expression process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  712. en:general pathology --- r_associated #0: 20 --> en:drug interaction
    n1=en:general pathology | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  713. en:generic and proprietary drug --- r_associated #0: 20 --> en:drug interaction
    n1=en:generic and proprietary drug | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  714. en:genetic aspects --- r_associated #0: 20 --> en:drug interaction
    n1=en:genetic aspects | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  715. en:genitourinary signs and symptoms --- r_associated #0: 20 --> en:drug interaction
    n1=en:genitourinary signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  716. en:glycosuria --- r_associated #0: 20 --> en:drug interaction
    n1=en:glycosuria | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  717. en:halogenation --- r_associated #0: 20 --> en:drug interaction
    n1=en:halogenation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  718. en:headache --- r_associated #0: 20 --> en:drug interaction
    n1=en:headache | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  719. en:herbal interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:herbal interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  720. en:hernia --- r_associated #0: 20 --> en:drug interaction
    n1=en:hernia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  721. en:heterotrophic processes --- r_associated #0: 20 --> en:drug interaction
    n1=en:heterotrophic processes | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  722. en:hirsutism --- r_associated #0: 20 --> en:drug interaction
    n1=en:hirsutism | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  723. en:hiv positivity --- r_associated #0: 20 --> en:drug interaction
    n1=en:hiv positivity | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  724. en:hydrogenation --- r_associated #0: 20 --> en:drug interaction
    n1=en:hydrogenation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  725. en:hydroxylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:hydroxylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  726. en:hypergammaglobulinemia --- r_associated #0: 20 --> en:drug interaction
    n1=en:hypergammaglobulinemia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  727. en:hyperglycemia --- r_associated #0: 20 --> en:drug interaction
    n1=en:hyperglycemia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  728. en:hyperlactemia --- r_associated #0: 20 --> en:drug interaction
    n1=en:hyperlactemia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  729. en:hyperplasia --- r_associated #0: 20 --> en:drug interaction
    n1=en:hyperplasia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  730. en:hypertriglyceridemic waist --- r_associated #0: 20 --> en:drug interaction
    n1=en:hypertriglyceridemic waist | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  731. en:hypertrophy --- r_associated #0: 20 --> en:drug interaction
    n1=en:hypertrophy | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  732. en:hyperuricemia --- r_associated #0: 20 --> en:drug interaction
    n1=en:hyperuricemia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  733. en:hypoxia --- r_associated #0: 20 --> en:drug interaction
    n1=en:hypoxia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  734. en:increased drug level --- r_associated #0: 20 --> en:drug interaction
    n1=en:increased drug level | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  735. en:increased tolerance --- r_associated #0: 20 --> en:drug interaction
    n1=en:increased tolerance | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  736. en:inhibitory drug interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:inhibitory drug interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  737. en:injection site atrophy --- r_associated #0: 20 --> en:drug interaction
    n1=en:injection site atrophy | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  738. en:injection site inflammation --- r_associated #0: 20 --> en:drug interaction
    n1=en:injection site inflammation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  739. en:injection site mass --- r_associated #0: 20 --> en:drug interaction
    n1=en:injection site mass | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  740. en:injection site reaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:injection site reaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  741. en:integumentary system signs and symptoms --- r_associated #0: 20 --> en:drug interaction
    n1=en:integumentary system signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  742. en:intentional drug overdose --- r_associated #0: 20 --> en:drug interaction
    n1=en:intentional drug overdose | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  743. en:interaction with illicit drug --- r_associated #0: 20 --> en:drug interaction
    n1=en:interaction with illicit drug | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  744. en:interference laboratory test --- r_associated #0: 20 --> en:drug interaction
    n1=en:interference laboratory test | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  745. en:intermediary metabolic process --- r_associated #0: 20 --> en:drug interaction
    n1=en:intermediary metabolic process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  746. en:intermittent claudication --- r_associated #0: 20 --> en:drug interaction
    n1=en:intermittent claudication | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  747. en:intracellular signaling process --- r_associated #0: 20 --> en:drug interaction
    n1=en:intracellular signaling process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  748. en:lack of drug action --- r_associated #0: 20 --> en:drug interaction
    n1=en:lack of drug action | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  749. en:lipid peroxidation --- r_associated #0: 20 --> en:drug interaction
    n1=en:lipid peroxidation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  750. en:lipogenesis --- r_associated #0: 20 --> en:drug interaction
    n1=en:lipogenesis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  751. en:lipolysis --- r_associated #0: 20 --> en:drug interaction
    n1=en:lipolysis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  752. en:lipoylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:lipoylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  753. en:macromolecular sequence alteration process --- r_associated #0: 20 --> en:drug interaction
    n1=en:macromolecular sequence alteration process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  754. en:malaise --- r_associated #0: 20 --> en:drug interaction
    n1=en:malaise | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  755. en:mental and behavioral signs and symptoms --- r_associated #0: 20 --> en:drug interaction
    n1=en:mental and behavioral signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  756. en:metabolic side effects of drugs and substances --- r_associated #0: 20 --> en:drug interaction
    n1=en:metabolic side effects of drugs and substances | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  757. en:mobility limitation --- r_associated #0: 20 --> en:drug interaction
    n1=en:mobility limitation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  758. en:molecular marker activity --- r_associated #0: 20 --> en:drug interaction
    n1=en:molecular marker activity | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  759. en:molecular mimicry --- r_associated #0: 20 --> en:drug interaction
    n1=en:molecular mimicry | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  760. en:motion sickness --- r_associated #0: 20 --> en:drug interaction
    n1=en:motion sickness | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  761. en:multiple congenital anomalies --- r_associated #0: 20 --> en:drug interaction
    n1=en:multiple congenital anomalies | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  762. en:multiple drug use --- r_associated #0: 20 --> en:drug interaction
    n1=en:multiple drug use | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  763. en:mycobacterium tuberculosis infection reactivated --- r_associated #0: 20 --> en:drug interaction
    n1=en:mycobacterium tuberculosis infection reactivated | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  764. en:myocardial stunning --- r_associated #0: 20 --> en:drug interaction
    n1=en:myocardial stunning | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  765. en:neoplasm --- r_associated #0: 20 --> en:drug interaction
    n1=en:neoplasm | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  766. en:neuroleptic malignant syndrome --- r_associated #0: 20 --> en:drug interaction
    n1=en:neuroleptic malignant syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  767. en:neurological signs and symptoms --- r_associated #0: 20 --> en:drug interaction
    n1=en:neurological signs and symptoms | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  768. en:neuropharmacology and toxicology --- r_associated #0: 20 --> en:drug interaction
    n1=en:neuropharmacology and toxicology | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  769. en:neurotoxin --- r_associated #0: 20 --> en:drug interaction
    n1=en:neurotoxin | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  770. en:nitrogen cycle --- r_associated #0: 20 --> en:drug interaction
    n1=en:nitrogen cycle | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  771. en:nitrosation --- r_associated #0: 20 --> en:drug interaction
    n1=en:nitrosation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  772. en:no additional pathologic finding in tumor specimen --- r_associated #0: 20 --> en:drug interaction
    n1=en:no additional pathologic finding in tumor specimen | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  773. en:nucleic acid denaturation --- r_associated #0: 20 --> en:drug interaction
    n1=en:nucleic acid denaturation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  774. en:nucleic acid hybridization --- r_associated #0: 20 --> en:drug interaction
    n1=en:nucleic acid hybridization | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  775. en:nucleic acid renaturation --- r_associated #0: 20 --> en:drug interaction
    n1=en:nucleic acid renaturation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  776. en:papular lesion --- r_associated #0: 20 --> en:drug interaction
    n1=en:papular lesion | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  777. en:parasitic infection --- r_associated #0: 20 --> en:drug interaction
    n1=en:parasitic infection | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  778. en:pathologic keratinization --- r_associated #0: 20 --> en:drug interaction
    n1=en:pathologic keratinization | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  779. en:pathology examination findings indeterminate --- r_associated #0: 20 --> en:drug interaction
    n1=en:pathology examination findings indeterminate | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  780. en:pathology examination findings present --- r_associated #0: 20 --> en:drug interaction
    n1=en:pathology examination findings present | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  781. en:pathophysiologic finding --- r_associated #0: 20 --> en:drug interaction
    n1=en:pathophysiologic finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  782. en:peptide biosynthesis --- r_associated #0: 20 --> en:drug interaction
    n1=en:peptide biosynthesis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  783. en:pesticide interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:pesticide interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  784. en:pharmacodynamic interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:pharmacodynamic interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  785. en:pharmacodynamics --- r_associated #0: 20 --> en:drug interaction
    n1=en:pharmacodynamics | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  786. en:pharmacokinetic interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:pharmacokinetic interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  787. en:pharmacokinetics --- r_associated #0: 20 --> en:drug interaction
    n1=en:pharmacokinetics | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  788. en:pharmacological phenomena --- r_associated #0: 20 --> en:drug interaction
    n1=en:pharmacological phenomena | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  789. en:pharmacology and toxicology --- r_associated #0: 20 --> en:drug interaction
    n1=en:pharmacology and toxicology | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  790. en:phase i detoxification --- r_associated #0: 20 --> en:drug interaction
    n1=en:phase i detoxification | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  791. en:phosphorylation process --- r_associated #0: 20 --> en:drug interaction
    n1=en:phosphorylation process | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  792. en:phototrophic processes --- r_associated #0: 20 --> en:drug interaction
    n1=en:phototrophic processes | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  793. en:physical chemical interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:physical chemical interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  794. en:prenylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:prenylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  795. en:prognosis/outlook finding --- r_associated #0: 20 --> en:drug interaction
    n1=en:prognosis/outlook finding | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  796. en:protein binding --- r_associated #0: 20 --> en:drug interaction
    n1=en:protein binding | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  797. en:protein carbonylation --- r_associated #0: 20 --> en:drug interaction
    n1=en:protein carbonylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  798. en:protein folding --- r_associated #0: 20 --> en:drug interaction
    n1=en:protein folding | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  799. en:protein modification, translational --- r_associated #0: 20 --> en:drug interaction
    n1=en:protein modification, translational | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  800. en:protein multimerization --- r_associated #0: 20 --> en:drug interaction
    n1=en:protein multimerization | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  801. en:proteinuria --- r_associated #0: 20 --> en:drug interaction
    n1=en:proteinuria | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  802. en:proteolysis --- r_associated #0: 20 --> en:drug interaction
    n1=en:proteolysis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  803. en:pseudophakia --- r_associated #0: 20 --> en:drug interaction
    n1=en:pseudophakia | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  804. en:psychological inhibition --- r_associated #0: 20 --> en:drug interaction
    n1=en:psychological inhibition | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  805. en:pulmonary pharmacology and toxicology --- r_associated #0: 20 --> en:drug interaction
    n1=en:pulmonary pharmacology and toxicology | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  806. en:renal colic --- r_associated #0: 20 --> en:drug interaction
    n1=en:renal colic | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  807. en:rna cleavage --- r_associated #0: 20 --> en:drug interaction
    n1=en:rna cleavage | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  808. en:rna folding --- r_associated #0: 20 --> en:drug interaction
    n1=en:rna folding | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  809. en:rna processing, post-transcriptional --- r_associated #0: 20 --> en:drug interaction
    n1=en:rna processing, post-transcriptional | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  810. en:sample exam - general pathol --- r_associated #0: 20 --> en:drug interaction
    n1=en:sample exam - general pathol | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  811. en:sclerosis --- r_associated #0: 20 --> en:drug interaction
    n1=en:sclerosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  812. en:seizure --- r_associated #0: 20 --> en:drug interaction
    n1=en:seizure | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  813. en:shock --- r_associated #0: 20 --> en:drug interaction
    n1=en:shock | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  814. en:signal transduction --- r_associated #0: 20 --> en:drug interaction
    n1=en:signal transduction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  815. en:signs and symptoms, respiratory --- r_associated #0: 20 --> en:drug interaction
    n1=en:signs and symptoms, respiratory | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  816. en:sleep disorder --- r_associated #0: 20 --> en:drug interaction
    n1=en:sleep disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  817. en:spatial orientation of specimen unknown --- r_associated #0: 20 --> en:drug interaction
    n1=en:spatial orientation of specimen unknown | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  818. en:stiffness --- r_associated #0: 20 --> en:drug interaction
    n1=en:stiffness | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  819. en:structure-activity relationship --- r_associated #0: 20 --> en:drug interaction
    n1=en:structure-activity relationship | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  820. en:structured product labeling limitation of use terminology --- r_associated #0: 20 --> en:drug interaction
    n1=en:structured product labeling limitation of use terminology | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  821. en:substrate cycling --- r_associated #0: 20 --> en:drug interaction
    n1=en:substrate cycling | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  822. en:sudden death --- r_associated #0: 20 --> en:drug interaction
    n1=en:sudden death | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  823. en:suicide attempt --- r_associated #0: 20 --> en:drug interaction
    n1=en:suicide attempt | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  824. en:syncope --- r_associated #0: 20 --> en:drug interaction
    n1=en:syncope | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  825. en:synergistic drug interaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:synergistic drug interaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  826. en:transcriptional repression --- r_associated #0: 20 --> en:drug interaction
    n1=en:transcriptional repression | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  827. en:tyramine reaction --- r_associated #0: 20 --> en:drug interaction
    n1=en:tyramine reaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  828. en:ulceration --- r_associated #0: 20 --> en:drug interaction
    n1=en:ulceration | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  829. en:up-regulation (physiology) --- r_associated #0: 20 --> en:drug interaction
    n1=en:up-regulation (physiology) | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  830. en:urological manifestations --- r_associated #0: 20 --> en:drug interaction
    n1=en:urological manifestations | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  831. en:weakness --- r_associated #0: 20 --> en:drug interaction
    n1=en:weakness | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  832. explication --- r_associated #0: 20 --> en:drug interaction
    n1=explication | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  833. formule --- r_associated #0: 20 --> en:drug interaction
    n1=formule | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  834. infection à méningocoques --- r_associated #0: 20 --> en:drug interaction
    n1=infection à méningocoques | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  835. inhibiteur --- r_associated #0: 20 --> en:drug interaction
    n1=inhibiteur | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  836. mal-être --- r_associated #0: 20 --> en:drug interaction
    n1=mal-être | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  837. médecine --- r_associated #0: 20 --> en:drug interaction
    n1=médecine | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  838. médoc
    (médicament)
     --- r_associated #0: 20 --> en:drug interaction
    n1=médoc
    (médicament)
    | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  839. patient --- r_associated #0: 20 --> en:drug interaction
    n1=patient | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  840. pharmacie
    (médicaments)
     --- r_associated #0: 20 --> en:drug interaction
    n1=pharmacie
    (médicaments)
    | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  841. pharmacie
    (science)
     --- r_associated #0: 20 --> en:drug interaction
    n1=pharmacie
    (science)
    | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  842. pharmacocinétique --- r_associated #0: 20 --> en:drug interaction
    n1=pharmacocinétique | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  843. pharmacothérapie --- r_associated #0: 20 --> en:drug interaction
    n1=pharmacothérapie | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  844. posologie --- r_associated #0: 20 --> en:drug interaction
    n1=posologie | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  845. potentialisation --- r_associated #0: 20 --> en:drug interaction
    n1=potentialisation | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  846. principe actif --- r_associated #0: 20 --> en:drug interaction
    n1=principe actif | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  847. rhabdomyolyse --- r_associated #0: 20 --> en:drug interaction
    n1=rhabdomyolyse | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  848. substrat --- r_associated #0: 20 --> en:drug interaction
    n1=substrat | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  849. syndrome de cachexie --- r_associated #0: 20 --> en:drug interaction
    n1=syndrome de cachexie | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  850. syndrome de cachexie progressive --- r_associated #0: 20 --> en:drug interaction
    n1=syndrome de cachexie progressive | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  851. Adénome --- r_associated #0: 15 --> en:drug interaction
    n1=Adénome | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  852. Dyspnée --- r_associated #0: 15 --> en:drug interaction
    n1=Dyspnée | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  853. Flu --- r_associated #0: 15 --> en:drug interaction
    n1=Flu | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  854. Hypotension orthostatique --- r_associated #0: 15 --> en:drug interaction
    n1=Hypotension orthostatique | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  855. Infection virale --- r_associated #0: 15 --> en:drug interaction
    n1=Infection virale | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  856. Influenza --- r_associated #0: 15 --> en:drug interaction
    n1=Influenza | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  857. Interaction médicamenteuse --- r_associated #0: 15 --> en:drug interaction
    n1=Interaction médicamenteuse | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  858. Interactions médicamenteuses --- r_associated #0: 15 --> en:drug interaction
    n1=Interactions médicamenteuses | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  859. Mycose --- r_associated #0: 15 --> en:drug interaction
    n1=Mycose | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  860. Métaplasie --- r_associated #0: 15 --> en:drug interaction
    n1=Métaplasie | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  861. Potentialisation --- r_associated #0: 15 --> en:drug interaction
    n1=Potentialisation | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  862. Réaction allergique --- r_associated #0: 15 --> en:drug interaction
    n1=Réaction allergique | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  863. Souffle au coeur --- r_associated #0: 15 --> en:drug interaction
    n1=Souffle au coeur | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  864. Syndrome d'immunodéficience acquise --- r_associated #0: 15 --> en:drug interaction
    n1=Syndrome d'immunodéficience acquise | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  865. Trouble de l'équilibre --- r_associated #0: 15 --> en:drug interaction
    n1=Trouble de l'équilibre | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  866. Troubles immunitaires --- r_associated #0: 15 --> en:drug interaction
    n1=Troubles immunitaires | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  867. agglutinines froides (neuropathie à) --- r_associated #0: 15 --> en:drug interaction
    n1=agglutinines froides (neuropathie à) | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  868. altération de l'état général --- r_associated #0: 15 --> en:drug interaction
    n1=altération de l'état général | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  869. choc (syndrome de) --- r_associated #0: 15 --> en:drug interaction
    n1=choc (syndrome de) | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  870. effet de souffle (lésion par) --- r_associated #0: 15 --> en:drug interaction
    n1=effet de souffle (lésion par) | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  871. en:dizzy spells --- r_associated #0: 15 --> en:drug interaction
    n1=en:dizzy spells | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  872. en:giddiness --- r_associated #0: 15 --> en:drug interaction
    n1=en:giddiness | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  873. en:medicament --- r_associated #0: 15 --> en:drug interaction
    n1=en:medicament | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  874. en:medicinal product --- r_associated #0: 15 --> en:drug interaction
    n1=en:medicinal product | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  875. en:scatterbrain --- r_associated #0: 15 --> en:drug interaction
    n1=en:scatterbrain | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  876. en:tablet --- r_associated #0: 15 --> en:drug interaction
    n1=en:tablet | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  877. en:urorrhea --- r_associated #0: 15 --> en:drug interaction
    n1=en:urorrhea | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  878. malentendant (enfant) --- r_associated #0: 15 --> en:drug interaction
    n1=malentendant (enfant) | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  879. medicament --- r_associated #0: 15 --> en:drug interaction
    n1=medicament | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  880. médicament --- r_associated #0: 15 --> en:drug interaction
    n1=médicament | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  881. snm --- r_associated #0: 15 --> en:drug interaction
    n1=snm | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  882. syndrome malin neuroleptique --- r_associated #0: 15 --> en:drug interaction
    n1=syndrome malin neuroleptique | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  883. vertiges --- r_associated #0: 15 --> en:drug interaction
    n1=vertiges | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  884. vertigineux --- r_associated #0: 15 --> en:drug interaction
    n1=vertigineux | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  885. Énurésie --- r_associated #0: 15 --> en:drug interaction
    n1=Énurésie | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  886. Étourdi --- r_associated #0: 15 --> en:drug interaction
    n1=Étourdi | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  887. Étourdie --- r_associated #0: 15 --> en:drug interaction
    n1=Étourdie | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  888. étourdie --- r_associated #0: 15 --> en:drug interaction
    n1=étourdie | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  889. étourdies --- r_associated #0: 15 --> en:drug interaction
    n1=étourdies | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  890. étourdis --- r_associated #0: 15 --> en:drug interaction
    n1=étourdis | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  891. étourdissements --- r_associated #0: 15 --> en:drug interaction
    n1=étourdissements | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
  892. boiterie --- r_associated #0: 11 --> en:drug interaction
    n1=boiterie | n2=en:drug interaction | rel=r_associated | relid=0 | w=11
  893. boîterie --- r_associated #0: 11 --> en:drug interaction
    n1=boîterie | n2=en:drug interaction | rel=r_associated | relid=0 | w=11
  894. Agnosie --- r_associated #0: 10 --> en:drug interaction
    n1=Agnosie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  895. Anomalie chromosomique --- r_associated #0: 10 --> en:drug interaction
    n1=Anomalie chromosomique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  896. Asthénie --- r_associated #0: 10 --> en:drug interaction
    n1=Asthénie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  897. Atrophie --- r_associated #0: 10 --> en:drug interaction
    n1=Atrophie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  898. Bouffées de chaleur --- r_associated #0: 10 --> en:drug interaction
    n1=Bouffées de chaleur | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  899. Chizé (virus) --- r_associated #0: 10 --> en:drug interaction
    n1=Chizé (virus) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  900. Chlamydiose --- r_associated #0: 10 --> en:drug interaction
    n1=Chlamydiose | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  901. Choc cardiogénique --- r_associated #0: 10 --> en:drug interaction
    n1=Choc cardiogénique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  902. DISEASE --- r_associated #0: 10 --> en:drug interaction
    n1=DISEASE | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  903. Disease --- r_associated #0: 10 --> en:drug interaction
    n1=Disease | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  904. Encoprésie --- r_associated #0: 10 --> en:drug interaction
    n1=Encoprésie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  905. Exophtalmie --- r_associated #0: 10 --> en:drug interaction
    n1=Exophtalmie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  906. Granulome inflammatoire --- r_associated #0: 10 --> en:drug interaction
    n1=Granulome inflammatoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  907. Grinker (encéphalopathie de) --- r_associated #0: 10 --> en:drug interaction
    n1=Grinker (encéphalopathie de) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  908. Halitose --- r_associated #0: 10 --> en:drug interaction
    n1=Halitose | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  909. Hyperthermie --- r_associated #0: 10 --> en:drug interaction
    n1=Hyperthermie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  910. INTERACTIONS --- r_associated #0: 10 --> en:drug interaction
    n1=INTERACTIONS | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  911. Incontinence fécale --- r_associated #0: 10 --> en:drug interaction
    n1=Incontinence fécale | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  912. Incontinence urinaire --- r_associated #0: 10 --> en:drug interaction
    n1=Incontinence urinaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  913. Infections bactériennes --- r_associated #0: 10 --> en:drug interaction
    n1=Infections bactériennes | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  914. Infections virales --- r_associated #0: 10 --> en:drug interaction
    n1=Infections virales | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  915. Interactions --- r_associated #0: 10 --> en:drug interaction
    n1=Interactions | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  916. Mal-être --- r_associated #0: 10 --> en:drug interaction
    n1=Mal-être | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  917. Maladie de Pierce --- r_associated #0: 10 --> en:drug interaction
    n1=Maladie de Pierce | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  918. Maladie virale --- r_associated #0: 10 --> en:drug interaction
    n1=Maladie virale | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  919. Maladies bactériennes --- r_associated #0: 10 --> en:drug interaction
    n1=Maladies bactériennes | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  920. Maladies virales --- r_associated #0: 10 --> en:drug interaction
    n1=Maladies virales | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  921. Malformation --- r_associated #0: 10 --> en:drug interaction
    n1=Malformation | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  922. Mort subite du nourrisson --- r_associated #0: 10 --> en:drug interaction
    n1=Mort subite du nourrisson | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  923. Médicament --- r_associated #0: 10 --> en:drug interaction
    n1=Médicament | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  924. Poids corporel --- r_associated #0: 10 --> en:drug interaction
    n1=Poids corporel | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  925. Retard de croissance --- r_associated #0: 10 --> en:drug interaction
    n1=Retard de croissance | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  926. Sarcome --- r_associated #0: 10 --> en:drug interaction
    n1=Sarcome | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  927. Sengstaken-Blakemore (sonde de) --- r_associated #0: 10 --> en:drug interaction
    n1=Sengstaken-Blakemore (sonde de) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  928. Sepsis --- r_associated #0: 10 --> en:drug interaction
    n1=Sepsis | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  929. Splendore-Hoeppli (corps astéroïdes de) --- r_associated #0: 10 --> en:drug interaction
    n1=Splendore-Hoeppli (corps astéroïdes de) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  930. Surinfection --- r_associated #0: 10 --> en:drug interaction
    n1=Surinfection | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  931. Séoul (virus) --- r_associated #0: 10 --> en:drug interaction
    n1=Séoul (virus) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  932. Tula (virus) --- r_associated #0: 10 --> en:drug interaction
    n1=Tula (virus) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  933. Tumarkin (vertige de) --- r_associated #0: 10 --> en:drug interaction
    n1=Tumarkin (vertige de) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  934. Virose --- r_associated #0: 10 --> en:drug interaction
    n1=Virose | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  935. aberration chromosomique --- r_associated #0: 10 --> en:drug interaction
    n1=aberration chromosomique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  936. acylation --- r_associated #0: 10 --> en:drug interaction
    n1=acylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  937. allocations --- r_associated #0: 10 --> en:drug interaction
    n1=allocations | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  938. aphasie --- r_associated #0: 10 --> en:drug interaction
    n1=aphasie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  939. biotinylation --- r_associated #0: 10 --> en:drug interaction
    n1=biotinylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  940. bouffée de chaleur --- r_associated #0: 10 --> en:drug interaction
    n1=bouffée de chaleur | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  941. cachexie --- r_associated #0: 10 --> en:drug interaction
    n1=cachexie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  942. claudication intermittente --- r_associated #0: 10 --> en:drug interaction
    n1=claudication intermittente | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  943. collapsus vasculaire périphérique --- r_associated #0: 10 --> en:drug interaction
    n1=collapsus vasculaire périphérique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  944. contrindication --- r_associated #0: 10 --> en:drug interaction
    n1=contrindication | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  945. curage --- r_associated #0: 10 --> en:drug interaction
    n1=curage | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  946. cyst --- r_associated #0: 10 --> en:drug interaction
    n1=cyst | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  947. cytoprotection --- r_associated #0: 10 --> en:drug interaction
    n1=cytoprotection | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  948. démence d'Alzheimer --- r_associated #0: 10 --> en:drug interaction
    n1=démence d'Alzheimer | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  949. démence frontotemporale --- r_associated #0: 10 --> en:drug interaction
    n1=démence frontotemporale | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  950. démence héréditaire et infarctus multiples cérébraux --- r_associated #0: 10 --> en:drug interaction
    n1=démence héréditaire et infarctus multiples cérébraux | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  951. démence myoclonique --- r_associated #0: 10 --> en:drug interaction
    n1=démence myoclonique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  952. démence parkinsonienne avec dégénérescence pallidopontonigrée --- r_associated #0: 10 --> en:drug interaction
    n1=démence parkinsonienne avec dégénérescence pallidopontonigrée | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  953. démence précoce --- r_associated #0: 10 --> en:drug interaction
    n1=démence précoce | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  954. démence pugilistique --- r_associated #0: 10 --> en:drug interaction
    n1=démence pugilistique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  955. démence régressive --- r_associated #0: 10 --> en:drug interaction
    n1=démence régressive | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  956. démence sémantique --- r_associated #0: 10 --> en:drug interaction
    n1=démence sémantique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  957. dérègle --- r_associated #0: 10 --> en:drug interaction
    n1=dérègle | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  958. en:acestoma --- r_associated #0: 10 --> en:drug interaction
    n1=en:acestoma | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  959. en:acquired immune deficiency syndrome --- r_associated #0: 10 --> en:drug interaction
    n1=en:acquired immune deficiency syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  960. en:bed wetting --- r_associated #0: 10 --> en:drug interaction
    n1=en:bed wetting | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  961. en:bloody urine --- r_associated #0: 10 --> en:drug interaction
    n1=en:bloody urine | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  962. en:bony frailty with craniostenosis --- r_associated #0: 10 --> en:drug interaction
    n1=en:bony frailty with craniostenosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  963. en:cacomorphosis --- r_associated #0: 10 --> en:drug interaction
    n1=en:cacomorphosis | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  964. en:cardiac murmur --- r_associated #0: 10 --> en:drug interaction
    n1=en:cardiac murmur | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  965. en:chromosomal disorder --- r_associated #0: 10 --> en:drug interaction
    n1=en:chromosomal disorder | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  966. en:enophtalmos --- r_associated #0: 10 --> en:drug interaction
    n1=en:enophtalmos | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  967. en:ethnological --- r_associated #0: 10 --> en:drug interaction
    n1=en:ethnological | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  968. en:flu-like --- r_associated #0: 10 --> en:drug interaction
    n1=en:flu-like | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  969. en:grippy --- r_associated #0: 10 --> en:drug interaction
    n1=en:grippy | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  970. en:gross hematuria --- r_associated #0: 10 --> en:drug interaction
    n1=en:gross hematuria | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  971. en:hypoacousic child --- r_associated #0: 10 --> en:drug interaction
    n1=en:hypoacousic child | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  972. en:influenzal --- r_associated #0: 10 --> en:drug interaction
    n1=en:influenzal | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  973. en:lesion by blast effect --- r_associated #0: 10 --> en:drug interaction
    n1=en:lesion by blast effect | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  974. en:loss of bladder control --- r_associated #0: 10 --> en:drug interaction
    n1=en:loss of bladder control | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  975. en:medicine --- r_associated #0: 10 --> en:drug interaction
    n1=en:medicine | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  976. en:nauseating --- r_associated #0: 10 --> en:drug interaction
    n1=en:nauseating | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  977. en:noxious --- r_associated #0: 10 --> en:drug interaction
    n1=en:noxious | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  978. en:on the black market --- r_associated #0: 10 --> en:drug interaction
    n1=en:on the black market | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  979. en:peripheral neuropathy in cold agglutinin disease --- r_associated #0: 10 --> en:drug interaction
    n1=en:peripheral neuropathy in cold agglutinin disease | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  980. en:pharmacotherapy --- r_associated #0: 10 --> en:drug interaction
    n1=en:pharmacotherapy | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  981. en:pill --- r_associated #0: 10 --> en:drug interaction
    n1=en:pill | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  982. en:respiratory problems --- r_associated #0: 10 --> en:drug interaction
    n1=en:respiratory problems | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  983. en:right sacrum anterior position --- r_associated #0: 10 --> en:drug interaction
    n1=en:right sacrum anterior position | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  984. en:septic nature --- r_associated #0: 10 --> en:drug interaction
    n1=en:septic nature | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  985. en:septicity --- r_associated #0: 10 --> en:drug interaction
    n1=en:septicity | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  986. en:sickening --- r_associated #0: 10 --> en:drug interaction
    n1=en:sickening | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  987. en:tendonitis --- r_associated #0: 10 --> en:drug interaction
    n1=en:tendonitis | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  988. en:tenonitis --- r_associated #0: 10 --> en:drug interaction
    n1=en:tenonitis | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  989. en:tenontitis --- r_associated #0: 10 --> en:drug interaction
    n1=en:tenontitis | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  990. en:tenositis --- r_associated #0: 10 --> en:drug interaction
    n1=en:tenositis | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  991. en:unlawfully --- r_associated #0: 10 --> en:drug interaction
    n1=en:unlawfully | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  992. en:virous --- r_associated #0: 10 --> en:drug interaction
    n1=en:virous | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  993. estérification --- r_associated #0: 10 --> en:drug interaction
    n1=estérification | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  994. flushing --- r_associated #0: 10 --> en:drug interaction
    n1=flushing | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  995. fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique; --- r_associated #0: 10 --> en:drug interaction
    n1=fragilité osseuse avec craniosynostose, exophtalmie, hydrocéphalie et faciès caractéristique; | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  996. granulome éosinophile (ou éosinophilique) vulvaire --- r_associated #0: 10 --> en:drug interaction
    n1=granulome éosinophile (ou éosinophilique) vulvaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  997. hirsutisme --- r_associated #0: 10 --> en:drug interaction
    n1=hirsutisme | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  998. hors bilan --- r_associated #0: 10 --> en:drug interaction
    n1=hors bilan | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  999. hydrogénation --- r_associated #0: 10 --> en:drug interaction
    n1=hydrogénation | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1000. hydroxylation --- r_associated #0: 10 --> en:drug interaction
    n1=hydroxylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1001. hyperglycémie --- r_associated #0: 10 --> en:drug interaction
    n1=hyperglycémie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1002. hyperplasie --- r_associated #0: 10 --> en:drug interaction
    n1=hyperplasie | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1003. influence (idées, syndrome d') --- r_associated #0: 10 --> en:drug interaction
    n1=influence (idées, syndrome d') | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1004. interruption de courant --- r_associated #0: 10 --> en:drug interaction
    n1=interruption de courant | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1005. lameness --- r_associated #0: 10 --> en:drug interaction
    n1=lameness | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1006. lipoylation --- r_associated #0: 10 --> en:drug interaction
    n1=lipoylation | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1007. maladie fongique --- r_associated #0: 10 --> en:drug interaction
    n1=maladie fongique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1008. mort imminente (expérience de la) --- r_associated #0: 10 --> en:drug interaction
    n1=mort imminente (expérience de la) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1009. médicaments --- r_associated #0: 10 --> en:drug interaction
    n1=médicaments | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1010. métaphyses pommelées (syndrome des) --- r_associated #0: 10 --> en:drug interaction
    n1=métaphyses pommelées (syndrome des) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1011. neurotoxine --- r_associated #0: 10 --> en:drug interaction
    n1=neurotoxine | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1012. nitrosation --- r_associated #0: 10 --> en:drug interaction
    n1=nitrosation | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1013. oedémateux (syndrome) --- r_associated #0: 10 --> en:drug interaction
    n1=oedémateux (syndrome) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1014. protéolyse --- r_associated #0: 10 --> en:drug interaction
    n1=protéolyse | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1015. sarcoïde de Spiegler-Fendt (sarcoïde de ) --- r_associated #0: 10 --> en:drug interaction
    n1=sarcoïde de Spiegler-Fendt (sarcoïde de ) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1016. signes et symptômes respiratoires --- r_associated #0: 10 --> en:drug interaction
    n1=signes et symptômes respiratoires | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1017. souffrance néonatale --- r_associated #0: 10 --> en:drug interaction
    n1=souffrance néonatale | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1018. syndrome malin d'un neuroleptique --- r_associated #0: 10 --> en:drug interaction
    n1=syndrome malin d'un neuroleptique | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1019. syndrome malin de neuroleptiques --- r_associated #0: 10 --> en:drug interaction
    n1=syndrome malin de neuroleptiques | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1020. syndrome malin des neuroleptiques --- r_associated #0: 10 --> en:drug interaction
    n1=syndrome malin des neuroleptiques | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1021. taches blanches évanescentes (syndrome des) --- r_associated #0: 10 --> en:drug interaction
    n1=taches blanches évanescentes (syndrome des) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1022. test vih positif --- r_associated #0: 10 --> en:drug interaction
    n1=test vih positif | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1023. trop forte dose --- r_associated #0: 10 --> en:drug interaction
    n1=trop forte dose | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1024. tumeur --- r_associated #0: 10 --> en:drug interaction
    n1=tumeur | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1025. tumeur à cellules claires --- r_associated #0: 10 --> en:drug interaction
    n1=tumeur à cellules claires | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1026. tumeur à cellules claires de l'ovaire --- r_associated #0: 10 --> en:drug interaction
    n1=tumeur à cellules claires de l'ovaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1027. tête de linotte --- r_associated #0: 10 --> en:drug interaction
    n1=tête de linotte | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1028. ulcération --- r_associated #0: 10 --> en:drug interaction
    n1=ulcération | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1029. vaginite --- r_associated #0: 10 --> en:drug interaction
    n1=vaginite | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1030. voile (signe de la) --- r_associated #0: 10 --> en:drug interaction
    n1=voile (signe de la) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1031. Érythème --- r_associated #0: 10 --> en:drug interaction
    n1=Érythème | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1032. Étourdissements --- r_associated #0: 10 --> en:drug interaction
    n1=Étourdissements | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1033. énolase spécifique des neurones --- r_associated #0: 10 --> en:drug interaction
    n1=énolase spécifique des neurones | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1034. érysipélatoïde (dermite) --- r_associated #0: 10 --> en:drug interaction
    n1=érysipélatoïde (dermite) | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1035. état de choc --- r_associated #0: 10 --> en:drug interaction
    n1=état de choc | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1036. état de mort apparente du nouveau-né --- r_associated #0: 10 --> en:drug interaction
    n1=état de mort apparente du nouveau-né | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1037. état infectieux --- r_associated #0: 10 --> en:drug interaction
    n1=état infectieux | n2=en:drug interaction | rel=r_associated | relid=0 | w=10
  1038. choc hypokinétique --- r_associated #0: 6 --> en:drug interaction
    n1=choc hypokinétique | n2=en:drug interaction | rel=r_associated | relid=0 | w=6
  1039. Altération de l'état général --- r_associated #0: 5 --> en:drug interaction
    n1=Altération de l'état général | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1040. Baclesse (ulcération de) --- r_associated #0: 5 --> en:drug interaction
    n1=Baclesse (ulcération de) | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1041. Coupure de courant --- r_associated #0: 5 --> en:drug interaction
    n1=Coupure de courant | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1042. Effets indésirables --- r_associated #0: 5 --> en:drug interaction
    n1=Effets indésirables | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1043. Hématurie --- r_associated #0: 5 --> en:drug interaction
    n1=Hématurie | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1044. Mauvaise haleine --- r_associated #0: 5 --> en:drug interaction
    n1=Mauvaise haleine | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1045. Panne de courant --- r_associated #0: 5 --> en:drug interaction
    n1=Panne de courant | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1046. Principe actif --- r_associated #0: 5 --> en:drug interaction
    n1=Principe actif | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1047. Sensation de rotation --- r_associated #0: 5 --> en:drug interaction
    n1=Sensation de rotation | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1048. Syndrome d'Immunodéficience Acquise --- r_associated #0: 5 --> en:drug interaction
    n1=Syndrome d'Immunodéficience Acquise | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1049. Tenckhoff (cathéter de) --- r_associated #0: 5 --> en:drug interaction
    n1=Tenckhoff (cathéter de) | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1050. Tuméfaction --- r_associated #0: 5 --> en:drug interaction
    n1=Tuméfaction | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1051. Virchow et Welcker (angle sphénoïdal de) --- r_associated #0: 5 --> en:drug interaction
    n1=Virchow et Welcker (angle sphénoïdal de) | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1052. agglutinines irrégulières --- r_associated #0: 5 --> en:drug interaction
    n1=agglutinines irrégulières | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1053. agglutinogène --- r_associated #0: 5 --> en:drug interaction
    n1=agglutinogène | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1054. agitation postopératoire --- r_associated #0: 5 --> en:drug interaction
    n1=agitation postopératoire | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1055. aglossie et adactylie --- r_associated #0: 5 --> en:drug interaction
    n1=aglossie et adactylie | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1056. aglycone --- r_associated #0: 5 --> en:drug interaction
    n1=aglycone | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1057. agnosie chromatique --- r_associated #0: 5 --> en:drug interaction
    n1=agnosie chromatique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1058. agnosie d'extensité --- r_associated #0: 5 --> en:drug interaction
    n1=agnosie d'extensité | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1059. agnosie d'intensité --- r_associated #0: 5 --> en:drug interaction
    n1=agnosie d'intensité | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1060. agnosie des couleurs --- r_associated #0: 5 --> en:drug interaction
    n1=agnosie des couleurs | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1061. amination --- r_associated #0: 5 --> en:drug interaction
    n1=amination | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1062. ascites --- r_associated #0: 5 --> en:drug interaction
    n1=ascites | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1063. candidiasis --- r_associated #0: 5 --> en:drug interaction
    n1=candidiasis | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1064. candidose --- r_associated #0: 5 --> en:drug interaction
    n1=candidose | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1065. choc affectif --- r_associated #0: 5 --> en:drug interaction
    n1=choc affectif | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1066. choc allergique --- r_associated #0: 5 --> en:drug interaction
    n1=choc allergique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1067. choc amphétaminique --- r_associated #0: 5 --> en:drug interaction
    n1=choc amphétaminique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1068. choc anaphylactique --- r_associated #0: 5 --> en:drug interaction
    n1=choc anaphylactique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1069. choc anaphylactoïde --- r_associated #0: 5 --> en:drug interaction
    n1=choc anaphylactoïde | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1070. choc apexien --- r_associated #0: 5 --> en:drug interaction
    n1=choc apexien | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1071. choc bactériémique --- r_associated #0: 5 --> en:drug interaction
    n1=choc bactériémique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1072. choc colloïdoclasique --- r_associated #0: 5 --> en:drug interaction
    n1=choc colloïdoclasique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1073. choc compensé --- r_associated #0: 5 --> en:drug interaction
    n1=choc compensé | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1074. choc de combat --- r_associated #0: 5 --> en:drug interaction
    n1=choc de combat | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1075. choc de levée de garrot --- r_associated #0: 5 --> en:drug interaction
    n1=choc de levée de garrot | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1076. choc décompensé --- r_associated #0: 5 --> en:drug interaction
    n1=choc décompensé | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1077. choc en dôme --- r_associated #0: 5 --> en:drug interaction
    n1=choc en dôme | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1078. choc endocavitaire --- r_associated #0: 5 --> en:drug interaction
    n1=choc endocavitaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1079. choc foetal --- r_associated #0: 5 --> en:drug interaction
    n1=choc foetal | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1080. choc froid --- r_associated #0: 5 --> en:drug interaction
    n1=choc froid | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1081. choc hyperkinétique --- r_associated #0: 5 --> en:drug interaction
    n1=choc hyperkinétique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1082. choc hémorragique --- r_associated #0: 5 --> en:drug interaction
    n1=choc hémorragique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1083. choc non précisé --- r_associated #0: 5 --> en:drug interaction
    n1=choc non précisé | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1084. choc électrique --- r_associated #0: 5 --> en:drug interaction
    n1=choc électrique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1085. choc émotionnel --- r_associated #0: 5 --> en:drug interaction
    n1=choc émotionnel | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1086. démence alcoolique --- r_associated #0: 5 --> en:drug interaction
    n1=démence alcoolique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1087. démence aluminique --- r_associated #0: 5 --> en:drug interaction
    n1=démence aluminique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1088. démence sous-corticale --- r_associated #0: 5 --> en:drug interaction
    n1=démence sous-corticale | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1089. démence sénile de type Alzheimer --- r_associated #0: 5 --> en:drug interaction
    n1=démence sénile de type Alzheimer | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1090. démence sénile mixte --- r_associated #0: 5 --> en:drug interaction
    n1=démence sénile mixte | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1091. démence traumatique --- r_associated #0: 5 --> en:drug interaction
    n1=démence traumatique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1092. démence vasculaire --- r_associated #0: 5 --> en:drug interaction
    n1=démence vasculaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1093. démence vésanique --- r_associated #0: 5 --> en:drug interaction
    n1=démence vésanique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1094. démence à corps de Lewy --- r_associated #0: 5 --> en:drug interaction
    n1=démence à corps de Lewy | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1095. démences et prions --- r_associated #0: 5 --> en:drug interaction
    n1=démences et prions | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1096. effet Hamburger --- r_associated #0: 5 --> en:drug interaction
    n1=effet Hamburger | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1097. effet indésirable d'un dispositif médical --- r_associated #0: 5 --> en:drug interaction
    n1=effet indésirable d'un dispositif médical | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1098. en:Neuroleptic malignant syndrome --- r_associated #0: 5 --> en:drug interaction
    n1=en:Neuroleptic malignant syndrome | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1099. en:contra-indication --- r_associated #0: 5 --> en:drug interaction
    n1=en:contra-indication | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1100. en:counterindication --- r_associated #0: 5 --> en:drug interaction
    n1=en:counterindication | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1101. en:potentialization --- r_associated #0: 5 --> en:drug interaction
    n1=en:potentialization | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1102. halistérique (fonte) --- r_associated #0: 5 --> en:drug interaction
    n1=halistérique (fonte) | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1103. incontinence anale --- r_associated #0: 5 --> en:drug interaction
    n1=incontinence anale | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1104. incontinence du cardia --- r_associated #0: 5 --> en:drug interaction
    n1=incontinence du cardia | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1105. incontinence isthmique --- r_associated #0: 5 --> en:drug interaction
    n1=incontinence isthmique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1106. incontinence pigmentaire --- r_associated #0: 5 --> en:drug interaction
    n1=incontinence pigmentaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1107. incontinence postmictionnelle --- r_associated #0: 5 --> en:drug interaction
    n1=incontinence postmictionnelle | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1108. infarctus du myocarde (indice de gravité de l') --- r_associated #0: 5 --> en:drug interaction
    n1=infarctus du myocarde (indice de gravité de l') | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1109. intention de traitement (analyse en) --- r_associated #0: 5 --> en:drug interaction
    n1=intention de traitement (analyse en) | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1110. malf ormation dysraphique --- r_associated #0: 5 --> en:drug interaction
    n1=malf ormation dysraphique | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1111. malformation kystique adénomatoïde du poumon --- r_associated #0: 5 --> en:drug interaction
    n1=malformation kystique adénomatoïde du poumon | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1112. malformation luxante de la hanche --- r_associated #0: 5 --> en:drug interaction
    n1=malformation luxante de la hanche | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1113. malformation mamelonnaire --- r_associated #0: 5 --> en:drug interaction
    n1=malformation mamelonnaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1114. malformation mammaire --- r_associated #0: 5 --> en:drug interaction
    n1=malformation mammaire | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1115. malformation ombilicale --- r_associated #0: 5 --> en:drug interaction
    n1=malformation ombilicale | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1116. malformation utérine --- r_associated #0: 5 --> en:drug interaction
    n1=malformation utérine | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1117. malformation vaginale --- r_associated #0: 5 --> en:drug interaction
    n1=malformation vaginale | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1118. malformation vasculaire cérébrale du nourrisson --- r_associated #0: 5 --> en:drug interaction
    n1=malformation vasculaire cérébrale du nourrisson | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1119. malformations de la charnière occipitocervicale --- r_associated #0: 5 --> en:drug interaction
    n1=malformations de la charnière occipitocervicale | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1120. souffle (lésions du) --- r_associated #0: 5 --> en:drug interaction
    n1=souffle (lésions du) | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1121. syndrome de choc --- r_associated #0: 5 --> en:drug interaction
    n1=syndrome de choc | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1122. sérologie vih positive --- r_associated #0: 5 --> en:drug interaction
    n1=sérologie vih positive | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1123. séropositif pour le vih --- r_associated #0: 5 --> en:drug interaction
    n1=séropositif pour le vih | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1124. séropositivité au vih --- r_associated #0: 5 --> en:drug interaction
    n1=séropositivité au vih | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1125. séropositivité vih --- r_associated #0: 5 --> en:drug interaction
    n1=séropositivité vih | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1126. test positif pour vih --- r_associated #0: 5 --> en:drug interaction
    n1=test positif pour vih | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1127. vih positif --- r_associated #0: 5 --> en:drug interaction
    n1=vih positif | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1128. Événement indésirable du syndrome de lyse tumorale --- r_associated #0: 5 --> en:drug interaction
    n1=Événement indésirable du syndrome de lyse tumorale | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1129. épithélioma --- r_associated #0: 5 --> en:drug interaction
    n1=épithélioma | n2=en:drug interaction | rel=r_associated | relid=0 | w=5
  1130. infection
    (puanteur)
     --- r_associated #0: -46 --> en:drug interaction
    n1=infection
    (puanteur)
    | n2=en:drug interaction | rel=r_associated | relid=0 | w=-46
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr